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T O  H Y  H U S B A N D
ABSTRACT
Studies were carried out on the developmental p ro f i le  of PB- 
cytochrome P-450 and cytochrome P-448-dependent mixed-function oxidase 
a c t iv i t ie s  in the foe ta l and neonatal ra t .  PB-Cytochrome P-450 
a c t iv i t y ,  as examplified by benzphetamine N-demethylase was low at b i r th  
but increased with age. In contrast, cytochrome P-448 a c t iv i t y ,  as 
exemplified by ethoxyresorufin O-deethylase (EROD) and biphenyl
2 -hydroxylase, was higher in the neonate, reaching maximum levels at 
about two weeks postpartum and decreased with age. Cytochrome P-448 
in d u c ib i l i t y  by 3-methylcholanthrene was low at b i r th  and increased with 
age.
Investigations were also carried out on the induction of cytochrome 
P-448, as measured by the 0-deethylation of ethoxyresorufin, by 
carcinogens and several other xenobiotics in hepatic and extrahepatic 
tissues of the adult male ra t .  EROD a c t iv i t y  was highest in the l iv e r ,  
followed by the kidney >  lung, in the untreated animal; a c t iv i t y  was 
not detectable in the heart and the bra in. Treatment with carcinogens 
enhanced EROD a c t iv i t y  most markedly in the l iv e r  and to a smaller 
extent, in the kidney and lung. In add it ion , induction of EROD a c t iv i t y  
was achieved with very low doses of the inducing agent. A s ingle 
in traperitonea l dose of 50 yg/kg of benzo(a)pyrene increased hepatic 
EROD a c t iv i t y  by 2 - fo ld . A c t iv i t y  was also s ig n i f ic a n t ly  enhanced by 
single in traperitonea l doses of 0.5 mg/kg of 2-acetamidofluorene or 
sa fro le . Maximum induction was achieved at dose levels of 2-5 mg/kg, 
with peak a c t iv i t y  occurring 24 hours a fte r  dosing.
In addition, the O-dealkylations of a series of a lkoxyresorufins 
(1C to 8C) and the debenzylation of benzyloxyresorufin were induced by
3-MC only in the responsive C57BL/6 mice but not in the non-responsive 
DBA/2 mice, ind ica ting  that these a c t iv i t ie s  are associated with the Ah 
locus.
The present study showed that carcinogens induced the 
0 -dealky la tion of the short-chain alkoxyresorufins (methoxy- to butoxy-) 
to a greater extent than did the long-chain deriva tives. In addition , 
heptoxyresorufin dealkylation was most markedly enhanced by DDT while 
benzyloxyresorufin debenzyl ation was induced to s im ila r  extents by 
carcinogens and non-carcinogens.
Although cimetidine has been shown to be an in h ib i to r  of hepatic 
drug metabolism by binding to cytochrome P-450 through i t s  imidazole 
r ing s truc tu re , the present study demonstrated that ne ither cimetid ine 
nor i t s  n itrosated de riva t ive , n itrosocimetid ine exhib ited any 
s ig n if ic a n t  in h ib i t io n  towards cytochrome P-448 a c t iv i t y  in the ra t ,  as 
measured by the EROD assay, even when administered at f iv e  times the oral 
therapeutic dose in man.
Results of the present study ind icate that the induction of 
cytochrome P-448 is  associated with chemical to x ic i ty /c a rc in o g e n ic ity .  
In addition, the O-deethylation of ethoxyresorufin is a very sens it ive  
and h ighly spe c if ic  marker fo r  cytochrome P-448 a c t iv i t y .
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CHAPTER 1: 
GENERAL INTRODUCTION
The cytochrome P-450-dependent mixed-function oxidase (MFO) system 
has several unique cha rac te r is t ics . I t  is present ub iqu itous ly  in 
almost every b io log ica l system, is capable of metabolizing a vast range 
of s t ru c tu ra l ly  diverse substrates, both endogenous and exogenous, and 
is markedly induced a fte r  exposure to xenobiotics. The broad substrate 
s p e c i f ic i ty  of the MFO system is due to the existence of m u lt ip le  forms 
of the enzyme, each exh ib it ing  d i f fe re n t  but often overlapping 
substrate s p e c i f ic i t ie s  (Lu & West, 1980).
Two major roles fo r  the cytochrome P-450-dependent MFO system have 
been suggested, that of biosynthesis and metabolic deactivation of 
endogenous substrates such as cho lestero l, s tero id hormones, 
prostaglandins and polyunsaturated fa t t y  acids (E l l in  et a l . ,  1973; 
C in t i et a l . ,  1976; Parke, 1981; Haurand & U l l r ic h ,  1985), and that of 
detoxication of xenobiotics by converting l ip o p h i l ic  compounds to polar 
derivatives (Phase I metabolism) which subsequently undergo conjugation 
with endogenous substrates (Phase I I  metabolism) to form harmless, 
water-soluble and re ad ily  excretable compounds. However, recent 
studies have revealed that certa in isozymes of the MFO system, namely 
the cytochromes P-448, almost inva riab ly  catalyze reactions which lead 
to the formation of reactive intermediates from otherwise in e rt  
chemicals (Parke & Ioannides, 1982). These reactive species, i f  not 
deactivated by conjugation with g lu tath ione, would in te rac t with v i ta l  
c e l lu la r  constituents leading to to x ic i t y ,  carc inogenic ity  or c e l l  
death. Even more in tr ig u in g  is the fac t that both the ac tiva tion  and 
detoxication pathways occur simultaneously, and the balance between 
these pathways may determine the net to x ic i t y  p ro f i le  of the chemical 
concerned.
Cytochrome P-450 gene fa m ilie s
To date at least fou r, and possibly s ix ,  d is t in c t  gene fam ilies  
have been id e n t i f ie d  (Nebert & Gonzalez, 1985), of which the two most 
extensively studied groups are the phenobarbital (PB)-inducible and 
po lycyc lic  aromatic hydrocarbon (PAH)-inducible fam il ie s . In the 
present thesis, the PB-inducible forms w i l l  be referred to as "PB- 
cytochromes P-450" (cytochromes P-450b and P-450e of the ra t ,  form 2 of 
the ra bb it)  and the PAH-inducible forms w i l l  be referred to as 
"cytochromes P-448" (cytochromes P-450c and P-450d of the r a t ) .  The 
term "cytochrome P-450" w i l l  be used to re fe r to the enzyme system in 
general. I t  has now been established that ra t cytochromes P-450c and 
P-450d correspond to forms 6 and 4 of the rabb it and cytochromes P i-450 
and P3-450 of the mouse, respective ly (Kimura et a^.,  1984a; Thomas et 
a l . ,  1984).
Isozymes of cytochrome P-450 are the products of d is t in c t  
s truc tu ra l genes, or a l le l i c  forms of a gene, synthesized as the 
complete, mature polypeptide and do not arise from p o s t- tra ns la t io na l 
modifications (Bresnick et a l . ,  1981; Hardwick et a l . ,  1983; Gozukara 
et a l . ,  1984). However, cytochrome P-448 proteins may be synthesized 
as precursor forms which then undergo pos t- trans la t iona l modifications 
such as peptide cleavage and g lycosyla tion (Kumar and Padmanaban, 1980;
Mechanism o f induction o f cytochromes P-448 and PB-cytochromes P-450
In v i t r o  nuclear tra n sc r ip t io n  studies in the in ta c t  mouse 
(Gonzalez et a l . ,  1984) and ra t (Foldes et a l . ,  1985), and in mouse 
hepatoma ce l l  cultures ( Is ra e l i  & Whitlock, 1984) have conclusively 
shown that induction of cytochrome P-448 proteins is mediated 
p r in c ip a l ly  by an increase in genomal t ra nsc r ip t iona l ra tes, with 
subsequent accummulation of cy toso lic  mRNAs encoding the corresponding 
isozymes. Furthermore, i t  has been shown that the induction of 
cytochrome P-448 involves a cy toso lic  receptor termed the Ah receptor, 
which upon binding to an inducing agent, undergoes a temperature- 
dependent trans location in to the nucleus where the inducer-receptor 
complex in teracts  with spec if ic  regions of the cytochrome P-448 gene 
and by as yet unknown mechanisms, leads to enhanced mRNA synthesis 
(Fig. 1.1) (Nebert & Gonzalez, 1985). The Ah receptor is a major 
product of the Ah locus which comprises a c lus te r of s t ru c tu ra l ,  
regulatory and possibly temporal genes regulating the induction of 
several drug-metabolizing enzymes, including the enzyme which 
metabolises PAH compounds, namely aryl hydrocarbon hydroxylase, or AHH 
(Nebert, 1985). The presence of th is  receptor appears to be necessary 
fo r  the induction process. For example, inbred mice in which AHH 
a c t iv i t y  is inducible by PAH treatment (termed "responsive") as 
exemplified by the C57BL s tra in ,  have at least 50 times more receptors 
in 'the ir hepatic cytosol than do the non-responsive s tra ins such as 
the DBA mice (Okey et a l . ,  1979). However in the presence of the 
more potent inducer 2,3,7, 8 -te trach lorodibenzo-p-d ioxin (TCDD), AHH 
induction occurs with normal k ine tics  even in non-responsive mice, 
although the dose of TCDD is much
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higher than that required fo r  responsive mice, ind ica ting that the 
"receptor defect" in D2 mice can be overcome by s u f f ic ie n t ly  large 
doses of TCDD (Poland & Glover, 1976). An excellent dose-response 
re la tionsh ip  exists between the appearance of the TCDD-receptor complex 
in the nucleus and the induction of cytochrome Pj-450 mRNA in both 
responsive and non-responsive mice (Tukey et a l . ,  1982). Furthermore, 
variant mouse hepatoma ce lls  in which the inducer-receptor complex 
binds weakly to the nucleus do not transcribe the cytochrome Pi-450 
gene ( Is ra e l i  & Whitlock, 1984) ind ica ting  that the inducer-receptor 
complex may act as a pos it ive  ac tiva to r of transcr ip t ion  (Israel-i et 
a l . ,  1985; Jones et a l . ,  1985).
S im ila r ly ,  i t  has been demonstrated that the administration of PB 
enhances the de novo synthesis of PB-cytochromes P-450 by increasing 
the rate of tra nsc r ip t ion  of the respective gene (Hardwick et a l . ,  
1983; Pike et a l . ,  1985). However, no receptor has been implicated in 
the PB-mediated induction process and the mechanism by which PB 
enhances genomal tra n sc r ip t io n a l rates remains to be elucidated.
Regulatory control of cytochromes P-448 and PB-cytochromes P-450
Studies in the ra t have shown that cytochrome P-450c and P-450d are 
co-induced by a number of xenobiotics but they are not under coordinate 
regulatory control in that the levels of these two haemoproteins are 
increased to d if fe re n t  re la t ive  extents by the various inducing agents
(Vlasuk et a l . ,  1982; Parkinson et al_., 1983; Thomas et a l . ,  1983).
Thus, safro le and 3 ,4 , 5 , 3 ' , 4 ' , 5 ' -hexachlorobiphenyl induce cytochrome 
P-450d to a greater degree than cytochrome P-450c; 3-methylcholanthrene 
(3-MC) and 3 -naphthoflavone p re fe re n t ia l ly  induce cytochrome P-450c
re la t iv e  to cytochrome P-450d, while Aroclor-1254 induces both 
haemoproteins to s im ila r extents (Vlasuk et a l . ,  1982, Thomas et a l . ,
1983). The mRNAs encoding cytochromes P-450c and P-450d e xh ib it  
d i f fe re n t  induction k ine tics  and d i f fe re n t  s ta b i l i t ie s ,  confirming that 
they are not under coordinate control (Fagan et a l . ,  1986). In 
addition when 3-MC-induced adult ra t hepatocytes were placed in to 
monolayer cu ltu re , the concentration of cytochrome P-450d ra p id ly  
declined while that of cytochrome P-450c remained re la t iv e ly  constant 
(Stewart et a l . ,  1985).
In contrast, the PB-inducible cytochromes P-450b and P-450e are 
co-ord inate ly regulated, the levels of cytochrome P-450b being always 
higher than that of cytochrome P-450e. (Vlasuk et a l . ,  1982; P ickett 
et a l . ,  1983) Furthermore, i t  has been suggested that the d iffe rence 
in the levels of cytochromes P-450b and P-450e during induction is 
gene t ic a l l y determined (Suwa et a l . ,  1985).
Developmental expression and regula tion of cytochromes P-448 
and PB-cytochromes P-450
Accumulated evidence has shown that cytochrome P-448 a c t iv i t y  is 
detectable .very early during gestation in the rodent foetus. For 
instance, Pedersen and coworkers (1985) showed that benzo(a)pyrene was 
activated to reactive intermediates which increased s is te r  chromatid 
exchanges in tissues from 7-and 8-day-old mouse embryos. Moreover, 
studies using foe ta l and neonatal ra t hepatocytes in cu ltu re  indicated 
that whereas foe ta l l iv e r  AHH was inh ib ited  by a-naphthoflavone and was 
insensit ive  to metyrapone, AHH a c t iv i t y  during the perina ta l period
became progressively inh ib ited  by metyrapone (Kremers & Gielen,1983). 
Hence, AHH a c t iv i t y  in ra t l iv e r  seemed to be supported by cytochrome 
P-448 u n t i l  b ir th  and the rea fte r by a PB-cytochrome P-450. In 
addition, cytochrome P-448-mediated a c t iv i t y  as exemplified by biphenyl
2-hydroxylase is highest in foe ta l l iv e r  and decreases with age (Basu 
et a l . ,  1971). In contrast PB-cytochrome P-450 a c t iv i t y  as exemplified 
by benzphetamine N-demethylase tends to be low at b ir th  and increases 
ra p id ly  postna ta lly  (Basu et a l . ,  1971). Furthermore, studies have 
shown that there was no detectable PB-cytochrome P-450-dependent 
a c t iv i t y  e ithe r in 9-day-old ra t embryos (Fantel et a 1. ,  1979) or in 
cultured ra t yolk sac ce l ls  (Allen et a l . ,  1981).
When the response to inducer treatment was studied in re la t io n  to 
age, there were again differences between the cytochromes P-448 and 
PB-cytochromes P-450. Thus, exposure to benzo(a)pyrene led to an 
increase in the metabolic ac tiva tion  of the compound in mouse embryonic 
tissues from the Ah responsive s tra ins ( F i l le r  & Lew, 1981; Pedersen et 
a l . ,  1985) and administration of 3-MC to pregnant responsive mice 
induced the synthesis of cytochrome P-448 mRNAs in the foe ta l l iv e r  
which was detectable by Western b lo t analysis as early  as day 15 of 
gestation (Ikeda et a l . ,  1983), with a concomitant increase in AHH and 
acetan ilide 4-hydroxylase a c t iv i t ie s  (Tuteja et . a l . ,  1985). In
contrast, administration of PB to the mother fa i le d  to induce 
PB-cytochrome P-450-dependent a c t iv i t y  in late foetuses (Guenthner & 
Mannering , 1977; C reste il et a l . ,  1979; Popova et a l . ,  1985), even 
though cytoso lic  mRNAs coding fo r  cytochromes P-450b and P-450e were 
detectable immunochemical ly  at, but not p r io r  to, day 22 of gestation 
(G iache lli & Omiecinski, 1986). Thus the fa i lu re  of PB to
induce MFO a c t iv i t ie s  in late foetuses cannot be due to lack of mRNA
accummulation but may instead be a ttr ibu ted  to regulation of the mRNA
tra ns la t io na l process in near-term foetuses. The fa i lu re  to detect any 
mRNAs encoding cytochromes P-450b and P-450e p r io r  to day 22 of 
gestation suggests the presence of endogenous in h ib i to ry  factors 
(Guenthner & Mannering, 1977), which may be removed or suppressed by 
the end of the normal gestational period rather than by p a r tu r i t io n  
(Schubert & Netter, 1981).
Another aspect of the development of cytochrome P-450 is that of 
temporal regulation and tissue s p e c i f ic i t y  of gene expression. Thus, 
AHH, which is associated with murine cytochrome P j-450, responds to 
3-MC induction e a r l ie r  during the gestation period than does 
acetan ilide 4-hydroxylase a c t iv i t y  which is p re fe re n t ia l ly  catalyzed by 
cytochrome P3-450 in a l l  three species studied, that is the mouse
(Guenthner & Nebert, 1978; Ikeda et a l . ,  1983; Tuteja et a l . ,  1985), 
ra t (Guenthner & Nebert, 1978) and rabb it (Atlas et a1♦, 1977).
Moreover, cytochrome P3-450 expression is more sensitive than that of 
cytochrome P1-450 in that the former is induced by lower doses of 3-MC 
(Tuteja et a l . ,  1985). In addition , whereas both cytochromes Pi-450 
and P3-450 are induced in the l iv e r ,  only cytochrome Px-450 but not
cytochrome P3-450 is induced in extrahepatic tissues most probably
because of the high basal levels of cytochrome P3-450 in the tissues
(Tuteja et a l . ,  1985). In contrast to the temporal regula tion of the
cytochromes P-448, the PB-inducible cytochromes P-450b and P-450e mRNAs 
are coordinately regulated throughout development with the level of 
cytochrome P-450b mRNA being constantly higher than that of cytochrome 
P-450e mRNA (G iachelli & Omiecinski, 1986).
In the rabb it ,  form 4 is undetectable in the neonatal l iv e r  but
becomes the predominant isozyme in the adult l iv e r ,  cons titu t ing  about
4056 of to ta l cytochrome P-450 protein (Chiang et al_., 1983). In
addition, TCDD induces form 4 as the major haemoprotein in adult rabb it 
l iv e r  whereas form 6 is the predominant form induced in neonates a fte r 
transplacental administration of TCDD (Norman et a l . ,  1978) ind ica ting  
an age-dependent control of gene expression. Unlike TCDD, PB induces 
the same major haemoprotein, namely form 2 , in both adult and neonatal 
rabbits (Schwab et a l . ,  1980).
Tissues and species differences in the d is t r ib u t io n  of cytochrome 
P-450 isozymes
I t  is now well-established that the d is t r ib u t io n  of the m u lt ip le  
forms of cytochrome P-450 may vary in d i f fe re n t  tissues as well as 
d i f fe re n t  species and s tra in  of animals (Lu & West, 1980). Using 
ethoxyresorufin O-deethylase (EROD) a c t iv i t y  as a probe, i t  has been 
shown that cytochrome P-448 a c t iv i t y  is lower in lung and kidney 
microsomes than in l iv e r  microsomes of untreated rats (Ioannides et 
a l . ,  1984, Iwasaki et a l . ,  1986).
In contrast, cytochrome P-450b, but not cytochrome P-450e, 
as well as other cytochrome P-450 polypeptides, are found in the lungs
of male and female rats (Rampersaud & Walz, Or., 1986). Likewise,
using immunofluorescent techniques, form 2 was detected in the lung and 
kidney microsomes of rabb its , but forms 4 and 6 were not, while in 
contrast, a l l  three forms are found in the l iv e r  (Dees et a l . ,  1982).
The response to inducing agents also exh ib its  t issue - and 
species-specific d iffe rences. Thus, while TCDD induces both 
cytochromes P-450c and P-450d in the ra t l i v e r ,  i t  induces only 
cytochrome P-450c, but not cytochrome P-450d, in extrahepatic tissues 
(Goldstein & Linko, 1984). In the ra bb it ,  TCDD treatment induces both 
forms 4 and 6 in the l iv e r ,  lung and kidney (Dees et a l . ,  1982). In 
contrast, PB induces form 2 in the rabb it l iv e r  and kidney but not in 
the lung (Wolf et a l . ,  1978, Dees et a l . ,  1982).
In the hamster, 3-MC induces AHH a c t iv i t y  in the lung, while 
a c t iv i t y  in the l iv e r  remains unaffected (Chiang & Steggles, 1983), 
which may p a r t ly  explain why the hamster is susceptible to tumours of 
the resp ira to ry  t ra c t  (Henry et a l . ,  1973).
More recently , two co n s t i tu t ive  forms of cytochrome P-450 have been 
isolated from rabb it in te s t in a l mucosa; one form was an tigen ica l ly  
d is t in c t  from l iv e r  form 2 on the basis of i ts  molecular weight, 
spectral properties, c a ta ly t ic  a c t iv i t ie s  and immunological 
charac te r is t ics  (Ichihara et a l . ,  1985).
Sex differences in hepatic drug metabolism
Sex differences in hepatic drug metabolism are not observed in 
immature animals, and are expressed only on sexual maturation (Vlasuk 
& Walz, 1982; Maeda et a l . ,  1984). At the onset of puberty, 
sex-specific forms of cytochrome P-450 which have h ith e rto  remained low 
or undetectable, become markedly increased (Vlasuk & Walz, 1982; 
Bandiera e t a l . , 1986).
Several forms of sex-specific  isozymes have been isolated and 
characterized, each e xh ib it in g  high re g io s e le c t iv i ty  and 
s te re o sp e c if ic i ty  towards stero ids. Two male-specific forms, namely 
cytochromes P-450g and P-450h (Ryan et a l . ,  1984), the la t te r  being 
identica l to isozyme P-4502c (Waxman, 1984; Rampersaud et a l . ,  1987) 
constitu te  30% of to ta l  cytochrome P-450 in the adult male l iv e r  
(Waxman,1984; Matsumoto et a l . ,  1986). Cytochrome P-450h is the main 
isozyme catalyzing the male-specific  s teroid 16a-hydroxylase a c t iv i t y  
in untreated animals (Waxman, 1984). On the other hand, a 
female-specific  form cytochrome P-450i in adult female ra t l iv e r  
(Kamataki et a l . ,  1982; Ryan et a l . ,  1984; Matsumoto et a l . ,  1986), 
p re fe re n t ia l ly  catalyzes stero id 153-hydroxyl at ion (MacGeoch et a l . ,
1984). Peptide mapping and immunochemical analysis ind icate that the 
male- and female-specific  isozymes show marked s truc tu ra l homology in 
th e ir  NH2-terminal sequences (Haniu et a l . ,  1984; Waxman; 1984).
In inbred s tra ins of mice there are at least two forms of 
testosterone 16a-hydroxylase whose expressions are sexually 
d if fe re n t ia te d .  T -P -4 5 0 i6 a  is female-predominant, is PB-inducible 
and i ts  mRNAs shown high homology to those encoding fo r  ra t cytochromes
P-450b and P-450e (Noshiro et al_., 1986). ‘ C ' - P ^ O ^  is a
co n s t i tu t ive ,  male-predominant isozyme which is the major form 
catalyzing testosterone 16a-hydroxylation in microsomes of untreated 
male mice (Harada & Negishi, 1984a). A female predominant form of 
cytochrome P-450, spec if ic  fo r  testosterone 15a-hydroxylation,has been 
p u r if ie d  from the l iv e r  of the female mouse (Harada & Negishi 1984b) 
while in contrast, a cytochrome P-450 form which s p e c i f ic a l ly  
catalyzes steroid 153-hydroxylation was found in the female ra t l iv e r  
(MacGeoch et a l . ,  1984). In te re s t in g ly ,  certa in inbred s tra ins of mice
such as the BALB/cJ s tra in  do not exh ib it  sexual d ifferences in 
re la t ion  to stero id 15a-hydroxylase a c t iv i t y  (Neims et a l . ,  1984). 
More recently , i t  has been shown that the sex-dependent expression of 
these steroid hydroxylases is regulated at the pre trans la tiona l stage 
by growth hormones which repress ‘ I ' -P-450i5a-dependent a c t iv i ty "  and 
the fem ale-specific  15a-hydroxylation but increases male-specific 
'C '-P-450i6a-dependent a c t iv i t y  (Noshiro & Nebert, 1986).
Besides the sex-specific  differences in stero id hydroxylase 
a c t iv i t y ,  numerous studies have also established that both in v i t r o  and 
in v i t r o , the male ra t metabolizes a number of substrates fas te r  than 
the female (Kato & G i l le t te  1965). In studies where cytochrome P-450 
mRNAs were quantif ied by tra ns la t io n  and immunoprecipitation, mRNAs
coding fo r  cytochrome P-450b were higher in males than in females,
whereas mRNAs coding fo r  cytochrome P-450c were higher in females
(Gozukara _et al_., 1984). This is consistent with the f ind ing  that
female rats e xh ib it  higher a c t iv i t y  towards the cytochrome 
P-450c-mediated O-deethylation of ethoxyresorufin (Vodicnik et a 1. ,  
1981). This data indicates that the known sex differences in lung 
metabolism may be a ttr ibu ted  at least p a r t ly  to the d i f fe re n t
d is t r ib u t io n  of cytochrome P-450 isozymes between the two sexes.
Neonatal imprinting of hepatic drug metabolism
I t  has now been established that the development of sex differences in 
hepatic drug metabolism is determined (" im prin ted") by androgen during 
the neonatal period. Thus castra tion of male rats at b ir th  abolishes 
the synthesis of male-specific isozymes of cytochrome P-450 and
prevents the development of sex differences in drug metabolism at 
puberty (Finnen & Hassall, 1984; Kamataki et a l . ,  1984). Treatment 
with testoste rone, of rats castrated at b i r th ,  restores the synthesis 
of male-specific isozymes and the development of a ty p ic a l ly  masculine 
pattern of drug metabolism in adult l i f e  (Finnen & Hassall, 1984). 
However, castra tion  of male rats a fte r  adulthood had no e ffec t on the 
sexually d if fe re n t ia te d  drug metabolism pattern. On the other hand, 
administration of testosterone to neonatal female rats during the f i r s t  
two weeks a fte r  b ir th  had no e ffe c t on the female pattern of drug 
metabolism unless the animals were ovarectomized prepuberta lly , 
ind ica ting  the influence of the ovaries on the neonatal imprinting by 
testosterone (Finnen & Hassall, 1984). The an terio r p i tu i ta r y  gland 
may also be involved in the development of sexual differences in drug 
metabolism, most probably via the regulation of sex-specific  forms of 
cytochrome P-450 (Kamataki et a l . ,  1984).
In addition to the sex hormones, exposure to pharmacologically 
active compounds during the neonatal period also appears to program 
drug-metabolizing enzymes in adulthood. Neonatal administration of PB 
resu lts  in higher hepatic microsomal MFO a c t iv i t ie s  of the cytochrome 
P-448 type such as increased in v i t ro  binding of benzo(a) pyrene to 
c a l f  thymus DNA and in vivo a f la tox in  Bx binding to c e l lu la r  
macromolecules (Faris & Campbell, 1983; Bagley & Hayes, 1985a). There 
is a long la tent period (>100 days) between neonatal PB treatment and 
expression of the altered drug-metabolizing enzyme a c t iv i t ie s ,  
ind ica ting  that the mechanism of PB neonatal imprinting is net d i r e c t ly  
re lated to the c lass ica l PB induction process (Faris & Campbel1, 1983; 
Bagley & Hayes, 1985a). In contrast, neonatally
administered 3-MC did not a ffec t hepatic drug metabolizing a c t iv i t ie s  
under the same conditions (Bagley & Hayes, 1985b).
Role of g lucocortico ids in cytochrome P-450 regulation
The pattern of cytochrome P-450 expression is t issu e -sp e c if ic  as 
well as sex- and age-dependent (Kamataki et a 1. ,  1985, Bandiera et a l . 
1986; Iwasaki et a l . ,  1986), ind ica ting  that factors other than 
exogenous inducers determine cytochrome P-450 gene expression. One of 
these factors appears to be the presence of steroid hormones. Recent 
f ind ings ind icate tha t the postnatal development of the cytochrome 
P-450-dependent MFO is dependent on g lucocortico ids. Thus, 
administration of dexamethasone to neonatal rats precociously 
stimulated the rate of development of hepatic cytochrome P-450 (Leakey 
& Fouts, 1979) while adrenalectomy inh ib ited  the cytochrome P-450 
developmental process (Leakey & Fouts, 1979) and prevented the 
induction of cytochrome P-448 and UDP-glucuronyltransferase a c t iv i t y  by 
3-MC (Wishart & Dutton, 1977). Glucucorticoids have also been found to 
potentiate the PAH-mediated induction of AHH and 7-ethoxycoumarin 
O-deethylase in human and ra t foe ta l hepatocytes maintained in primary 
monolayer cu ltu re (Mathis et a 1. ,  1986a, 1986b). The increase in 
monooxygenase a c t iv i t ie s  was accompanied by increased accumulation of 
mRNAs encoding cytochrome P-450c and increased de novo synthesis of the 
corresponding protein (Mathis et a l . ,  1986b). Dexamethasone-mediated 
induction of AHH in cultured ra t c e l l  systems has been reported 
previously (Kremers et a l . ,  1983; Edwards et a l . ,  1984) while Kremers & 
Gielen (1983) observed that the presence of dexamethasone produced a 
change from a cytochrome P-448 to a PB-cytochrome P-450-supported AHH
a c t iv i t y  in ra t foe ta l hepatocytes. S ig n i f ic a n t ly ,  the rodent adrenal 
begins to produce cortiscosterone ju s t  p r io r  to p a r tu r i t io n  (Graham 
et a l . ,  1979) which coincides with the time beyond which induction of
MFO a c t iv i t ie s  by xenobiotics is e ffe c t ive  (Creste il et a h ,  1982).
Furthermore, the human foe ta l l iv e r  exh ib its  appreciable monooxygenase 
a c t iv i t y  early  in i ts  gestational development and the human foe ta l 
adrenal produces glucocorticoids during th is  stage (Pelkonen et a l . ,  
1971; Pelkonen,1973).
I t  therefore appears that in ra t l i v e r ,  g lucocortico ids play an 
important ro le  in the ontogenic development of the cytochrome 
P-450-dependent MFO system, probably v ia the binding of the 
g lucoco rt ico id -c lass ica l Type I I  receptor complex to a regula tory 
region of the cytochrome P-450 gene (Mathis et a l . ,  1986b).
Comparison between cytochromes P-448 and PB-cytochromes P-450
The cytochromes P-448 and PB-cytochromes P-450 belong to d is t in c t  
gene fam il ie s . Furthermore, whereas cytochromes P-448 catalyze the 
formation of reactive intermediates, PB-cytochromes P-450 generally 
d ire c t metabolism towards detoxication (Parke & Ioannides, 1982). 
Nevertheless, studies on th e ir  cDNA nucleotide and amino acid sequences 
have shown that these two fam ilies evolved from a common ancestor more 
than 200 m il l io n  years ago (Sogawa et a l . ,  1984). Comparison between 
the cytochromes P-448 and PB-cytochromes P-450 reveals some common 
cha rac te ris t ics  as well as d ifferences.
S im ila r i t ie s  - Both fam ilies of cytochromes P-450 occur at very low
levels in l ive rs  of untreated animals and increase markedly a fte r 
treatment with the appropriate inducing agents. For instance, 
cytochromes P-450c and P-450d, which constitu te  less than 5% of to ta l
haemoprotein in the untreated ra t l i v e r ,  are enhanced by as much as 70- 
to 80-fold in the induced animal (Thomas et a l . ,  1983; Scholte et a l . ,
1985). Inducers of both of these fam ilies  also induce a minor form of 
the haemoprotein, namely cytochrome P-450a, which exh ib its  high 
re g io s e le c t iv i ty  in the la-hydroxyl at ion of androstenedione, 
progesterone and testosterone (Wood et a l . ,  1983). Cytochrome P-450a 
is a male-specific  isozyme and is induced by PB and 3-MC only in 
females and immature animals but not in adult males (Vlasuk & Walz, 
1982, Matsumoto et a l . 1986).
Treatment with PB or 3-MC has been shown to induce the de novo 
synthesis of a number of d is t in c t  cytochrome P-450 prote ins. PB 
induces cytochrome P~450pcn» a unique form induced by pregnenolone 
16a-carbon itr i le  (PCN) (Heuman et a l . ,  1981) and another form termed
PB-1 which is present in uninduced ra t l iv e r  microsomes (Waxman &
Walsh,1983). S im ila r ly ,  B-naphthoflavone-treated ra t l iv e r  microsomes 
contain f iv e  an tigen ica lly  d is t in c t  forms of cytochrome P-450 each 
exh ib it ing  d i f fe re n t  c a ta ly t ic  a c t iv i t ie s  towards several substrates 
(Lau & Strobel, 1982), of which the two major forms are cytochromes
P-450c and P-450d (Thomas et a l . ,  1983). More recen tly , four 
cytochrome P-450 proteins were p u r i f ie d  and characterized from 
3-MC-induced ra t l iv e rs ,  of which one form, designated MC-B, appeared 
to have a unique N-terminal amino acid sequence compared to cytochromes 
P-450a, P-450b and P-450c (Siedel & Shires, 1986). Induction of
PB-cytochromes P-450 or cytochromes P-448 is generally
accompanied by suppression of other isozymes. For example, i t  has been 
shown that although $-naphthoflavone treatment increased the to ta l 
cytochrome P-450 content in ra t l iv e r  microsomes, i t  decreased 
PB-cytochromes P-450 by as much as 55% (P h i l l ip s  et a l . ,  1985). 
S im ila r ly ,  PB or 3-MC treatment represses the levels of co n s t itu t ive  
forms of cytochrome P-450 (Dannan et a l . ,  1983; Bandiera et a l . 1986).
Although cytochromes P-448 and PB-cytochromes P-450 are d is t in c t  
prote ins, they share certa in  regions of high homology in th e ir  
amino acid sequences. A cyste iny l residue near the C-terminal is 
conserved in a l l  cytochrome P-450 proteins sequenced to date (Kawajiri 
et a l . ,  1984; Kimura et a l . ,  1984a; Ozols, 1986, Khani et a l . 1987); a 
second h ighly conserved region,the so-called "analogous tr idecapeptide" 
which was f i r s t  id e n t i f ie d  in rabbit cytochromes P-450 (Ozols et a l . ,  
1981), is found to be 54% homologous between cytochromes P450b and 
P-450c while th e ir  overa ll homology is only 30% (Adesnik & Atchison,
1986). The s ign if icance of these conserved regions is s t i l l  a matter 
of conjecture, although i t  has been suggested that these regions may be 
involved in functions common to both fa m il ie s , such as haem-binding and 
in haemoprotein-reductase in te raction  (Ozols, 1986).
Despite these s im i la r i t ie s ,  PB-cytochromes P-450 and cytochromes 
P-448 exh ib it  several important functional and s truc tu ra l d iffe rences.
Differences in immunological c h a ra c te r is t ic s : -  Although the two major
3-MC-inducible isozymes in ra t l iv e r ,  namely cytochromes P-450c and 
P-450d, have d is t in c t  physicochemical properties and d i f fe re n t
substrate s p e c i f ic i t ie s ,  they are immunochemically re lated and 
antibodies raised against these isozymes cross-react with each other
(Thomas et a jk , 1983). In contrast, the PB-cytochromes P-450b and
P-450e are immunologically ind is t ingu ishab le  using polyclonal 
antibodies and have s im ila r  substrate s p e c i f ic i t ie s ,  although 
cytochrome P-450e catalyzes reactions at one-tenth the rate of 
cytochrome P-450b (Ryan et a l . ,  1982).
Of nine monoclonal antibodies raised against cytochrome P-450c,
three cross-reacted with cytochrome P-450d, showing the presence of
common epitopes, but none cross-reacted with cytochromes P-450b and
P-450e (Thomas et a l . ,  1984). Likewise, of twelve monoclonal
■ )
antibodies produced against cytochrome P-450b, ten also bound to 
cytochrome P-450e but none reacted with cytochromes P-450c and P-450d 
(Reik et a l . ,  1985). Moreover, monoclonal antibodies against rabb it 
form 4 did not cross-react with form 2 (Sesardic e t a l . , 1986).
Differences in primary s tru c tu re : -  To date, the complete primary 
s tructure of several isozymes of cytochrome P-450 have been elucidated 
(Fujii-Kuriyama et a l ., 1982; Heinemann and Ozols, 1983; Yuan et a l . ,  
1983; Kawajiri et a 1. ,  1984; Kimura et a l . , 1984a; Sogawa et a l . ,
1984). Comparison of the primary structures of these isozymes 
generally shows that members w ith in  the same gene fam ily  e xh ib it  at 
least 70% homology whereas between fam il ie s , isozymes share less than 
35% homology. Thus, cytochromes P-450c and P-450d share 68% homology 
(Kawajiri et a l . ,  1983a; Sogawa et a l . ,  1984) with iden tica l sequences 
fo r  the 18 NH2-terminal amino acids (Sakaki et a l . ,  1984). However, the 
homology between cytochrome P-450d and
cytochromes P-450b and P-450e is only 30% (Kawajiri et a l . ,  1984;
Sogawa e t a l . ,  1985). The murine cytochromes Px-450 and P3-450 show
73% s im i la r i t y  in amino acid sequence and are 69% and 93% respective ly
homologous to cytochrome P-450d (Kimura et a l . ,  1984). In contrast, 
the overall protein homology between cytochromes Px-450 and P3-450 with 
cytochrome P-450e and rabb it form 2 is only 20% (Kimura et a l . ,  1984). 
In addition, ra t cytochromes P-450b and P-450e are more c lose ly related
to rabb it form 2 (77% homology) (Tarr et a ! . , 1983) than to
3-MC-inducible cytochrome P-450d in the same species (30%) (Kawajir i et 
a l . ,  1984; Sogawa et a l . ,  1985). On the other hand, the PB-inducible
ra t cytochromes P-450b and P-450e are s t r ik in g ly  s im ila r ,  with a
homology of 97% and d i f fe r in g  in only 14 amino acids in a 491 amino
acid sequence (Fujii-Kuriyama et a l . ,  1982; Mizukami et a l . ,  1983; Yuan 
et a l . ,  1983), and possess iden tica l NH2-terminal sequences fo r  the 
f i r s t  302 amino acids.
Differences in mRNAs: -  The mRNAs coding fo r the PB- and 3-MC-inducible 
isozymes d i f f e r .  Thus, the mRNAs encoding murine cytochromes Px-450 
and P3-450 are both contro lled by the Ah locus and e xh ib it  an overa ll 
homology of at least several hundred base pairs (Tukey & Nebert,
1984). In the ra t,  mRNAs coding fo r  cytochromes P-450c and P-450d are 
of d i f fe re n t  sizes and have unique regions as well as regions of high 
homology (M orville  et a l . ,  1983; Fagan et a l . ,  1986). Furthermore, the
3-MC-inducible mRNAs did not hybrid ize to cloned probes fo r  
PB-cytochromes P-450 in Northern b lo t t in g  experiments, ind ica ting  that 
these mRNAs do not possess detectable sequence homology to the mRNAs 
coding fo r the major PB-inducible cytochromes P-450b and P-450e 
(M orv il le  et a l . ,  1983). In contrast, the mRNAs coding fo r
cytochromes P-450b and P-450e are of s im ila r size and th e ir  nucleotide 
differences seem to be re s tr ic te d  to a few isolated bases 
(Fujii-Kuriyama et a l . ,  1982; Kumar et a l . ,  1983, Yuan et a l . ,  1983).
Differences in gene s tru c tu re : -  Comparison of the gene structures fo r  
the 3-MC-inducible murine cytochromes Px-450 and P3-450 show that they
have s im ila r intron-exon arrangements, and a 68% homology in coding
nucleotide sequence (Gonzalez et al_., 1984). The ra t cytochromes
P-450c and P-450d also have very s im ila r gene arrangements and share 
75% coding nucleotide sequence homology (Sogawa et a l . ,  1984). A 
comparison of the murine and ra t cytochromes P-448 coding nucleotide 
sequences showed a high homology of more than 80% (Kimura et. a l. 1984,
Sogawa et a 1. ,  1985). In contrast, the gene structures fo r  the
3-MC-inducible ra t cytochromes P-448 d i f f e r  markedly from those fo r  the 
PB-inducible isozymes both in terms of intron-exon patterns and coding 
nucleotide sequences (Mizukami et a l . ,  1983; Sogawa et a l . ,  1984,
1985).
Formation of reactive intermediates by cytochromes P-448
Xenobiotics are metabolized in two stages, namely Phase I metabolism 
(biotransformation reactions) and Phase I I  metabolism (conjugations) 
(Fig. 1.2). In the detoxication pathway, oxidative reactions re su lt  in 
the formation of polar metabolites which read ily  undergo conjugation 
with endogenous substrates to form water-soluble conjugates and are 
then excreted from the body, leading to overa ll de tox ica tion . In 
contrast, in the ac tiva tion  of tox ic  chemicals and carcinogens,Phase I
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oxidations resu lt in the formation of proximate carcinogens or reactive 
intermediates which are poor substrates fo r  the conjugating enzymes 
{e.g. epoxide hydrolase, glutath ione transferases) (Oesch & Guenthner, 
1983; G la tt e t a l . ,  1983), and therefore react non-enzymically with 
prote ins, DNA and other c e l lu la r  macromolecules, leading to ce l l  
in ju ry ,  mutation, malignancy and ce ll  death (Parke & Ioannides, 1982). 
Hence, there are two d i f fe re n t  modes of oxygenation catalyzed by 
d i f fe re n t  fam ilies  of cytochrome P-450, one eventually leading to 
inactive metabolites while the other producing tox ic  reactive species.
I t  has now been recognized that the reason oxygenation resu lts  in 
the ac tiva tion  of tox ic  chemicals and carcinogens rather than leading 
to detoxication is that the oxygen has been inserted in s te r ic a l ly  
hindered positions which are not eas ily  accessible to the conjugating 
enzymes and hence react non-enzymically with v i t a l  c e l lu la r  
constituents. In contrast, oxygenation at the conformationally 
unhindered positions would f a c i l i t a t e  conjugation reactions and
detoxication . Indeed, studies have shown that whereas epoxide 
hydrolase e f fe c t iv e ly  inh ib ited  the covalent binding of the non- 
carcinogenic 9-hydroxybenzo(a)pyrene-4,5-oxide to nuclear DNA, i t  did 
not in h ib i t  the binding of the ultimate carcinogen benzo(a)pyrene-7,
8-dihydrodiol-9,10-epoxide (Oesch & Guenthner, 1983). S im ila r ly ,  the 
glutathione transferases are much less active in decreasing the
mutagenicity of benz(a)anthracene-8,9-diol-10,11-oxide than in 
decreasing the mutagenicity of the non-carcinogenic, K-region
benz(a)anthracene-5,6-oxide (G latt et a l . ,  1983). Likewise, an inverse 
re la tionsh ip  exists between the carc inogenic ity  of 2-aminonaphthalene,
2-acetamidofluorene (2-AAF) and 4-acetylaminobiphenyl and the ease of 
glucuronidation of th e ir  hydroxamic acid derivatives by ra t hepatic 
microsomal UDP-glucuronyltransferases (Wang et. a l . ,  1985).
Most recently , studies using computer graphic techniques have 
convincingly shown that spec if ic  substrates, in h ib ito rs  and inducing 
agents of the PB-cytochrome P-450 fam ily  of enzymes are non-planar, 
generally bulky, globular molecules characterized by small area/depth 
ra t io s  and f le x ib le  molecular conformation. In contrast the spec if ic  
substrates, in h ib ito rs  and inducing agents of the cytochromes P-448 
isozymes are esse n tia l ly  r ig id ,  planar molecules characterized by large 
area/depth ra t ios  (Lewis et a l . ,  1986). The vastly  d i f fe re n t  molecular 
dimension and spa tia l conformation of the substrates of these two 
fam ilies  of cytochrome P-450 indicate that th e ir  substrate binding 
s ites are also correspondingly d i f fe re n t .
Various classes of chemical carcinogens can be activated by 
cytochromes P-448 such as the PAHs, aromatic amines and amides, 
heterocyc lic  amines and azo compounds.
Polycyclic aromatic hydrocarbons: - The ac tiva tion  of PAHs to th e ir  
u lt im ate carcinogens requires oxygenation at s te r ic a l l y  hindered 
(bay-region) positions of the phenanthrene nucleus (Jerina & 
Daly ,1974). Benzo(a)pyrene, the most extensively studied chemical 
carcinogen, is m etabolica lly  activated to mutagens by hepatic 
post-mitochondrial supernatant (S9 f ra c t io n )  from 3-MC-treated rats 
whereas s im ila r preparations from PB-induced animals are much less 
active (Ioannides et al.,1981b) the mutagenic a c t iv i t y  is inh ib ited  by 
9-hydroxyel1ip t ic in e ,  a spec if ic  in h ib i to r  of cytochrome P-448
a c t iv i ty  (Ph i 11ipson et a l . ,  1985) and by antibodies raised to
cytochrome P-450c but was not affected by antibodies to cytochrome 
P-450b (Kawajiri et a l . ,  1980). Using p u r i f ie d  PB-cytochromes P-450 
and cytochromes P-448 (Levin et a l . ,  1977), i t  was shown conclusively 
that the 9,10-epoxidation of benzo(a)pyrene-7,8-dihydrodiol to form the 
ultimate carcinogen is p re fe re n t ia l ly  catalyzed (1000-fold) by
cytochrome P-448. Other PAH compounds such as 3-MC, benzo(a)anthracene 
dibenz(a,h)anthracene and dibenz(a,c)anthracene have also been found to 
be p re fe re n t ia l ly  activated by cytochromes P-448 (Wood et a l . ,  1976,
1978; Nordqvist et a l . 1979; Kawajiri et a l . ,  1980; Kawano et 
al_. ,1985).
Aromatic amines and amides: -  Several studies have provided irrevocable 
evidence that aromatic amines are activated to th e i r  proximate 
mutagenic forms via N-hydroxylation (Weisburger & Weisburger, 1973; 
Irv in g , 1979). Thus, 4-aminobiphenyl and 2-aminofluorene are
p re fe re n t ia l ly  N-hydroxylated to mutagens in the Ames tes t by p u r i f ie d  
cytochromes P-450c and P-450d (Kamataki et a l . ,  1983; Masson et a l . ,  
1983), in contrast to the PB-inducible forms of the cytochrome 
(Kamataki et a l . ,  1983; Hammons et a l . ,  1983; Kawano et a l . ,  1985). 
S im ila r ly ,  2-naphthylamine is more re ad ily  activated by 3-MC or 
Aroclor-1254-induced ra t l iv e r  microsomes than by PB-induced microsomes 
(Tong et a l . ,  1986), and the isozyme involved appears to be cytochrome 
P-450d (Hammons et a l . ,  1985). In addition, whereas rabb it l iv e r  form 
4 p re fe re n t ia l ly  metabolizes 2-aminoanthracene into a mutagen, form 2 
is inactive (Norman et a l . ,  1978).
The heterocyclic aromatic amine premutagens found in pyrolysates of 
protein and amino acids are N-hydroxylated at the amino group to form
mutagenic intermedi-ates by cytochromes P-448 but not by PB-cytochromes 
P-450 { Is h i i  et a l . ,  1980, Yamazoe et a l.,1983). These N-hydroxy 
derivatives require fu r th e r  metabolism to generate the u lt im ate 
carcinogen possible via sulphate conjugation (Nagao et a l . ,  1983). 
Thus Trp-P-1 (3-amino-l,4-dimethyl-5H-pyrido-4,3-b indo le ), Trp-P-2 
(2-aminomethyldipyrido 1,2-a: 3 ' ,2 ' - d  imidazole), Glu-P-1 (3-amino-l- 
methyl-5H-pyrido-4,-3-b indole) and IQ (2-amino-3-methylimidazo (4 ,5 - f)  
quinoline are a l l  m etabo lica lly  activated by cytochromes P-448, 
p a r t ic u la r ly  the high spin form, namely cytochrome P-450d ( Is h i i  et 
a l . ,  1980, 1981; Kamataki et a l . ,  1983; Yamazoe et a l . ,  1983;
Abu-Shakra et a l . ,  1986). The mutagenicity of Trp-P-2 is inh ib ited  85% 
by antibodies to cytochromes P-448, but only 8% by antibodies to 
PB-cytochromes P-450 (Kawajiri et a l . ,  1983b). Furthermore, the 
metabolic ac tiva tion  of Trp-P-2 by hepatic microsomes is markedly 
increased by 3-MC-treatment in responsive mice but not in non- 
responsive mice (Nebert et a l . ,  1979; Yamazoe et a l . ,  1980).
The aromatic amide 2-AAF is also m etabo lica lly  activated via 
N-hydroxylation which is p re fe re n t ia l ly  catalysed by 3-MC-inducible 
cytochromes P-448 (L o t l ik a r  & Wang, 1982; Astrom and DePierre, 1985). 
The mutagenicity of 2-AAF is inh ib ited  60% by antibodies to cytochromes 
P-448 but only 30% by antibodies to PB-cytochromes P-450 (Kawajir i et_ 
a l . ,  1980). Antibodies raised to cytochromes P-448 also caused 80% 
in h ib i t io n  of covalent binding of 2-AAF metabolites to DNA whereas 
antibodies against PB-cytochromes P-450 caused only 5% in h ib i t io n  (Hara 
et a l . ,  1981). Rabbit l iv e r  form 4 catalyzed the N-hydroxylation of
2-AAF more e f f ic ie n t ly  than did forms 2 and 6 (Johnson et a l . ,  1980).
The above date indicates that although cytochromes P-450c and 
P-450d are s t ru c tu ra l ly  s im ila r  (68% homology) (Sogawa et a l . ,  1984), 
they exh ib it  d i f fe re n t  substrate s p e c i f ic i t ie s .  Thus, whereas 
cytochrome P-450c (rabb it form 6) is p a r t ic u la r ly  e f f ic ie n t  in the 
metabolic ac tiva tion  of po lycyc lic  aromatic hydrocarbons (Norman et 
a l . 1978), cytochrome P-450d (rabb it form 4) is mainly involved in the 
N-hydroxylation of aromatic amines and amides as well as 
aminoazobenzenes (L o t l ik a r  et a l . ,  1984; Kimura et a l . ,  1985).
Azo compounds: -  The carcinogenic aminoazo dyes such as 
3 ' -methyl-N,N-dimethyl-4-aminoazobenzene and 31- methyl-N-methy 1-4- 
aminoazobenzene are m etabo lica lly  activated to th e i r  proximate 
carcinogenic forms via N-demethylation, followed by N-hydroxylation, 
both of which are catalyzed by cytochromes P-448 (Igarashi et a l . ,
1982, Kimura et al_., 1985). Nevertheless, the N-hydroxylation of
aminoazo compounds can also be catalyzed by the f la v in  monooxygenase 
system which constitu tes the major pathway in untreated rats (Kimura et_ 
aj_. ,1984b; 1985). In 3-MC-treated animals, cytochrome P-450d is more 
active than cytochrome P-450c in cata lyzing the N-hydroxylation 
reaction, although the la t te r  is more active at r ing-hydroxy la tion  
(Kimura et a l . ,  1985). However, the ac tiva tion  of o-aminoazotoluene to 
mutagens appears to be mediated exc lus ive ly  by cytochrome P-450c 
(Kawano et a l . ,  1985).
Drugs and other chemicals: -  Paracetamol (acetaminophen,
4-acetyl-p-aminophenol) is activated to a reactive intermediate, 
postulated to be N-acetyl-p-benzoquinoneimine (Huggett & B la ir ,  1983), 
which is capable of covalent binding to proteins (Jollow et a l . ,  
1973). Studies have shown that 3-MC-induced hamster l iv e r  microsomes
are more e f f ic ie n t  in ac t iva t ing  paracetamol than PB-induced 
microsomes; ac tiva tion  by 3-MC-induced microsomes was inh ib ited  by
9 -hyd roxye ll ip t ic ine  but not by metyrapone (Ioannides et a l . ,  1983). 
Subsequent to th is ,  using h igh ly  p u r i f ie d  preparations i t  was 
demonstrated that cytochromes P-448,but not PB-cytochromes P-450, 
catalyzed the ac tiva t ion  of paracetamol to metabolites tha t bind 
covalently to proteins (Steele et a l . ,  1983). S im ila r ly ,  the na tu ra l ly  
occurring pulmonary tox in  4-ipomeanol is metabo lica lly  activated 
p re fe re n t ia l ly  by 3-MC-inducible forms of the cytochrome (Stratham & 
Boyd, 1982). Other carcinogens which are activated by 3-MC include the 
polyhalogenated biphenyls (S in c la ir  et a l . ,  1984), a f la to x in  B i , 
(Robertson et a l . ,  1983) and 2 -n itro f luo rene  (Kawano et a l . ,  1985).
Metabolic ac t iva t ion  involv ing other cytochrome P-450 isozymes: - 
Although cytochromes P-448 are the main isozymes involved in the 
metabolic ac tiva tion  of tox ic  chemicals and carcinogens, other isozymes 
have also been implicated. Thus, the nitrosamines are a large class 
of widely occurring carcinogens which require metabolic ac t iva tion  to 
th e ir  u lt im ate carcinogenic forms. The b ioac tiva tion  of N, 
N'-dimethylnitrosamine (DMN), the simplest member of th is  series, is 
believed to involve oxidative demethylation to the monomethyl 
nitrosamine, which is unstable and breaks down to the methyldiazonium 
ion, and eventually to the carbonium ion which is the u ltimate 
carcinogenic form (Magee, 1977). The enzymology of DMN metabolism had 
been a matter of controversy (Rowland et a l . ,  1980; P h i l l ip s  et a l . ,  
1982). However, more recent studies have shown that the metabolic 
ac tiva tion  of the nitrosamines does not involve cytochromes P-448.
Thus, DMN demethyl at ion is most e f f ic ie n t ly  catalyzed by cytochrome 
P-450j, an isozyme which is inducible by ethanol or isoniazid treatment 
in the ra t l iv e r  (Tu & Yang, 1985; Levin et a 1. ,  1986, Ryan et a l . ,
1986). The ac tiva t ion  of other nitrosamines such as the 
N-nitrosopropylamines and N-nitrosomethylaniline appears to involve 
PB-inducible cytochromes P-450 (Mori et a l . ,  1985; Tu & Yang, 1985).
In addition, i t  is reasonably well-established that the metabolic 
ac tiva tion  of cyclophosphamide in rats is markedly enhanced by 
treatment with PB but not by 3-MC (Hales & Jain, 1980). In agreement 
with th is ,  hepatic S9 frac tions  from PB-treated rats but not those from 
3-MC-treated animals catalyzed the bioconversion of cyclophosphamide to 
embryotoxic metabolites (Juchau et a l . ,  1985).
Although numerous studies have shown that the azo compounds are 
activated by cytochromes P-448 (Igarashi et a l . ,  1982; Kimura et a l . ,
1985), 3-methoxy-4-aminoazobenzene seems to be unique in that i ts  
mutagenic ac tiva tion  is found to be more e f f ic ie n t ly  catalyzed by 
PB-induced microsomes (Degawa et a l . ,  1985); 3-MC-induced microsomes 
are also active but to a lesser extent (Degawa et a l . ,  1986).
Determination of cytochromes P-450
An abundance of l i te ra tu re  is now available ind ica ting  that the 
types and proportions of the various forms of microsomal cytochrome 
P-450 in a tissue w i l l  determine the metabolic p ro f i le  of a compound 
and hence is a cruc ia l fac to r in regula ting ind iv idua l s u s c e p t ib i l i ty
to t o x ic i t y  and carc inogen ic ity . As such, e f fo r ts  have been made to 
quantify  isozymes of cytochrome P-450 in microsomal preparations, but 
each approach has i ts  own inherent l im ita t io n s .  For instance, 
ind iv idua l forms of cytochrome P-450 have been isolated and pu r if ied  to 
apparent e lectrophoretic  homogeneity using methods such as SDS-gel 
e lectrophoresis, a f f in i t y  chromatography, column chromatography, and 
more recently , high-pressure l iq u id  chromatography (Ryan et a l . ,  1979; 
Warner & Neims, 1979; F u j i ta  et a l . ,  1985; Bornheim & Correia, 1986), or 
a combination of these methods. However y ie lds from such p u r i f ic a t io n  
studies are very poor (Guengerich, 1979); besides the procedure 
involved is laborious and unsuitable fo r  routine use.
Another approach employed fo r  the characterization and 
quan tif ica t ion  of subpopulations of cytochrome P-450 is the use of 
ligands. Concentrations of cytochrome P-450 in microsomal suspensions 
have been determined by the carbon monoxide-ligand spectral d iffe rence 
method (Omura & Sato, 1964). However, th is  method is in s u f f ic ie n t ly  
spec if ic  and spectral parameters determined in microsomal suspensions 
appear to represent a composite value of a l l  the d i f fe re n t  forms of 
cytochrome P-450 in the p a rt icu la r  microsomal preparation (Lu & West, 
1980). Furthermore, i t  is now well-established that changes in the 
to ta l  cytochrome P-450 content do not re f le c t  the actual changes in 
isozyme compositions. Thus, while PB-treatment produces a 2- to 3-fo ld  
increase in to ta l microsomal cytochrome P-450 levels in the ra t l i v e r ,  
radioimmunoassay techniques actua lly  revealed a more than 40-fo ld 
se lective  induction of cytochromes P-450b (+P-450e); likew ise,
3-naphthoflavone-treatment caused a 55% decrease in the amount of
cytochromes P-450b (+P-450e), although to ta l cytochrome P-450 content 
was increased (P h i l l ip s  et a l .-, 1985). The metyrapone-reduced
cytochrome P-450 complex was proposed as a spec if ic  assay fo r the major 
PB-inducible forms of cytochrome P-450 (Luu-The et a l . ,  1980), but was 
subsequently shown to be inaccurate and nonspecific (Ivanetich et a l . ,  
1982; Liu and Franklin , 1985).
In recent years, a number of investigators have raised antibodies 
to h ighly p u r if ie d  cytochrome P-450 isozymes and used these antibody 
preparations to study m u lt ip le  forms of cytochrome P-450 in the in ta c t 
microsomal preparation (Ryan et a l . ,  1979; Reik et a l . ,  1982; Adams 
et a l . ,  1985; Frey et a l . ,  1985). For instance antibodies have been 
employed fo r  the immunohistochemical loca liza t ion  of cytochrome P-450 
isozymes in rat l iv e r  (Baron et a l . ,  1981), and fo r characterization 
and qu an tif ica t ion  of various cytochrome P-450 forms (Thomas et a 1. ,  
1979; Guengerich et a l . ,  1982b). However, the use of antibodies as 
probes fo r m ult ip le  forms of cytochrome P-450 have been hampered by the
problem of c ro s s -re a c t iv i ty  (Ryan e t al_., 1980; Guengerich et a l . ,
1982b, Reik et a l . ,  1982; Thomas et a l . ,  1983).
More recently, workers have generated monoclonal antibodies which 
being chemically homogenous and having a discrete binding a f f in i t y  fo r  
a single epitope, can be highly spec if ic  probes fo r antigenic s ite s . 
Indeed, monoclonal antibodies have been shown to be useful too ls fo r  
phenotyping cytochrome P-450 species on the basis of th e ir  epitope 
content (Fujino et a l . ,  1982; Beaune et a l . ,  1984). Nevertheless, even 
with monoclonal antibodies, the problem of c ro s s - re a c t iv i ty  has not
been to t a l l y  overcome (Thomas et a l . ,  1984; Boobis et a l . ,  1985). 
Furthermore, as with polyclonal antibodies, monoclonal antibody-based 
studies su ffe r from the disadvantage that a pure antigen is required 
before an appropriate antibody can be raised, and th is  is p a r t ic u la r ly  
d i f f i c u l t  where the form represents a small proportion of the to ta l 
cytochrome P-450 present. A radioimmunoassay based on monoclonal 
antibodies has been developed and used to phenotype the cytochrome 
P-450 p ro f i le  of various tissues (Song et a l . ,  1984). However, the use 
of antibodies detects proteins with common epitopes which may not be 
fu n c t io n a l ly  important; apoproteins which are not enzymically active 
can also react with the respective antibodies.
A number of compounds forming metabolites which are measurable by 
simple and sensitive  quan t if ica t ion  techniques have gained wide use as 
substrates fo r monitoring MFO a c t iv i t ie s  in various mammalian tissues. 
S t u d ie s in d ic a t e t h a t  a ld r in  is a h igh ly  se lective substrate fo r
PB-inducible cytochrome P-450 forms and a poor substrate fo r  cytochrome 
P-448 (Wolff et a l . ,  1980; Van Cantfort et a l ., 1983). Other enzyme 
a c t iv i t ie s  such as ethylmorphine, aminopyrine and benzphetamine
demethylation are not very sensitive  to induction with phenobarbital
and hence of lim ited use in tissue exh ib it ing  weak a c t iv i t ie s  (Tredger 
& Chhabra, 1976).
The enzymic MFO a c t iv i t ie s  that have been employed fo r  the spe c if ic  
determination of cytochromes P-448 include biphenyl 2-hydroxylase
(Creaven et a l . ,  1965), aryl hydrocarbon hydroxylase, or more 
s p e c if ic a l ly  benzo(a)pyrene hydroxylase (Dehnen et a l . ,  1973) and 
ethoxyresosufin 0-deethylase (Burke & Mayer, 1974) a l l  of which are
assayed by f lu o r im e tr ic  methods. However, studies have shown that 
biphenyl 2-hydroxylase is in s u f f ic ie n t ly  spe c if ic  as certa in 
carcinogenic metabolites may in te r fe re  with the fluorescence assay 
(Tong et a l . ,  1977), unless the high-pressure l iq u id  chromatographic 
method is used (Burke et a l . ,  1977). The benzo(a)pyrene hydroxylase 
assay also possesses serious inherent l im ita t io n s .  I t  does not detect 
a l l  the metabolites of BP and the extraction process involved is both 
tedious and in e f f ic ie n t  (DePierre et a l . ,  1975, Yang et a l . ,  1975). In 
addition, the assay is g reatly  affected by the solvent used to dissolve 
the substrate and by the preincubation conditions (Yang et a l . ,  1978). 
Warfarin has also been used successfully to monitor simultaneously a 
number of d i f fe re n t  cytochrome P-450 proteins including cytochrome 
P-450c, which hydroxylates warfarin s p e c i f ic a l ly  at the 6- and 
8-positions, that is ,  on the planar moiety of the molecule (Kaminsky 
et a l . ,  1983). Extensive studies with pu r if ie d  ra t l iv e r  microsomal 
preparations ind icate that the O-deethylation of ethoxyresorufin (EROD) 
is catalyzed by cytochrome P-450c, and to a lesser extent by cytochrome 
P-450d but not by any of the PB-inducible cytochromes P-450 (Goldstein 
et a l . ,  1982; Guengerich et a 1. ,  1982a; Astrom & DePierre, 1985). In 
addition, the reaction y ie lds  a single metabolite namely resoru fin  
which can be measured f lu o r im e t r ic a l ly  and does not undergo fu r th e r  
metabolism (Burke & Mayer, 1974, 1975). Furthermore, the methodology 
involved is re la t iv e ly  simple, h igh ly sensitive and the resu lts  are 
highly reproducible (Burke & Mayer, 1974, 1975; Burke et a l . ,  1977).
B rie f ou tl ine  of present study
In the present experiments, using EROD as a probe, we studied the
development of cytochrome P-448 in foe ta l and neonatal rats and the 
induction of cytochrome P-448 a c t iv i t y  by chemical carcinogens in rats 
and inbred s tra ins of mice. The data obtained was then discussed in 
re la t ion  to the ro le of these isozymes in malignancy, in pa rt icu la r, the 
re la tionsh ip  between the induction of cytochrome P-448 a c t iv i t y  and 
chemical carcinogenesis and the possible physiological s ign if icance of 
the cytochrome P-448-dependent MFO system.
CHAPTER 2: 
MATERIALS AND METHODS
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This chapter encompasses a l l  the materials and methods generally 
used in th is  pro ject and w i l l  be con tinua lly  re ferred to in subsequent 
chapters. Where the materials or methods used in conjunction with a 
p a r t ic u la r  experiment d if fe re d  from those described in th is  chapter, 
these w i l l  be detailed in the relevant chapters.
MATERIALS
Chemicals
A l l  cofactors were purchased from Sigma, Poole, Dorset, U.K. The 
cytochrome c was from horse heart (Type I I I )  and the glucose 6-phosphate 
dehydrogenase was from Bakers Yeast (Type V I I ) .
The fo llow ing chemicals were a l l  purchased:-
3-Methylcholanthrene (3-MC), 2-anthramine, 2-acetamidofluorene (2- 
AAF), benzo(e)pyrene, benzo(a)pyrene, N,N'-dimethylnitrosamine (DMN), 
2-aminobiphenyl, 4-aminobiphenyl, 3 ,3 ' -d ich lorobenzidine, 3 ,3 ' -
diami nobenzidine, an tipyrine , r ifam pic in  and paracetamol (Sigma, Poole, 
Dorset, U.K.), phenobarbital (PB), biphenyl and i t s  hydroxy de r iva tives , 
phenylbutazone, DDT and saccharin (BDH, Poole, Dorset, U .K .), 1 ,2 ,5 ,6 - 
dibenzanthracene, N-methyl-N' -n itro-N-n itrosoguanid ine (MNNG) (A ldrich 
Chemicals L td . ,  Gillingham, Dorset, U.K.), a ld r in  (Phase Separations 
L td .,  Queensferry, Deeside, U.K.), safro le  (Hopkins & Williams, Chadwell 
Heath, Essex, U.K.), resorufin  and 7-ethoxyresorufin (Pierce Chemicals, 
Rockford, 111., U.S.A.). Benzidine, 3 ,3 ' , 5 ,5 ' -tetramethylbenzid ine, 4- 
n itroqu ino line-N-ox ide, 3-m ethyl-4-n itroquino line-N-oxide, 4- 
dimethylaminoazobenzene, 4-dimethylaminoazobenzene-4-sulphonic acid Na 
s a l t  and a - and £-naphthylamines were a l l  samples from those used in 
the In ternationa l Programme fo r  the Evaluation of Short-Term Tests fo r  
Carcinogenicity.
The fo llow ing chemicals were generous g i f t s  from the fo llow ing 
companies:-
Aroclor-1254 (Monsanto Chemical Co., St. Louis, MI., U.S.A.), 7,12- 
dimethylbenzanthracene ( IIT  Research In s t i tu te ,  Chicago, 111., U.S.A.), 
feprazone ( In s t i tu to  di Angeli, Milan, I t a ly ) ,  imipramine hydrochloride 
(Biorex Laboratories, London, U.K.), theophylline (Courtin & Warner 
L td .,  Sussex, U.K.), benzphetamine (The Upjohn Co., Kalamazoo, Michigan, 
U.S.A.), c lo f ib r ic  acid sodium s a lt  (ICI Pharmaceuticals, Macclesfie ld, 
U.K.), cimetidine (Smith, Kline & French, H erts ., U.K.).
N itrosocimetidine was synthesized from cimetidine by the method of 
Foster et aj_. (1980).
Phenoxazone and the homologous series of 7-alkoxyresorufins were 
g i f t s  from Dr. M.D. Burke (Department of Pharmacology, U n ivers ity  of 
Aberdeen, U.K.).
Materials fo r  the Ames Test
P las t ic  disposable tubes ( S te r i l in ,  Teddington, Middlesex) and 
ready poured agar plates ( Vogel-Bonner 1E1 plates from Gibco B iocu lt ,  
Paisley, Scotland), were used in the Ames te s t .  This was always carried 
out under an Intermed Microflow Pathfinder a ir - f lo w  chamber and p la s t ic  
disposable (Microtouch) gloves were worn fo r  handling 
bacteria/carcinogens. Oxoid No.2 nu tr ien t broth was used fo r  cu ltu r in g  
and d i lu t in g  the bacteria cu ltu re , while Difco-Bacto nu tr ien t agar was 
used in the top agar. F i l t e r  s te r i l i z a t io n  of solutions was achieved 
through M il l ip o re  Swinnex f i l t e r s  with 0.45 upore.
Stock cultures of Salmonella typhimurium TA-100 were supplied by 
Professor B. Bridges (MRC Cell Mutation Unit, U nivers ity  of Sussex), but 
orig inated from the laboratories of Professor B. Ames (U n ive rs ity  of 
C a li fo rn ia , Berkeley, CA., U.S.A.). They were stored at -80°C in 
nu tr ien t broth (0.8 ml) containing dimethylsulphoxide (0.07 ml) in 
t ig h t ly  capped glass v ia ls .
Animals
In general, adult male Wistar albino rats (150-200 g) supplied by 
the Animal Breeding Unit, U n ivers ity  of Surrey have been used, unless 
s p e c i f ic a l ly  stated otherwise. The animals were kept in constant 
environmental conditions of 50% humidity at 21°C with an automatic 
12 hour l ig h t /d a rk  cycle. They were allowed water and food (Spratts 
Laboratory Animal Diet No.l, L i l l i c o , Wonham M i l l ,  Surrey), ad l ib i tu m .
Male and female adult C57BL/6 and DBA/2 mice (35-40 g) purchased 
from Charles River U.K. Ltd. (Margate, Kent,—U.K.), were used in the 
experiment on alkoxyresorufin 0-dealkylases (Chapter 7). The animals 
were housed on woodchips (J.C. Lee, Chertsea, Surrey, U.K.), and were fed 
water and SBS No.l d ie t ad l ib i tu m .
METHODS
Animal treatment
In the induction studies, animals received a s ing le in trape ritonea l 
in jec t io n  of the inducing agent dissolved in normal saline or corn o i l  
and were k i l le d  24 hours la te r .  Control animals were untreated. Where 
the treatment regimen varied in a p a r t ic u la r  experiment, d e ta i ls  w i l l  be 
given in the relevant chapter.
Preparation of hepatic microsomes
Animals were k i l le d  by cerv ica l d is loca tion . Livers were excised 
in to  ice-cold 1.15% KC1, rinsed of blood, b lo tted dry and transferred 
in to  pre-weighed beakers containing a su itab le  volume of 1.15% KC1. The 
tissues were scissor-minced and then homogenized in a Potter-Elvehjem 
homogenizer (Arthur H. Thomas Co., PA., U.S.A.), f i t t e d  with a te f lo n  
pestle . The homogenate volume was adjusted with 1.15% KC1 to give 4 ml 
per g l iv e r  (wet weight) and was centrifuged at 9,000 g fo r  20 minutes in 
a re fridgera ted MSE 18 centr ifuge. The post-mitochondrial supernatant 
(S9) was e ithe r used fresh (w ith in  a few hours, kept on ice) or 
d is tr ib u te d  in to  2 ml a liquo ts , frozen and stored at -80°C. When 
required, the samples were thawed on ice, and any unused portion 
discarded at the end of the day.
Microsomes were prepared from the S9 supernatant by fu r th e r  
cen tr ifug ing aliquots at 105,000 g fo r  60 minutes in a Beckman L5-65B 
re fridgera ted u ltracen tr i fug e . The-microsomal pe lle ts  were resuspended 
immediately by a Potter hand-homogenizer in 50 mM phosphate bu ffer 
pH 7.4 containing 1 mM EDTA and 20% glycerol (1 ml per g l i v e r ) .  The 
microsomal suspensions (100%) were then d is tr ibu ted  in to  1 ml a liquo ts , 
frozen and stored at -80°C. When required, the samples were thawed on 
ice, d ilu ted  1:3 with 0.1 M phosphate buffer pH 7.4 and any unused 
portion discarded by the end of the day.
Enzyme assays
A ll  assays, except phenoxazone hydroxylation and alkoxyresorufin 0- 
dealkylation (including ethoxyresorufin 0-deethylation) were carried out 
in duplicates.
Benzphetamine N-demethylase: The demethylation of benzphetamine was
determined by an adaptation of the method of Holtzman et al_. (1968), 
using the microsomal supernatant.
The hydroxylation of the methyl group resu lts  in the formation of an 
unstable amino carbinol intermediate, which breaks down to release 
formaldehyde (Prough & Z ieg le r, 1977). Semicarbazide is added to trap 
the formaldehyde which is then measured co lo r im e tr ic a l ly  a f te r  colour 
development in the Nash reaction (Nash, 1953).
The incubation mixture consisted o f: 
Tris-HCl bu ffer (0.3 M) pH 7.6 0.5 ml
Magnesium ch loride (0.1 M) 0.1 ml
Semicarbazide HC1 (2%) pH 7.0 0.2 ml
Glucose 6-phosphate (0.03 M) 0.5 ml
NADP+ (2.5 mM) 0.5 ml
Microsomal supernatant 25% 0.25 ml
Benzphetamine (10 mM) 0.25 ml
The reaction was started by addition of the substrate. The tubes 
were incubated in a shaking water bath at 37°C fo r  10 minutes. The 
reaction was then terminated by the addition of 15% ZnSO^  (1 m l), 
followed by a 2:1 mixture of saturated solutions of BatOH^ and Na2B^0 y 
(1 ml). P recip itated prote in was removed by cen tr ifuga tion  in a M is tra l 
6L centrifuge (2,000 rpm, 10 min) and aliquots of the supernatant 
(2.0 ml) were added to 2.0 ml of f re sh ly  prepared Nash reagent (4 M 
ammonium acetate containing 4 ml acetyl acetone per l i t r e ) .  The mixture 
was incubated fo r  40 minutes in a shaking water bath at 37°C fo r  
40 minutes. The absorbance was measured at 412 nm in a Cecil CE 272 
l inear readout spectrophotometer.
Suitable blanks (substrate added a fte r protein p re c ip ita t io n )  and 
standards (0.4, 0 .8 ymole formaldehyde) were prepared and carried
through the same procedure.
Biphenyl 2- and 4-hydroxylase: The hydroxylation of biphenyl was
followed using the f lu o r im e tr ic  method of Creaven et al_. (1965).
The major route of biphenyl metabolism is the 4-hydroxylation with 
the 2-hydroxylation being a minor pathway, and together these account 
fo r  about 90% of the metabolites formed (Burke & Bridges, 1975; Burke & 
Mayer, 1975). Although th is  method does not d is t ingu ish  between the 2- 
and 3-hydroxy derivatives as both e xh ib it  excited-sta te ion iza t ion , the
4-hydroxybiphenyl does not show th is  property and so can be determined 
f lu o r im e t r ic a l ly  in the same preparation (Bridges et a]_., 1965).
The incubation mixture consisted o f : -
Tris-HCl bu ffe r (0.05 M) pH 8.1 (at 37°C) 0.5 ml
Magnesium chloride (0.05 M) 0.2 ml
1.15% Potassium ch loride 0.3 ml
NADP+ (0.006 M) 0.25 ml
Microsomal supernatant 25% 0.5 ml
Biphenyl, re c rys ta l l ize d  (0.012 M in
4% Tween 80) 0.25 ml
The reaction was started by the addition of the substrate (absent in 
blanks and standards) and the tubes were shaken in a water bath at 37°C 
fo r  10 minutes. The reaction was terminated by the addition of 2 M HC1 
(0.5 ml) in ice. Substrate was then added to the blanks and the 
standards (6 yg 2-hydroxybiphenyl or 30 y g 4-hydroxybiphenyl dissolved 
in 5% ethanol) were added to the appropriate tubes.
N-Heptane (7 ml) was added to extract biphenyl and i t s  metabolites 
in a ro ta ry  shaker fo r  5 minutes. The tubes were then centrifuged at 
2,000 rpm fo r  10 minutes in a MSE J-6 centrifuge and 2 ml of the heptane 
layer was fu r th e r  extracted with 0.1 M NaOH (7 ml) fo r  5 minutes and 
centrifuged as before. F in a l ly ,  a liquots (2 ml) of the aqueous layer 
(containing the hydroxy deriva tives) were placed in a f luo rim ete r 
cuvette, to which was added 0.5 M succinic acid (0.5 ml) to adjust the pH 
to 5.5. Fluorescence was measured at 338 nm and 415 nm with exc ita t ion  
at 275 nm and 295 nm respective ly , using a Perkin-Elmer MPF-3 
fluorescence spectrophotometer. Readings were taken immediately as 2- 
hydroxybiphenyl is unstable at i t s  exc ita t ion  wavelength and decomposes 
at the rate of about 1%/min (Bridges et aj_., 1965).
The concentration of 4-hydroxybiphenyl can be calculated from the 
fluorescence reading at 338 nm ( x QV = 275 nm), as 2-hydroxybiphenyl
6 X
does not in te r fe re  at th is  wavelength. From the reading at 415 nm ( x  e x  
= 295 nm), the amount of 2-hydroxybiphenyl can be determined a f te r  
allowing fo r  the con tr ibu tion  to the fluorescence by 4-hydroxybiphenyl 
(Creaven et ad . ,  1965).
Ethoxyresorufin 0-deethylase (EROD): Ethoxyresorufin 0-deethylation was 
measured in microsomal suspensions by the method of Burke & Mayer (1974) 
including those improvements outlined in a la te r  paper (Burke et a l . ,  
1977).
Ethoxyresorufin is 0-deethylated to y ie ld  resoru fin  as the only 
metabolite, which can be followed f lu o r im e t r ic a l ly  at the e xc ita t io n  
wavelength ( x OY) of 510 nm (to minimize l ig h t  scatte r due to the
c  X
tu rb id i ty  of the microsomes) and emission wavelength ( A em) of 586 nm. 
There is no interference from amino acids or NADPH at these wavelengths.
s/V 'W 1 C2H5 t/V'N/VOH.
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The fo llow ing  reaction mixture was prepared in a f luo rim ete r 
cuve tte :-
Tris-HCl bu ffe r (0.1 M) pH 7.8 
Microsomal suspension 25%
Ethoxyresorufin (50 yM in ethanol)
The baseline fluorescence was recorded in a Perkin-Elmer MPF-3
fluorescence spectrophotometer ( X = 510 nm, X = 586 nm, s l i t -w id th
g x  6  m
3.5 nm). A fte r 2 minutes incubation at 37°C, the reaction was started by 
the addition of 10 p i NADPH (50 mM) and a progressive increase in 
fluorescence was recorded over 3 to 5 minutes.
The f luo rim ete r was always ca librated before use with a f re s h ly  
d ilu ted  sample of quinine sulphate (1 ug/ml in 0.05 M H2SO4 ) and the 
reaction quantif ied  by means of m ultip les of 10 yl resoru fin  (0.01 mM in 
ethanol). The fluorescence of resoru fin  is  proportional to i t s  
concentration in the range 0.5-400 nM (Burke & Mayer, 1974) and the 
reaction may be followed in the range of 0 . 02 - 1 .0 0  mg microsomal prote in 
per ml in the cuvette. Therefore, in the case of microsomes from contro l 
animals where the a c t iv i t y  is generally low, an increased volume of 
microsomes (up to 50 y l ,  about 0.15 mg protein/ml in the cuvette) was 
used.
Care was taken not to unnecessarily expose resoru fin  or 
ethoxyresorufin to l ig h t  or heat, as they are both unstable, 
p a r t ic u la r ly  when in aqueous so lu tion .
Phenoxazone hydroxylase and alkoxyresorufin 0-dealkylase: Phenoxazone
hydroxylase and alkoxyresorufin 0 -dealkylase a c t iv i t ie s  were assayed
2 .0  ml 
0 .0 2  ml 
0 .0 1  ml
using the same procedure as fo r  ethoxyresorufin 0-deethylase, except 
tha t the substrates were dissolved in dimethylsulphoxide and the 
reaction was followed at  ^ex = 530 nm, = 585 nm (Burke £ t  a l . ,
1977), and s l i t -w id th  6 nm as the rates of phenoxazone hydroxylation and 
0-dea lky la tion of the long-chain derivatives were generally very low, 
p a r t ic u la r ly  in control microsomes.
Cytochromes P-450 and b^: The spectral assays fo r  the determination of
cytochromes P-450 and b^ were based on the observations of Omura & Sato 
(1964).
Freshly prepared microsomal suspensions (25%) were d ilu ted  1:10 
with 0.1 M phosphate bu ffer pH 7.4 to give a f in a l  protein concentration 
in the range of 1-3 mg/ml. Difference spectra were recorded between 
390 nm and 500 nm using a Varian Cary double-beam spectrophotometer, 
equipped with an automatic base-line correction . The d iffe rence 
spectrum obtained by adding 0.1 ml NADH (1 mg/ml) to the sample cuvette 
was used to calcu late the cytochrome b^ content of the microsomes, using 
the ex tinc t ion  c o e f f ic ie n t ,  £425 -410  nm = 185 mM~^  cm  ^ fo r  the
difference in op tica l density between 410 nm (trough) and 426 nm (peak). 
Cytochrome P-450 was estimated by f i r s t  gently bubbling carbon monoxide 
in to  the sample cuvette fo r  30 sec., followed by reducing both sample and 
reference cuvettes with a few grains of sodium d i th io n i te .  The oxidized 
carbon monoxide spectrum gives an estimation of the haemoglobin 
contamination of the microsomes by a peak at 420 nm; the oxidized carbon 
monoxide spectrum was more stable than the reduced form, so th is  method 
helped to minimize cytochrome P-450 loss during the assay. The 
cytochrome P-450 content was calculated by using the e x t in c t io n  
co e f f ic ie n t  £4 5 0 .49 0  nm = 91 cm~** In th is  assa^» PB-cytochromes
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P-450 and cytochromes P-448 could not be distinguished as there was a 
broad absorption peak in the range 448-452 nm. Hence, th is  assay gave 
estimates of the to ta l concentration of cytochrome P-450 isozymes in the 
microsomal preparation.
NADPH-cytochrome c reductase: The NADPH-dependent reduction of
cytochrome c was measured by the method of Williams & Kamin (1962). 
Cytochrome c was used as an a lte rna tive  substrate to cytochrome P-450 as 
i t s  reduction could be eas ily  followed by an increase in absorbance at 
550 nm. Moreover, the two reductase a c t iv i t ie s  are ind is t ingu ishab le  
(Masters et al_., 1973; Vermilion & Coon, 1974), although the reduction 
of cytochrome c is believed to involve a hydroph ilic  s i te  while 
reduction of cytochrome P-450, a hydrophobic s i te  on the reductase 
(Guenthner et a]_., 1980).
The fo llow ing reaction mixtures were prepared in two cuvettes:
Sample Reference
Potassium phosphate bu ffer (0.05 M)
-3pH 7.6, containing 10 potassium
cyanide 1.7 ml 1.8 ml
Cytochrome c (0.1 mM) 1.0 ml 1.0 ml
Microsomal suspension (25%) 0.2 ml 0.2 ml
A fte r establishing a base-line, the reaction in the sample cuvette 
(at 37°C) was in i t ia te d  by addition of 0.1 ml NADPH (0.03 M) and the 
reaction was immediately followed at 550 nm fo r  1-2 minutes on a Varian 
Cary double-beam spectrophotometer. The i n i t i a l  rate of reaction 
calculated from the gradient was taken as the measure of cytochrome c 
reduction. The ex tinc tion  co e f f ic ie n t  of 18.5 mM"'*' cm"'*' was used.
I t  was observed tha t the reaction leve lled o f f  ra p id ly  due to 
depletion of the substrate and also because NADP+ formed during the 
reaction had an in h ib i to ry  e f fe c t  on the enzyme (Willaims & Kamin, 1962).
Protein determination: Protein content in microsomes was determined by
the method of Lowry et a l . (1951).
Microsomal suspensions (25%) were d ilu ted  1:200 in 0.1 M NaOH to
give a protein concentration of about 20yg /m l. Freshly prepared
Solution C (see below) (5 ml) was added to a liquots (1 ml) of the d ilu ted  
preparation, mixed well and allowed to stand fo r  10 minutes. Fo lin - 
Ciocalteau phenol reagent (0.5 m l), f re sh ly  d ilu ted  1:1 with 0.1 M NaOH, 
was then ra p id ly  added and mixed immediately. The absorbance was read at 
750 nm 30 minutes la te r ,  using a Unicam SP 500 spectrophotometer.
A standard curve was prepared using bovine serum albumin (0-300 yg) 
dissolved in 0.1 M NaOH. The standards and su itab le  blanks (1 ml of 
0.1 M NaOH) were assayed concurrently with the samples and carried 
through the same procedure.
Solution C was prepared immediately before use from the fo l low ing  
stock solutions:
Solution A : 4 g NaOH and 20 g Na2C03 per l i t r e  
Solution B-^  : 1% CuSO^
Solution B£ : 2.21% Na K ta r t ra te  
Solution C = A : B^  : B^  = 50 : 0.5 : 0.5
The Ames assay: The method used was esse n tia l ly  tha t of Ames et a l .
(1975).
( i ) General
A l l  glassware and heat-stable solutions were autoclaved while 
other solutions including the S9 mix were s te r i l iz e d  by f i l t e r in g  
through a 0.45 ypore Swinnex f i l t e r .  Top agar consisting of 0.6% 
n u tr ie n t agar and 0.5% NaCl (w/v in water) was always made up fresh , 
autoclaved and maintained at 45°C before use.
( i i ) Preparation of bacteria cu ltu re
Fresh cultures of Salmonella typhimurium s tra in  TA-100 were 
prepared by inocu lating 5 ml nu tr ien t broth with stock cu ltu re . 
This was then incubated in a shaking water bath at 37°C overnight 
(16 hours) and the resu ltan t cu ltu re  kept at 0-4°C fo r  up to one 
week.
( i i i ) Test fo r  bacteria l v ia b i l i t y
The bacteria cu ltu re  was tested fo r  v ia b i l i t y  by colony growth 
on agar supplemented with L -h is t id in e .  The cu ltu re  was s e r ia l ly  
d ilu ted  three times with nu tr ien t broth to give a f in a l  d i lu t io n  
fa c to r  of 10 . Aliquots (0.1 ml) of the f in a l  d i lu t io n  were 
transferred to 2 ml of nu tr ien t top agar ( f o r t i f i e d  with 0.2 ml of a 
so lu tion containing 0.1 M L -h is t id in e  and 0.5 mM b io t in ) ,  mixed, 
and poured on to minimum agar p la tes. These were allowed to set and 
incubated at 37°C fo r  24 hours, a f te r  which the colonies were 
counted and the number of bacteria per ml of the o r ig in a l cu ltu re  
calculated.
( iv )  Test fo r  spontaneous mutation rate
This tes t was performed to detect any contamination or 
a lte ra t io n  of the t r a i t s  of a p a r t ic u la r  s t ra in .  To 2 ml of
nu tr ien t agar ( f o r t i f i e d  with 0.2 ml of a solution containing 
0.5 mM L -h is t id in e  and 0.5 mM b io t in )  was added 0.1 ml of the 
bacteria l cu ltu re , mixed and poured onto minimum agar plates. 
These were allowed to set and were incubated fo r  48 hours, a fte r 
which the number of revertant colonies were counted.
The number of revertant colonies obtained fo r  the bacteria 
cu ltu re  was 87, which was w ith in  the range of 80-150 ch a ra c te r is t ic  
of Salmonella typhimurium TA-100.
Mutagenesis assay
This was always carried out in t r ip l ic a te s .
The volume of S9 mix was calculated and prepared in the
fo llow ing proportion:
KH2P04-Na0H buffer (0.2 M) pH 7.4 10 ml
Potassium ch loride (0.033 M) 2 ml
Magnesium chloride (0.08 M) 2 ml
*Cofactor so lu tion 4 ml
S9 f ra c t io n  (25%) 2 ml
* Cofactor solution contained NADP+ (2 0 y mol/ml) and glucose 6-
phosphate (2 5 ymol/ml).
Benzo(a)pyrene was prepared as 200 yg/ml so lu tion  in
dimethylsulphoxide.
To 2 ml of nu tr ien t agar containing 0.2 ml of 0.5 mM
L -h is t id in e  and 0.5 mM b io t in  so lu tion was added 0.1 ml of the
bacteria cu ltu re  (approximately 10^ bac te r ia /m l), followed by an
appropriate volume of benzo(a)pyrene (or the maximum volume of 
solvent (100:yl) fo r  the blank). F in a l ly  the S9 mix (0.5 ml) was 
added to each tube, mixed rap id ly  and poured onto a minimum agar 
p late so that the enzyme preparation was not maintained at the 
temperature of the molten agar (45°C) fo r  more than a few seconds. 
The plates were gently t i l t e d  to d is t r ib u te  the agar uniformly 
before i t  had started to harden. The agar was then allowed to 
s o l id i f y  before incubating the plates at 37°C fo r  48 hours. A fte r 
th is  period, the number of revertant colonies were counted.
S ta t is t ic a l  analysis
Comparison between two sets of data were carried out using a 
Student's t - t e s t  programme on an O l iv e t t i  microcomputer. The 
s ta t is t ic a l  s ign if icance was calculated using (n^ + n2 - 2) degrees of 
freedom where n^ and n2 are the number of samples in each group.
CHAPTER 3:
FOETAL AND NEONATAL DEVELOPMENT OF PB-CYTOCHROME P-450- AND 
CYTOCHROME P-448-CATALYSED MIXED-FUNCTION OXIDASES IN THE 
RAT: INDUCTION BY 3-METHYLCHOLANTHRENE
INTRODUCTION
Numerous studies have shown that foe ta l and neonatal animals of 
most mammalian species have a very low capacity to oxidize xenobiotics 
(Jondorf et a l . ,  1959; Short & Davis,1970; Fouts & Devereux, 1972;
Guenthner and Mannering, 1977; Blake et_ , 1976). The l im ited
capacity fo r drug metabolism has been a ttr ibu ted  largely to a d e f ic i t  
in the contents of foe ta l and neonatal hepatic mixed-function oxidases 
and of other enzymes involved in drug metabolism (Neims et a l . ,  1976). 
However, sho rt ly  a fte r  b i r th ,  drug-metabolizing enzyme a c t iv i t ie s
develop ra p id ly ,  reaching adult levels during the f i r s t  few weeks 
postpartum (Short & Davis, 1970; MacLeod et a l . ,  1972; Tredger et a l . ,  
1976). F in a l ly ,  there is a decline in hepatic MFO a c t iv i t ie s  in
senescent animals (Kato et a l . ,  1964; Birnbaum & Baird, 1978; Rikans & 
Not le y ,1982).
Evidence available now suggests that the postnatal changes in 
hepatic monooxygenase a c t iv i t ie s  are re lated to q u a l i ta t iv e  and 
quan tita t ive  a lte ra t ions  in the population of spec if ic  forms of the 
cytochromes P-450 (Vlazuk & Walz, 1982; Maeda et a l . ,  1984; Kitada et_ 
a l . ,  1985). Indeed, several reports have indicated that the foe ta l and 
neonatal hepatic MFO system d i f fe rs  sub s tan t ia l ly  from that of the
adult in i ts  k in e t ic  cha rac te r is t ics , c a ta ly t ic  properties, pH optima, 
spectral in te ractions with various substrates and s e n s i t iv i t y  to 
in h ib ito rs  (Jondorf et a l . ,  1959; Soyka, 1969; Pelkonen, 1973; Iba
et a l . ,  1977; Tredger & Chhabra, 1980). More recently , Kitada and 
associates (1985) have p u r i f ie d  and characterized a d is t in c t  form of 
cytochrome P-450 in human foe ta l l iv e r ,  namely cytochrome P-450 HFLa. 
Cytochrome P-450HFLa comprises about 50% of the to ta l  cytochromes P-450 
in human foe ta l l iv e r ,  but decreases with maturation to less than 5% of 
the to ta l haemoprotein content of adult l iv e r  microsomes. S im ila r ly ,  
while cytochromes P-450 forms 2 and 4 are both apparently absent from 
rabbit neonatal l iv e rs ,  th e ir  subsequent appearance in adult l ive rs  
indicates that the natural occurrence of these forms is regulated by an 
age-dependent process (Schwab et a l .,1980; Chiang et a4 . ,  1983).
The two most extensively studied forms of cytochrome P-450 are the 
PB-inducible cytochromes P-450 (ra t cytochromes P-450b and P-450e, 
rabb it form 2) and the 3-MC-inducible cytochromes P-448 (ra t 
cytochromes P-450c and P-450d, rabb it forms 6 and 4). These forms 
possess d is t in c t ly  d i f fe re n t  substrate binding s ites (P h il l ipson  et 
a l ♦, 1982; Lewis et a l . ,  1986) and show marked differences in -substrate 
s p e c i f ic i t ie s  and in regio- and s te re o -s e le c t iv i ty  (Lu & West, 1980; 
Lewis et a 1. ,  1986). They have also been shown to play contrasting 
roles in the ac tiva tion  and deactivation of xenobiotics (Parke & 
Ioannides, 1982). The developmental p ro f i le  of these two isozymes also 
appears to be markedly d i f fe re n t .  Thus the cytochrome P-448-catalyzed 
biphenyl 2-hydroxylase a c t iv i t y  is highest at b i r th  and gradually 
declines with age while in contrast, PB-cytochrome P450-catalyzed 
a c t iv i t y  as exemplified by benzphetamine N-demethylase, is lowest at 
b ir th  and increases to adult levels pos tna ta lly  (Basu et a l . ,  1971;
- bU -
Atlas et a l . ,1977, Song et a l . ,  1986).
Previous studies on the development of cytochrome P-448 have 
employed benzo(a)pyrene hydroxylase, or AHH, as a spec if ic  probe fo r  
th is  isozyme. However, i t  has now been shown that AHH a c t iv i t y  may be 
catalyzed by e ithe r PB-cytochrome P-450 or cytochrome P-448 and that 
both these types of AHH systems ex is t in ra t (Wiebel & Gelboin, 1975)
and mouse (Nebert et a l . ,  1975) l i v e r .  On the other hand, studies with
p u r if ie d  ra t l iv e r  microsomal preparations showed tha t the
O-deethylation, of ethoxyresorufin is catalyzed p re fe re n t ia l ly  by 
cytochrome P-450c in the ra t ,  and to a much lesser extent by cytochrome 
P-450d, but not by any of the PB-inducible cytochromes P-450 (Goldstein 
et a l . ,  1982; Guengerich et a t . ,  1982a; Tamburini et a l . ,  1984; Astrom 
and DePierre, 1985). S im ila r ly  in the ra bb it ,  form 4 induced by PAHs 
s p e c i f ic a l ly  catalyzes the EROD reaction , but form 2 induced by PB does
not (Johnson et a l . ,  1979; Nilsen e t al_., 1981; Domin and Philpo t,
1986). However in the ra b b it ,  another isozyme namely form 6 which is 
inducible by TCOD in the neonatal animal also catalyzes the EROD 
reaction (Norman et a l . ,  1978; Domin and Philpo t, 1986). An excellent 
co rre la t ion  is obtained in the ra t between the 0-deethylation of
ethoxyresorufin and the cytochrome P-448-dependent ac tiva t ion  of
benzo(a) pyrene (Ph il l ipson et a l . ,  1985). These resu lts  ind icate that 
the EROD assay may be used as a spec if ic  probe to monitor cytochrome 
P-448-mediated a c t iv i t ie s .
- b l ­
i t  has generally been found that the response of the foe ta l l iv e r  
to inducing agents is d i f fe re n t  from that of the neonatal and adult 
l iv e r .  For instance, administration of TCDD to the pregnant rabb it 
induces predominantly form 4 in the maternal l iv e r  and form 6 in the 
neonatal l iv e r  (Norman et a1. ,  1980). In contrast, PB induces the same 
major isozyme, namely form 2, in both adult and neonatal rabbits 
(Schwab et a l . ,  1980). Moreover, whereas administration of PB to the 
pregnant ra t fa i le d  to induce the foe ta l mixed-function oxidases 
(Guenthner & Mannering, 1977; Creste il et a l . ,  1979; Popova et a l . ,  
1985), administration of PAHs or polychlorinated biphenyls resulted in 
transplacental induction of AHH a c t iv i t y  (Nebert & Gelboin, 1969; 
Guenthner & Mannering, 1977), but not the N-demethylation of
3-methyl-4-methylaminoazobenzene (Bresnick and Stevenson, 1968), a 
reaction which is now known to be catalyzed by both cytochromes P-450c 
and P-450d in 3MC-induced microsomes (Kimura et a1. ,  1985). These 
observations indicate that the gene expression of the cytochrome P-450 
isozymes during ontogenesis is under d i f fe re n t  regulatory con tro l. 
Indeed, recent studies have demonstrated that 3-MC-induced AHH a c t iv i t y  
appears e a r l ie r  during the gestation period than does acetan il ide
4-hydroxylase in the mouse (Guenthner & Nebert, 1978; Ikeda et a l . ,  
1983, Tuteja et a 1. ,  1985), ra t (Guenthner & Nebert, 1978) and rabb it 
(Atlas et a l . 1977).
In the present study, using more spec if ic  methodology, we 
investigated the foe ta l and neonatal development of PB-cytochromes 
P-450 and cytochromes P-448 in the ra t l iv e r ,  and th e ir  in d u c ib i1i t y  by 
3-MC.
MATERIALS AND METHODS
Animal treatment
Male animals were used in a l l  developmental studies except fo r  the
1-day and 1-week-old when animals of e ithe r sex were used. Induction 
of the mixed-function oxidases was achieved by a single
in trape r it ion ea l administration of 3-MC (20mg/kg) in corn o i l  (5mg/ml), 
a l l  animals being k i l le d  24 hours la te r .
In the pregnancy studies, 6 females were mated with a proven male 
breeder fo r 24 hours. The next day was considered as day 1 gestation
and pregnancy was confirmed by abdominal p a lp ita t io n  at day 7. For the
induction studies, animals received on the 21st day of gestation a
single in tra p e r it io n e a l in je c t io n  of 3-MC (20mg/kg). A l l  foetuses were 
obtained by Caesarean section 24 hours la te r .
A l l  control animals were untreated.
Preparation of microsomes
Liver microsomes were prepared from 1-day and 1-week old neonates 
as described in Chapter 2.
Foetuses were removed in utero and decapitated l ive rs  from each 
l i t t e r  were pooled together and homogenized in a bu ffer containing 
sucrose (0.25M), EDTA (ImM) and T r is -b u f fe r  (ImM), pH 7.4 (C reste il
et a l . ,  1979). Placentae were removed and freed from a l l  connective 
tissue; the placentae from each l i t t e r  were pooled. L iver and 
placental postmitochondrial (9,000g) supernatant and microsomal 
suspensions were prepared as described in Chapter 2.
Enzyme Assays
The fo llow ing assays were determined: on microsomal supernatants,
benzphetamine N-demethylase, biphenyl 2- and 4-hydroxylase; on
microsomal suspensions, ethoxyresorufin O-deethylase (EROD), 
NADPH-cytochrome c reductase, cytochromes P-450 and b5, and prote in . 
Detailed methodology is described in Chapter 2.
RESULTS
Cytochrome P-450 levels were low at b ir th  but increased ra p id ly  to 
reach adult levels at 4 weeks of age (Table 3.1). The same 
developmental pattern was observed with cytochrome b5. However, 
NADPH-cytochrome c reductase was s t i l l  increasing at 8 weeks of age.
Microsomal protein content was increased 2-fo ld  by 2 weeks of age 
and subsequently decreased in the older age groups (Table 3.1) The
N-demethylation of benzphetamine could not be detected in 1-day-old 
neonates but increased ra p id ly  during the postnatal period. In 
contrast, the 0-deethylat ion of ethoxyresorufin was present in neonatal 
l iv e rs ,  reaching a maximum at 2 weeks of age and then decreased with
increasing age (Fig. 3.1).
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F ig .3.1 THE EFFECT OF AGE ON THE DEVELOPMENT 
OF HEPATIC MICROSOMAL ETHOXYRESORUFIN 
O-DEETHYLASE AND BENZPHETAMINE N-DEMETHYLASE 
ACTIVITIES IN THE RAT.
Each point represents the mean ± S.E.M. 
fo r  f iv e  animals. (■) ethoxyresorufin
0-deethylase; ( • )  benzphetamine N-demethylase.
-  66 -
Benzphetamine N-dem ethylase (um ol/m in  per nmol cytochrome P-450)
t \ j  O  CO vO CM
o  o  o  o
oooooo
cm o  co vo cm
r— o  o ' O  O
(OSfr-d swojtpo^Ao iol'ju ja o  uiiu /iouju) as e iX ifja o p -g  u ijn jo sauA xo iftg
Following 3-MC administration, to ta l cytochrome P450 content was 
increased s l ig h t ly  in a l l  age groups but was s ta t is t i c a l l y  s ig n if ic a n t  
only in the 8- and 14-week old animals. The N-demethylation of 
benzphetamine and 4-hydroxyl at ion of biphenyl were unaffected by 3-MC 
treatment; in contrast, the 2-hydroxylation of biphenyl and
0-deethylation of ethoxyresorufin were induced in a l l  age groups 
studied, the extent of induction (as % control a c t iv i t y )  being higher 
with increasing age (Table 3.2).
MFO a c t iv i t ie s  were present in 21-day-old foe ta l hepatic microsomes 
but at very low levels compared to the maternal l iv e r  a c t iv i t ie s ,  with 
the exception of EROD which was higher in the foe ta l l iv e r  (Table 
3.3). However, no cytochrome P-450 was detected in the foe ta l 
microsomes when determined spec tra lly  as the carbon monoxide-reduced
cytochrome P-450 spectrum. Perinatal administration of 3-MC to the 
mother caused a marked enhancement of a c t iv i t y  only in the maternal
l iv e r  but not in the foe ta l l iv e r  (Table 3.3). Benzphetamine
N-demethylase and NADPH-cytochrome c reductase a c t iv i t ie s  in both the 
maternal and foe ta l l ive rs  were unaffected by 3-MC administra tion.
In placental microsomes from untreated animals, the EROD a c t iv i t y  
was detectable only in one sample (6 pmol/min per mg pro te in ) while 
benzphetamine N-demethylase, cytochrome P-450 and cytochrome b5 
a c t iv i t ie s  were not detectable (Table 3 .4 ). A fte r 3-MC treatment, only 
the EROD a c t iv i ty  was induced and was found in a l l  four samples while 
other MFO a c t iv i t ie s  were not s ig n if ic a n t ly  affected (Table 3 .4 ).
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TABLE 3.4
PLACENTAL MICROSOMAL MIXED-FUNCTION OXIDASES: EFFECT OF 
3-METHYLCHOLANTHRENE (3-MC)
Pregnant animals received a sing le in traperitonea l administration of 
3-methylcholanthrene (20mg/kg). Placentae of 21-day old foetuses were 
removed and pooled fo r  each l i t t e r .  Results are presented as mean ± 
S.E.M. fo r  four determinations.
Parameter Control 3-MC
Benzphetamine N-demethylase 
(nmol/min per mg prote in)
ND ND
Biphenyl 2-hydroxylase 
(nmol/min per mg prote in)
0.21±0.09 0.17±0.10
Biphenyl 4-hydroxylase 
(nmol/min per mg prote in)
2. 4± 1.6 1.2±0.4
Ethoxyresorufin O-deethylase 
(pmol/min per mg prote in)
(a) 12±7
Cytochrome P-450 
(mg/g l iv e r )
ND ND
Cytochrome bs 
(mg/g l iv e r )
ND ND
Microsomal protein 
(mg/g l iv e r )
H
-*
I i
4.8±0.6
ND = not detectable
(a) A c t iv i ty  detected in only one sample (6 pmol/min per mg prote in)
DISCUSSION
In the present study, we have investigated the developmental 
p ro f i le  of two fam ilies  of cytochrome P-450, namely'the PB-inducible 
cytochromes P-450 and the PAH-inducible cytochromes P-448, and the
enzyme a c t iv i t ie s  associated with them, in ra t  l iv e r .  Sex differences 
have been shown to ex is t in the postnatal development of co n s t itu t ive  
forms of cytochrome P-450 isozymes and in the age-associated changes in 
drug metabolizing enzyme a c t iv i t ie s  in hepatic tissues. (Maeda et a l . ,  
1984; Kamataki et a l . ,  1985). Furthermore, EROD a c t iv i ty  is higher in 
hepatic microsomes from adult female rats than from male animals, 
ind ica ting  that the l iv e r  of female rats has a higher content of
cytochromes P-448 (Vodicnik et al_., 1981). Thus, in our present
investigation only male animals were used, except fo r  the 1-day and
1-week-old where animals of e ithe r sex were used. No sex differences 
in MFO or constituent forms of cytochrome P-450 occur at these ages 
(MacLeod et a l . ,  1972; Vlasuk and Walz, 1982; Maeda et a l . ,  1984).
When the MFO a c t iv i t ie s  are expressed per un it  of to ta l  
haemoprotein, the development patterns of the PB-cytochrome P-450 and 
cytochrome P-448 a c t iv i t ie s  d i f f e r  markedly. Benzphetamine
N-demethylase was f i r s t  detected in the 1-week old neonates but no 
a c t iv i t y  was seen in the 1-day old animals. Thereafter N-demethylase 
a c t iv i t y  increased with age. S im ilar f ind ings were observed in the 
human l iv e r  in which benzphetamine N-demethylase a c t iv i t y  was lower in 
the foetus than in the adult (C reste il et a l . ,  1985). Likewise, very
low a c t iv i t y  was seen in 1-day and 4-day old rabb it neonatal l ive rs  
compared to a c t iv i t y  in adult l ive rs  (Schwab et a l . ,  1980; Tredger & 
Chhabra, 1980).
On the other hand, EROD was the only enzyme detected in the
1-day-old animals; peak a c t iv i t y  was reached at about 2 weeks 
postpartum and subsequently decreased with age (Fig. 3.1). These 
observations ind icate that cytochrome P-448 may be one of the 
predominant forms in the neonatal animal, but as the animal develops to 
maturity , PB-cytochrome P-450 a c t iv i t y  rises while that of cytochrome 
P-448 is suppressed. I t  is now well-established that the increased de 
novo synthesis of some forms of cytochrome P-450 is accompanied by a 
decrease in the concentration of other forms, re su lt in g  in a 
substitu tion  of cytochrome P-450 isozymes without any marked change in 
to ta l cytochrome P-450 content (Maeda et a l . , 1984; P h i l l ip s  et a 1. ,  
1985).
In traperitonea l administration of 3-MC enhanced the 0-deethylat ion 
of ethoxyresoruf in and the 2-hydroxyl at ion of biphenyl at a l l  ages 
postpartum. Extent of induction increased with age and no plateau was 
achieved even at 14 weeks a fte r b ir th  (Fig. 3.2). The 4-hydroxyl at ion 
of biphenyl, a reaction catalyzed by both cytochrome P-448 and 
PB-cytochrome P-450 isozymes (Johnson et a l . ,  1979), showed a modest 
increase in the older animals but th is  was not s t a t i s t i c a l l y  
s ig n if ic a n t  (Table 3.2). Modest increases in the to ta l cytochrome 
P-450 concentrations were observed at a l l  ages studied but were 
s t a t i s t i c a l l y  s ig n if ic a n t only in the older animals. These resu lts  
demonstrate that in the ra t ,  in d u c ib i l i t y  of cytochrome P-448
F ig .3.2 THE EFFECT OF AGE ON THE INDUCIBILITY 
OF HEPATIC MICROSOMAL ETHOXYRESORUFIN 
O-DEETHYLASE AND BIPHENYL 2-HYDROXYLASE 
ACTIVITIES BY 3-METHYLCHOLANTHRENE 
ADMINISTRATION IN THE RAT.
Animals received a s ing le in trape ritonea l 
adm inistra tion of 3-methylcholanthrene (20mg/kg) 
and were k i l le d  24 hr. la te r .  Each point 
represents the mean ± S.E.M. fo r  5 animals.
Control a c t iv i t ie s  were fo r  biphenyl 2-hydroxylase 
( • )  a t 1,4,8,14 weeks = 0.54±0.13, 0.24±0.01, 
0.23±0.16, 0.16±0.03; ethoxyresorufin O-deethylase 
(■) at 1,4,8,14 weeks: 0.35±0.11, 0.25±0.05,
0.16±0.02, 0.09±0.03; nmol/min per nmol 
cytochrome P-450.
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a c t iv i t ie s  is low at b ir th  and increases with age. In contrast, 
e a r l ie r  workers have demonstrated that the in d u c ib i l i t y  by PB of 
PB-cytochrome P-450-dependent a c t iv i t ie s  was higher in young than in 
older animals (Kato & Tanaka, 1968; Basu et a l . ,  1971; Sunouchi et a l . ,
1984).
S im ila r ly ,  Schwab and coworkers (1980) reported that fo llow ing 
treatment with PB, benzphetamine N-demethylase a c t iv i t y  in rabb it 
neonatal l iv e r  microsomes was 3-fo ld  higher than that in adult l iv e r  
microsomes.
Results of our present study c le a r ly  showed that in the ra t ,  
development and in d u c ib i l i t y  of PB-cytochromes P-450- and cytochrome 
P-448-mediated a c t iv i t ie s  fo llow  markedly d i f fe re n t  patterns. Basal 
cytochrome P-448 a c t iv i t y  is high in the neonates and i ts  in d u c ib i l i t y  
increases with age. In contrast, basal PB-cytochrome P-450 a c t iv i t y  is 
lowest at b ir th  and i ts  in d u c ib i l i t y  decreases with age. I t  is
possible that the low in d u c ib i l i t y  of cytochrome P-448 in the neonate
is due at least p a rt ly  to the fac t that th is  isozyme is already present 
as a predominant form at th is  age. S im ila r ly ,  the in d u c ib i l i t y  of
PB-cytochrome P-450 is lowest in the adult where th is  isozyme is a 
major form.
EROD was the only enzyme a c t iv i t y  that was higher in foe ta l l iv e r  
when compared to maternal (Table 3 .3 ), ind ica ting  that as in the
neonate, cytochrome P-448 is also a major isozyme in the foetus.
Recent studies have shown that cy toso lic  mRNAs coding fo r  
cytochromes P-450b and P-450e were detectable immunochemically at, but 
not p r io r ,  to day 22 of gestation (G iachelli & Omiecinski, 1986). 
Hence the fa i lu re  of PB to induce MFO a c t iv i t ie s  in la te foetuses 
cannot be due to lack of mRNA accumulation, but may instead be due to 
regulation of mRNA tra n s la t io n ;  a l te rn a t iv e ly ,  some endogenous
in h ib i to ry  factors may be present (Guenthner & Mannering, 1977) which
appear to be removed or suppressed by the end of the normal gestational
period rather than by p a r tu r i t io n  per se (Schubert & Netter, 1981).
Furthermore, the development of the male pattern of drug
metabolism, which although not manifested u n t i l  puberty, requires the 
presence of androgens during the neonatal period ("neonatal 
androgen^imprinting") (Finnen & Hassall, 1984; Kamataki et a l .,1984). 
However, administration of testoterone to neonatal female rats had no 
effec t on the female pattern of drug metabolism unless the animals were 
ovarectomized, ind ica ting  the influence of the ovaries on the neonatal 
imprinting by testosterone (Finnen & Hassall, 1984). I t  has been 
reported that an increase in microsomal MFO a c t iv i t ie s  of the 
cytochrome P-448 type, such as increased binding of benzo(a)pyrene to 
ca lf  thymus DNA in v i t r o , occurred in adult rats which have been 
treated with PB during the neonatal period (Faris & Campbell, 1983; 
Bagley & Hayes, 1985a). These observations ind icate tha t the 
developmental patterns of the hepatic MFO system may be more 
complicated than e a r l ie r  believed.
Although mammalian placentae possesses cytochrome P-450-associated 
enzymes which are involved in the synthesis of s tero id  hormones 
(Pelkonen & Pasanen, 1984; Tan & Muto, 1986), i ts  capacity for
xenobiotic metabolism is generally very low (Rettie et a l . ,  1985). 
However, exposure to PAH (e.g. in c iga re tte  smoke), or to
polychlorinated biphenyls markedly enhances cytochrome P-448-dependent 
a c t iv i t ie s  including AHH, EROD and the 6- and 8-hydroxyl at ion of 
warfarin (Kaelin & Cummings, 1983; Rettie et a l . 1985; Wong et a l . ,  
1986). Moreover placental microsomes from human subjects exposed to 
polychlorinated biphenyls were found to contain an isozyme of 
cytochrome P-450 which cross-reacted with an antibody to rabb it form 6 
(Wong et a l ., 1986). In the present study, 3-MC-treatment induced EROD 
but not other MFO a c t iv i t ie s  in the ra t placenta, ind ica ting  that th is  
assay may be used as a sens it ive  probe to monitor the placental
cytochrome P-448 levels and hence the xenob io tic -ac tiva ting  po ten tia l 
of th is  t issue.
In conclusion, resu lts  of the present study support previous
find ings that the appearance and in d u c ib i l i t y  of m u lt ip le  forms of 
cytochrome P-450 are regulated by an age-dependent process. 
Furthermore, the temporal regulation of these m ult ip le  cytochrome P-450 
forms may explain the age-development of the various MFO a c t iv i t ie s .  
Cytochrome P-448 is a predominant form in the foe ta l and neonatal l iv e r  
but is gradually replaced by PB-cytochrome P-450 in the adult animal. 
Since cytochrome P-448 is associated with the metabolic ac tiva tion  of 
drugs and carcinogens to th e ir  tox ic  reactive intermediates (Parke & 
Ioannides, 1982; Steele et a l . ,  1983), the foetus and neonate may be 
more susceptible to the to x ic i t y  of these chemicals. Indeed i t  has
been shown that neonatal rats have a higher capacity to activate tox ic  
doses of paracetamol to covalently  bound intermediates (Green & 
Fischer, 1984).
CHAPTER 4 :
TISSUE DIFFERENCES IN THE INDUCTION OF 
CYTOCHROMES P-448 BY CHEMICAL CARCINOGENS
INTRODUCTION
I t  is now well recognised that PB-cytochromes P-450 and cytochromes 
P-448 represent two d is t in c t  enzyme proteins with widely d i f fe re n t  
substrate binding s ites and exh ib it ing  markedly d i f fe re n t  substrate 
s p e c i f ic i t ie s .  Moreover, cytochromes P-448 are found in malignantly 
transformed ce l ls  and are induced, instead of PB-cytochrome P-450, by 
chemical carcinogens (Parke & Gray, 1978). Thus, in a study of the 
biochemical changes in the l iv e rs  of rats repeatedly dosed with various 
hepatotoxins and hepatocarcinogens, i t  was observed tha t hepatic 
carcinogens such as safro le  and 2-acetamidofluorene (2-AAF) caused a 
marked increase in the cytochrome P-448-mediated biphenyl 2- 
hydroxylation (Parke & Gray, 1978). In contrast, chemicals such as 
butylated hydroxytoluene and PB led to an extensive hypertrophy of the 
l iv e r  with marked p ro l i fe ra t io n  of the endoplasmic re ticu lum , and a 
substantia l increase in cytochrome P-450 content but with no increase in 
cytochrome P-448 a c t iv i t y  (Parke & Gray, 1978). I t  was therefore 
suggested tha t an increase in cytochrome P-448 may be a marker of 
hepatocarcinogenicity (Parke & Gray, 1978).
Genetic studies with inbred mouse s tra ins  have demonstrated tha t 
the induction of cytochrome P-448 and i t s  associated MFO a c t iv i t ie s  is 
regulated by a spec if ic  gene or group of genes that has been re ferred to 
as the "Ah locus". Aryl hydrocarbon hydroxylase (AHH), ace tan ilide  
4-hydroxylase and several other monooxygenase a c t iv i t ie s  are induced by 
po lycyc lic  aromatic hydrocarbons (PAHs) only in responsive mice such as 
the C57BL s tra in ,  but not in the DBA and other non-responsive s tra ins  
(Nebert et a K , 1973). Nevertheless, TCDD is capable of f u l l y  expressing 
induction of cytochrome P-448-related a c t iv i t ie s  in both responsive and 
non-responsi ve mice (Poland et a1_., 1974; Atlas & Nebert, 1976),
although about 10 times more TCDD is needed to induce DBA than C57BL mice 
(Poland & Grover, 1975). I t  has fu r th e r  been shown that the induction of 
cytochrome P-448 is  mediated by a cy toso lic  protein receptor which is  a 
major product of the Ah locus. This receptor binds with high a f f in i t y  to 
TCDD and other cytochrome P-448 inducers; the inducer-cytoso lic  receptor 
complex then translocates to the nucleus (Okey et aj_., 1979; Greenlee & 
Poland, 1979; Tukey et ai[., 1982), where subsequent binding to DNA leads 
to altered gene expression (Carlstedt-Duke et al_., 1981).
Genetica lly "non-responsive" s tra ins  of inbred mice appear to have 
a lower number, or poorer a f f in i t y ,  of cy toso lic  binding s ite s ,  or both 
(Okey et 1979). An excellent co rre la t ion  has been found to  ex is t
between the a f f in i t y  fo r  the cy toso lic  receptor and the capacity to 
induce cytochrome P-448 in human and ra t hepatoma H-4-II-E  c e l ls  fo r  a 
large number of PAHs and other compounds (Bigelow & Nebert, 1982). Other 
studies have demonstrated that responsive mice activa te  carcinogens much 
more e f f ic ie n t ly  than non-responsive s tra ins ; responsive mice are also 
more susceptible to PAH-initiated tumorigenesis, presumably because the 
higher cytochrome P-448 content in responsive mice resu lts  in higher 
steady-state levels of ultimate carcinogenic intermediates (Nebert & 
Oensen, 1979).
In view of the association of cytochrome P-448 with 
carc inogen ic ity , the present study was undertaken to investiga te  the 
induction of cytochrome P-448 by carcinogens and several other 
xenobiotics in ra t hepatic and extrahepatic tissues. Ethoxyresorufin, 
which is 0-deethylated exclus ive ly  by cytochrome P-448 (Goldstein et 
a l ., 1982; Guengerich et a K , 1982a; Astom & DePierre, 1985) was used 
as a spec if ic  substrate fo r  th is  cytochrome.
MATERIALS AND METHODS
Animal treatment
Animals received a sing le in traperitonea l administration (50 mg/kg) 
of the tes t compound dissolved in e ithe r saline or corn o i l .  Animals 
were k i l le d  24 hours la te r  by cerv ica l d is loca tion , and the l iv e r ,  
lungs, kidneys, heart and brain were qu ick ly  excised.
Preparation of microsomes
Hepatic microsomes were prepared as described in Chapter 2. 
Microsomes from kidney and brain tissues were prepared using the same 
procedure as that fo r  hepatic microsomes. The lungs and the heart, being 
fib rous tissues, were f i r s t  homogenized in a polytron homogenizer p r io r  
to homogenization in a Potter-Elvehjem homogenizer; a l l  other subsequent 
steps were the same as those fo r  the preparation of hepatic microsomes.
Enzyme assays
The fo llow ing assays were carried out on the microsomal 
suspensions: ethoxyresorufin O-deethylase (EROD), cytochrome P-450 and 
protein determination. Detailed methodology is described in Chapter 2.
RESULTS
In untreated adult male ra ts , EROD a c t iv i t y  was detected not only in 
the l iv e r ,  but also in the kidney and lung, the l iv e r  being by fa r  the 
most active tissue. In contrast no a c t iv i t y  was detected in e ith e r the 
heart or brain (Table 4 .1 ). S ign if ica n t a c t iv i t y  was also detected in 
the gut when isolated ce lls  instead of mucosal scrapings were used 
(Scott, A., 1985).
Table 4.1:
MICROSOMAL ETHOXYRESORUFIN O-DEETHYLASE ACTIVITY IN 
VARIOUS TISSUES OF THE UNTREATED RAT
Each value is presented as the mean + S.E.M. of four determinations.
Tissue Ethoxyresorufin O-deethylase 
(pmol/min per mg prote in)
L iver 75 + 18
Kidney 10 + 2
Lung 23 + 7
Heart <  1
Brain < 1
Hepatic O-deethylation of ethoxyresorufin was enhanced by a l l  
carcinogens studied (Table 4 .2 ), the extent o f s tim ulation ranging from 
4 -fo ld  fo r  7,12-dimethylbenz(a)anthracene and 2-AAF to 65-fo ld fo r  3-MC. 
When a c t iv i t ie s  were expressed per nmol of haemoprotein instead of per mg 
of microsomal pro te in , the increase in a c t iv i t y  was generally higher 
ind ica ting  that the increased enzymic a c t iv i t y  was due not only to 
increased synthesis of enzymic haemoprotein, but also to the synthesis 
of a new form of the cytochrome exh ib it ing  high a f f in i t y  towards 
ethoxyresorufin. The questionable carcinogens DDT, a ld r in ,  saccharin 
and ethanol gave r ise  to no s ig n if ic a n t  increase, but su rp r is in g ly  the 
hepatotoxic but non-carcinogenic anti-inflammatory drug, phenylbutazone 
caused a fo u r - fo ld  increase in a c t iv i t y  when expressed per nmol of 
haemoprotein, though not when a c t iv i t y  was expressed in terms of 
microsomal pro te in . Drugs such as antipyrine and imipramine had no 
e ffe c t on EROD a c t iv i t y  (Table 4 .2 ). Extrahepatic EROD a c t iv i t y  was 
also enhanced by administration of carcinogens, but to a much lesser 
extent. Generally, the degree of stim ula tion followed the pattern l iv e r  
>  kidney >  lung (Table 4 .3 ).
The po lycyc lic  aromatic hydrocarbons benzo(a)pyrene and 1 ,2 ,5 ,6 - 
dibenzanthracene enhanced EROD a c t iv i t y  in a l l  tissues while th e ir  non- 
carcinogenic analogues benzo(e)pyrene and anthracene had no such e f fe c t  
and even gave r ise  to in h ib i t io n  (Table 4 .4 ). Both isomers of 
naphthylamine enhanced EROD a c t iv i t y  in a l l  tissues studied, and to a 
s im ila r extent. The known carcinogens benzidine, N -n itroqu ino line  
N-oxide and 4-dimethylaminoazobenzene, and th e ir  "matched-pair" non- 
carcinogenic analogues, did not increase EROD a c t iv i t y ,  indeed they 
tended to exh ib it  in h ib i t io n .
IN
DU
CT
IO
N 
OF 
RAT
 
HE
PA
TIC
 
MI
CR
OS
OM
AL
 
ET
HO
XY
RE
SO
RU
FIN
 
O-
DE
ET
HY
LA
SE
 
BY 
CA
RC
IN
OG
EN
IC
 
AN
D 
NO
N-
CA
RC
IN
OG
EN
IC
 
CH
EM
IC
AL
S
- 85 -
oo
cu
J3>
rd
•
S-
<u
+->
rO
co
s - O
33 S-
O 4->
SZ £3
*0"
O
o
o o
* u
o
4->
(U
TO
r— <U
•r— S-
(O
cu
Q .
E
S- O
<u • o
S  cn
£3 <u
-O  o CO
c r • ! - fO
rO 4-> (U
fO %-
X J  C a
£3 • ! - c
zs E • i—
o  s - 
a t u H -
E  4-> o
O  CU 
O  TO cu
cu i -
* o
33
SZ  33 4->
+ j  o • i—
4- £3
4- cn
O  4- to
O E
c n  • 4-
-x s: O
cnuo S-
E  • cu
o o * o
O , s -
c o  + | o
c (U
CU ro sz
cn CU +0
O  E  
TO +->
CU c
• SZ cu
CL+J CO
• (U
• r -  CO s_
ro CL
<u cu
CD T3J S-
cz cu
•<- 4-> co
CO C3 cu
CU CO
rO co cu
CU 03
- a  s_ 4->
cu c l c
> cu
•1— co i~
CU - r - rO
o CL
cu cu
S- 33 C3i— • i—
tn  rC
i— > CO
rO cu
E  SZ 33
•r- O t—
£3 ro rO
C  LxJ
4- 
33
5- 
O  
co 
CU 
i -  >> 
X
osz40UJ
£3
E * —
\  13
>> C  *r-
40 •r- CU
•r— 4— 4->
> 33 O
• r- S- S-
4-» O  CL
O CO
rO cu cn 
s- E
CU
CO r— S_
rO o  CU
r — E  CL
>3 CL
SZ v—*
+J
cu
cu -—»
-a o
i LO
o C ’ f
c E  Q-
CU
EO
s-
X3o
o
4->
S_ o
0 
E01
o
Ec
S-
cu
CL
>>
4->
O tO
•r- O
£3 -r-
cu e  
cn <u
o  J3c o 
o 4—
o
ro
C_3
oi—i o on o on i-h coN«tOONVOHt-(UHO<-HtniDlCCMLn
+1+1+1+1+1+1+1+1+1+1+1+1+1+1+1+1
cn o o o o ^co co r—i«3-criO't^fio«—icor-'. H O O c o c o o w o o n w ^ w fO H H H
i—i i—f t—i *—ioo
in  ro
CO CO OO r - x r — ^
 -------------------OO CO CO CO '  T—l
o  O O s——'
o  c o  n  co  cm  oo a iOMO’^ COCOHH(OOOOlHCO<d-lOiniD
+ 1+ 1+ 1+ 1+ 1+ 1+ 1+ 1+ 1+ 1+ i+ 1+ 1+ 1+ 1+ I 
o o o o o i D i n o o o i N ' d - c n ^ N O
n O O H O H O H M O l D O O H O O O O
O  i—i r— co  i—i h  «—i
OO r-H
+ + + + + + I I I -f* 1+ I I I I I
cu
c
cuoro
s-
sz
4->C3ro
<u
C rO cu
CU -__- £3
i— f M CU
ro x : C3 s_
a 4-> CU o
•i— -—v £3 X ) 33 cu
E i— ro I— r— £3
cu O i— «o- CU >> 4 - O
sz £_ O LO £3 sz O N r—“
(_) 4-> _£3 OO •(— 4-> T3J rO o C
£3 CJ r-H E CU -1— 4-> E •r— <zz
cn O r— 1 rO E E 33 rO <_> •r—
£3 c_> >> £- cu S- •1— ro JD 4-> •i— S-
• 1— v__ X 3 o 1— J3 O 4-> i— CU C L rO
O +-> r— o 4~> 1 CU >> O E J3
33 <U CU O S- £3 OO O £3 rO ro CJ
T3J £3 s o 4 - <C 1— I < CU S- 4 - l_>
£3 O 1 £- rO 1 1 X3 rO •r— rO
►—i £23 ro c CO OO OO CL Cl CC CO
c  o
•r- C3 
S_ ro
cu
s-
CL
r— 4-> £3
< U J <
-  86 -
ro
'Ct
CD
xz
r d
o
E
C l
+ 1
. ro
S- oo<D
4-1
rd rccn
cz
c/1 Z3
UJ S- 1 •
oo Z3 C/l
c O cz
_J x z • in o
> - OO •1—
r c oo *3" 4-1
I— oo 4 . ]1 ^LU «=c T  11 CZ
LU CJ TO • I—
O 1—1 CD o E
1 z : i— 1—1 S-
O LU r— CD
z c •i— 4-1
z c CJ _X > , CD
i—i CD TO
Ll_ CJ CD C
ZO 1—1 TO S_
CC z . <D •r— Z5
o LU X o
oo CD 4 -
LU O TO
CC Z CZ 4 -
> - i—i rd • ft O
X CD CO
o CC TO x—1 CZ
D Z < E rd
t- CJ rs +  CD
LU 1 o E
■ZC Ol LOLi_ o E r^. CD
O 2 O XZ
CJ 4-1
z : o *
O z c CD C/l
i—i < x z CD 4-1
»— 4-1 > CZ
o CJ •r— CD
ro 1—1 4 - ( C/l
Q 2 : O ' —" CD
2 : LU S-
i—i CD -■—- C/l Q .
O CD CD CD
LU ZC -X Z3 S-
r c 1— 1 _ i—
h - CD cn rd CD
CC E > Z3
2 : < r—i—i CJ O i— rd
LO O >
oo > - ■>—ft s_
LU CO 4-1 XZ
CJ CD CZ CJ
1— c/l o rd
LU <c O CJ CD
cc cc TO
LU
U_ LU . 4 -Q • «
U_ ZC Q . -—-
f—I 1— • CZ
Q • r— •1—
z : CD
LU i—t CD c/l 4->
ZD t— rd O
OO cn s-
oo c TO Q .
in- a  £  cu
CU , C l
u Q>
1/1 CO 4 -
1/1 LOa> aj
>>
4-1
4->U
r d
cui/i
r d
XT
4-1a)<u*oi
o
4-
EoLOa)c>iX
o
c nc
Z5
>1
cdc
to
•r -
> 1
4-1
CJ r d  
•i—  CJ
C  -r-
cd E  
cn cuo  XZc u 
O 4-s- o  
r d  
O
Q <=> PS LO
o o•=d" olo
ro
co co lo co co co o
<;)• CO CM H  r t  ^  H
ocn
oro
oo
ro
CO CO CO 
l o  uo oo cn oo
O•=d*
ro
O O 
O  OO oo oo
O  cn lo oo oo o  o  co oo
oco
o  o o  o
+ + + + + + i 1+ I i i i i i i i i
CD CD
cz r —
1 CD • r -
o CJ s_
c / l r d 4-1
O i - •r—
S- x z e
4-1 4—1 o
•i— CZ x z
CZ r d S-
CD 1 -■— - r d
c X r d CD CJ
CD 1 v__- CZ 1
r— S- o N l CD
r d x z s_ CZ S- C5
CJ 4-> 4-1 CD o L O
•i— CZ • r - XZ zo CD i— t
E r d CZ i— 1— CZ
CD i— «=}• CD 1 CD X 4 - o CD
x : O L O CZ - CZ x z o N i— CZ
CJ XZ o o •r— X * 1— 4-1 TO r d o CD CD o
CJ X— 1 E 1 TO CD •i— 4-> CZ E CZ CD CZ 1----
cn 1— r d i— • f— E E Z3 • 1— r d • r - CZ • 1— o
cz >1 S- CD L - > 1  CZ r d X3 5 - 4-> s- O E cz
•1— x z o t— x z x z r d Q 4-1 i— r d  C CD > 1 M r d CD
CJ 4-1 1— o 4-> 4-> Z3 1 CD > 1  XZ *1— CJ Q . r d S- CZ
Z3 CD CJ s_ CZ CD cn o o CJ cz CJ i_ r d • i— S_ CZL cn
TO s o 4 - C z i 1 <C CD ( J  1—  T O S - 4-> C L ■1— CD
CZ 1 C- r d i 1 i XZ r d  O  i— r d CZ CD E S-
i— i r o  <C C O C \J X X o o Q _ C O  Q  C Q _ c Li_ H—4 Q _
CJ I—
• r -  > ,
o .x z  
E  Q - 
r d  O  
4 -  CD
CC ND 
(n
ot
 
de
te
ct
ab
le
),
 
<1
 
pm
ol
/m
in
 
pe
r 
mg 
pr
ot
ei
n
TH
E 
IN
DU
CT
IO
N 
OF 
ET
HO
XY
RE
SO
RU
FIN
 
O-
DE
ET
HY
LA
SE
 
BY 
CA
RC
IN
OG
EN
S 
AN
D 
TH
EIR
 
NO
N-
CA
RC
IN
OG
EN
IC
 
AN
AL
OG
UE
S
IN 
RA
T 
LI
VE
R,
 
KID
NE
Y 
AN
D 
LU
NG
- 87 -
o
E
CL
J O
rO
r-^
+ 1 
co•COS-
cu4-5rO
r\
cn
cz
Z3
cn•—
S-
ZZ •
O • «toXZ CO£Zo
•O' • f—CJ + 4-5ro
■ao CZcuX--1•1—Ei— S-• r— r\>>cu+->CUcu
cu
S-
c•a *o
cu*r—S-
3=.x C3o
■u 4-
c • rrOCO 1—1
4-O
•a
c: . CZ
Z3 + 1 rd
o CU
Q_LO EEo ajCJ xzc+j
cu
xz
S—
CUcn
4-> > 4-»,r—C
4- ' ^CU
O cncu---■Vm s_cncu Cl
.vc Z5 CUi— S-
CDrd
E > CUZ3
O t—LOO rO---- s- >4-5CUcz JO
in o oO o rO*a CU
CL
4—O
• C• i—
CU
<u to4->(-- ro Ocn S-
cz _  
on cn 
« c E 03 cu .
•o S “
d ) r  CL > o
CUO cu 
cu S-
J _  ro
i/) tn  M—
i—  -P  O  
rO i—  S_ 
E  =3 O
•r— CO ( / I
CZ <D (U  
C  CX u .
4-5
4-5
a
fO
<u
to
fO
*>»
xz
4-5
CU
CU
■ai
o
o
S-
o
in
cus~>>X
o
xz
4-5
LU
cn
czO
>>
cu
c:•a
>>
4-5
■ i—  r—
CJ rO 
•r- O  
C  - i -
cu E cn a)
o  JO
cz a
o M— 
s- o 
rO  
C_J
O
L O
O
L O or^ .
Oco LO
i—i
Oco
co
O O 
L O  L O
o
L O
CO
+ I
o  o
r-H CVI 
CM C\J
O O 
CVI t—l
O O O
• O '
L O
CO
L O
o  o  
l o  r - -  
l o  r ^ -
O  o
o  o o
CO
o
o
o  o
« 0 - L O  
C O  C O
o  o
CO CO
LO O  
i—H CO
o
o LOLO
+  +  +  I + I
a
cu XZ
T3 C L
* i— i—-
cu X zzs
cz o m
• 1— 1 i
•a z : 'O '
• i— 1
INI cu cu cu
cu CZ cu cz c: c:
cz cu TO •1— CU cu
cu JO • 1— r— INI N
CJ 1— X o CZ CZ
rO >■> o cz cu cu
S- s z 1 •1—- JO JO
x z 4-5 z : zz o o
1— 4—5 cu c r N INI
rO CZ cu CU E cu o rO fO
CJ rO c c: CO cr s_ O o 4-5
CU CU N •r— •i— S- • i—■ 4-5 CZ cz i—
E cz CZ CZ E E 4-5 i— •r— •1— • r— rO
cu cu CU CU rO rO CU o CZ E E m
-C S- s- JO i— i— 1— cz 1 r o r d
(J >1 >3 • i— CU > 3 1 •I— 1— i— rO
CL CL CJ cr XZ JO cu — o 1 >> > > 2 :
c n -—^-•—■» 1 cu 4-5 4-5 so LO C T r - JO SZ
c: rd CU LO o -C XZ •1— O > > 4-5 4-5 30
• i— V__•-----r rs rO CL Cl • a LO c . J O CU CU •i—
cj O o LO S- rO CO •i— ** 4-5 4-5 E E CJ
13 ro M r\ s z 2: INI — •r - CU •i— ■i— rO
T3 CZ CZ CVI 4-5 1 I c c o 21 Q o
C (U cu rs CZ cu rs i 1 1 i
I—i CQ CO i—H < c oa a co oo •O' co •O'
DISCUSSION
I n i t i a l l y ,  i t  was considered that the PB-inducible cytochrome P-450 
isozymes and the po lycyc lic  hydrocarbon-inducible cytochromes P-448 did 
not represent d is t in c t  prote ins. Instead, i t  was postulated that 
cytochrome P-448 was formed by the inducing agent such as sa fro le , 
benzo(a)pyrene or 3-MC, or one of th e ir  metabolites forming a ligand 
complex with cytochrome P-450 (F ranklin , 1977; Delaforge e t a/[., 1985), 
thereby blocking the substrate s i te ,  or causing a conformational change 
which prevented a type 1 substrate in te rac t io n . Consistent with th is  
suggestion is the f ind ing  that fo llow ing administration of ^C-3-MC to 
rabb its , 1.2 nmol of 3-MC ra d io a c t iv i ty  remained bound to 1.6 nmol of 
cytochrome P-448 four days la te r  (Jefcoate & Gaylor, 1969); more than 
90% of th is  ra d io a c t iv i ty  was extractable with acetone ind ica ting  that 
i t  was not covalently bound. Furthermore, Hashimoto & Imai (1976) had 
p u r if ie d  cytochrome P-448 from l iv e r  microsomes of 3-MC-treated rabb its  
to e lectrophoretic  homogeneity and showed that i t  was a c tu a lly  a complex 
of 3-MC with cytochrome P-450 in an equimolar ra t io ;  heptane extracts of 
the preparation showed an absorption spectrum s im ila r to tha t of 3-MC in 
heptane. Hepatic microsomes from 3-MC-treated rats incubated with 
biphenyl, which displaces ligands from the haem (Ioannides et a l . ,  
1981a; Delaforge et a4., 1982, 1985), showed a 25% increase in the amount 
of cytochrome determined as the carbon monoxide-reduced complex; no such 
e ffe c t was observed when microsomes from PB-treated ra ts  were used. 
These observations ind icate that 3-MC, or a m etabolite, may be 
associated with the s ix th  ligand of the haem, preventing i t s  in te ra c t io n  
with carbon monoxide. S im ilar resu lts  have been obtained with sa fro le ; 
the ligand complex formed by a reactive metabolite of sa fro le  with 
cytochrome P-450 is accompanied by a decrease in the concentration of 
free cytochrome P-450 and by a concomitant loss of MFO a c t iv i t y  (Anders,
1968; Parke & Rahman, 1971; Franklin , 1972). Some type I and reverse 
type I ,  but not type I I ,  substrates are able to displace the complex, 
leading to res tora tion  of the c a ta ly t ic  a c t iv i t y  of the cytochrome 
(Elcombe et a K , 1975; Delaforge et a K , 1980, 1985), presumably by 
removal of the haem-bound safro le metabolite.
In addition , electron spin state studies have shown tha t 3-MC 
treatment induced two forms of cytochrome P-448 in the ra t ,  one low spin 
and one high spin form (Ryan et a ^ . , 1975). Addition of 3-MC to the low 
spin form converted i t  to the high spin form, ind ica ting  tha t the la t te r  
is  a complex of the cytochrome with the carcinogen. More recent studies 
showed tha t benzo(a)pyrene and some phenolic de riva tives of 
benzo(a)pyrene form a s to ich iom etric  complex with p u r i f ie d  ra t  l i v e r  
cytochrome P-450c, inducing a low to high sp in-sta te  t ra n s it io n  in the 
cytochrome P-450c in the process (Marcus £ t  a /L , 1985; Turner e t a l . ,  
1985).
Nevertheless, administration of in h ib ito rs  of prote in synthesis 
such as ethionine or actinomycin D blocks the induction of MFO 
a c t iv i t ie s  by 3-MC (Conney & Gilman, 1963; Alvares et aj_., 1968) and 
TCDD (K itch in  & Woods, 1978), ind ica ting  tha t de novo synthesis of 
cytochrome P-448 is also involved in the induction process. I t  thus 
appeared that treatment of animals with carcinogens led f i r s t l y  to an 
immediate enhancement of cytochrome P-448 a c t iv i t y  re su lt in g  from 
conversion of cytochrome P-450 to cytochrome P-448, followed by de novo 
synthesis of cytochrome P-448 (Parke, 1980). However, i t  is now known 
that induction of cytochrome P-448 resu lts  p r in c ip a l ly  from die novo 
protein synthesis fo llow ing an increase in genomal mRNA tra n s c r ip t io n a l 
rate ( Is ra e l i  & Whitlock, 1984; Foldes et a l . ,  1985; Gonzalez et a l . ,
1985). Furthermore an increase in cytochrome P-448 may be accompanied by 
a suppression of PB-specific forms of the cytochrome (P h i l l ip s  et a l . ,  
1985; Steele & Ioannides, 1986).
In the present study, a va r ie ty  of chemical carcinogens, including 
the non-polycyclic hydrocarbons, N-methyl-N '-n itro-N-nitrosoguanid ine, 
Aroclor-1254, safro le  and 2-anthramine, were shown to markedly enhance 
EROD a c t iv i t y ,  presumably by induction of cytochrome P-448. A c t iv i t y  
was also enhanced in the lung and kidney, but to a much lesser extent. 
Moreover, studies with the two po lycyc lic  hydrocarbon pairs 
benzo(a)pyrene and benzo(e)pyrene, 1,2,5,6-dibenzanthracene and 
anthracene, only the carcinogenic analogues, benzo(a)pyrene and 1,2 ,5 ,6 - 
dibenzanthracene, enhanced EROD a c t iv i t y .  Both benzo(e)pyrene and 
anthracene were found to have no induction e f fe c t  on EROD a c t iv i t y .  
Unlike benzo(a)pyrene, the isomeric benzo(e)pyrene has at best marginal 
mutagenic and carcinogenic a c t iv i t y  in mammalian systems (Buening et 
a l . ,  1980; Chang ert aj_., 1981), presumably because the th e o re t ic a l ly  
predicted ultimate carcinogenic metabolites, the dio l-epoxides of 
benzo(e)pyrene, are not formed metabol ica l ly  (Wood ert a1_., 1979; MacLeod 
et aj_., 1980). Anthracene is metabolized mainly to inac tive  cysteine 
conjugates and hydroxylated products (Sims, 1964).
Both naphthylamines were pos it ive  in th is  enzyme assay in a l l  three 
tissues. Although 3 -naphthylamine is well established as a carcinogen, 
the carc inogenic ity  of the a -analogue is s t i l l  controvers ia l (Radomski, 
1979). Nevertheless, both compounds are mutagenic in the Ames te s t  
fo llow ing l iv e r  microsomal ac tiva t ion  (de Serres & Ashby, 1981). 
Moreover, l ik e  B-naphthylamine, a-naphthylamine is metabolized to the 
N-hydroxylamine deriva tive  which has been found to be mutagenic (Belman
et al_., 1968; Ames et a/L> 1972; Kadlubar et aJL, 1978; Oldham et a l . ,  
1981); these observations would ind icate a carcinogenic potentia l of 
the a -analogue. Of in te res t is the observation that the naphthylamines 
resulted in greater induction in the kidney than in the l iv e r .
In contrast to the re la t iv e ly  successful corre la tions of enzyme 
induction with carcinogenic p o te n t ia l ,  the three pairs of the 
carcinogens, benzidine, N -n itroqu ino line  N-oxide, 4-dimethyl- 
aminoazobenzene and th e ir  non-carcinogenic analogues could not be 
distinguished, and none of these showed any induction of the enzyme in 
any of the tissues (Table 4 .4 ). A common cha rac te r is t ic  of benzidine and 
4 -n itroqu ino line  N-oxide, which may account fo r  th e ir  lack of 
co rre la t ion  and lack of induction, is tha t th e ir  metabolic ac t iva t ion  to 
ultimate carcinogens is not catalyzed by cytochrome P-450-dependent 
mixed-function oxidation or they are activated only by th is  pathway 
a fte r  i n i t i a l  metabolism by other enzymes. Thus benzidine is  activated 
to mutagens by hepatic microsomal S9 preparations but no ac tiva t ion  was 
achieved when h igh ly p u r i f ie d  preparations of PB-cytochrome P-450 and 
cytochrome P-448 were used (Ioannides, C., personal communication). I t  
has been suggested that benzidine is  f i r s t  acetylated by hepatic 
cy toso lic  enzymes to give N-acetylbenzidine which is  fu r th e r  
N-hydroxylated by cytochrome P-448-dependent oxygenation to y ie ld  the 
proximate carcinogen; loss of hydroxyl ion from the hydroxyl amine would 
give a reactive aryln itren ium ion, the ultimate carcinogenic form 
involved in the covalent binding with DNA (Martin et a l . ,  1982; Frederick 
e_t a1_., 1985). Other workers have shown that benzidine is metabolized to 
N-acetylbenzidine and N,N '-diacetylbenzidine by ra t l i v e r  S9 
preparations supplemented with acetyl Co enzyme A, which is  accompanied 
by a marked increase in benzidine mutagenesis (Kenelly et a l . ,  1984). In
addition benzidine is inactive  in the Ames tes t when Salmonella 
typhimurium s tra in  TA 98/1,8-DNPg which is  d e f ic ie n t in acetylation 
a c t iv i t y ,  was used (DeFrance et aj_., 1985), ind ica ting  the importance of 
the acety lation step in benzidine ac t iva t ion . Benzidine can also be 
activated in vivo by the hydroperoxidase component of the prostaglandin 
synthetase system to form metabolites which are mutagenic (Robertson e t 
a l . ,  1983) and are capable of covalent binding to t issue nucleophiles 
(Rapp et a4. ,  1980; Zenser, 1980, 1983a, 1983b). N-Nitroquinoline 
N-oxide is  a potent carcinogen and mutagen (Nagao & Sugimura, 1976; 
Sharma et al_., 1984) but i t  did not induce EROD a c t iv i t y  in the present 
study. The activa t ion  of N -n itroqu ino line  N-oxide involves i n i t i a l  
reduction by soluble enzymes, followed by e s te r i f ic a t io n  to generate the 
u ltimate carcinogen (Radomski et a /h , 1973). Other aromatic n i t ro  
compounds such as 2 -n itro f luo rene , 4-n itrobiphenyl and
1-nitronaphthalene have also been shown to be reduced by cy toso lic  
aldehyde oxidase to the corresponding hydroxyl amines (Tatsumi et a l . ,
1986). With 4-dimethylaminoazobenzene, metabolic ac tiva t ion  involves an 
i n i t i a l  N-demethylation followed by N-hydroxylation, both reactions 
being mediated by cytochrome P-448 (Levin & Levin, 1983; Raza & Levin, 
1986; Kimura et , 1985). Furthermore, recent studies have shown that 
4-dimethylaminoazobenzene is  a se lective inducer of the high spin form 
of cytochrome P-448, namely cytochrome P-450d (Degawa et al_., 1986). 
Hence, i t  is surpris ing that 4-dimethylaminoazobenzene did not induce 
EROD a c t iv i t y  in the present study, espec ia lly  when the same dose regimen 
resulted in enhancement of the a c t iv i t y  in subsequent studies 
(Chapter 6).
In conclusion, the resu lts  of our present study ind icate tha t EROD 
is p re fe re n t ia l ly  induced by carcinogens which are activated p r in c ip a l ly  
by the cytochrome P-448-dependent MFO system.
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CHAPTER 5:
ALKOXYRESORUFIN O-DEALKYLASES: 
ASSOCIATION WITH THE MURINE Ah LOCUS
INTRODUCTION
Studies conducted in inbred stra ins of mice have provided extensive 
data on the genetic regula tion of cytochromes P-448 (Pi-450 and
P3-450). I t  is now known that administration of PAH compounds induces
hepatic microsomal hepatic AHH a c t iv i t y ,  which is associated with
cytochrome P i-450, much more read ily  in some s tra ins , termed 
"responsive" than in other s tra ins , termed "non-responsive". This 
genetic control of responsiveness to induction by PAH compounds is
exercised by the Ah locus which comprises numerous regula tory, 
s truc tu ra l and temporal genes (Nebert, 1979). The major product of the 
Ah locus is the Ah receptor, a high a f f in i t y ,  low capacity, cy toso lic  
receptor protein which has been id e n t i f ie d  in mammalian ce ll  cultures 
and in the hepatic and extrahepatic tissues of diverse animals 
including genetica lly  inbred responsive mice, rats and primates 
(Gasiewicz & Neal, 1982; Gasiewicz et a l .,  1984; Okey et a l . ,  1984a, 
1984b). The mechanism of induction involves an i n i t i a l  binding of the 
inducer with the Ah receptor in the cy toso lic  compartment followed by 
translocation of the inducer-receptor complex into the nucleus 
(Greenlee & Poland, 1979; Okey et a l . ,  1979; Mason & Okey, 1982) where 
i t  binds to DNA (Carlstedt-Duke et a1. ,  1981; Gonzalez & Nebert, 1985) 
or histones (Kurokawa & Sugano, 1983; Kurokawa & MacLeod, 1985a, 1985b) 
and somehow stimulates production of spec if ic  mRNAs which code fo r  
enzymes regulated by the Ah gene complex (Tukey et a l . ,  1982). 
Presumably, the i n i t i a l  binding process results  in a conformational
change(s) in the inducer-receptor protein complex which fa c i l i t a te s  
subsequent in teraction of the ligand complex with nuclear binding s ites
(Denomme et aV. , 1985). I t  has been shown that 3-MC treatment results  
in an increased rate of tra nsc r ip t ion  of the cytochrome P-450c gene in 
the ra t l iv e r  nucleus with subsequent accumulation of cytochrome 
P-450c mRNA in the cytosol (Foldes et a l . ,  1985; Hardwick et a l . ,  
1985).
Evidence now indicates that the Ah locus may code fo r  more than one 
type of Ah receptor. At least two d is t in c t  receptor proteins have so 
fa r  been id e n t i f ie d ,  a 4 -4 .5S protein that binds to substrates such as 
3-MC and benzo(a)pyrene (Tierney et a l . , 1983; Collins & M arietta ,
1984) and a 8-9S protein that binds to TCDD and a va r ie ty  of PAHs (Okey 
et a l . ,  1979, 1984a; Nebert et a l . ,  1984; Denison et a l . , 1986). The
8-9S protein is detectable only in hepatic cytosol of responsive mice 
and i ts  inheritance segregates with the Ah locus in genetic crosses, 
whereas the 4S component is present in hepatic cytosol from responsive 
and non-responsive mice and is not associated with the Ah^ a l le le  
governing AHH responsiveness (Okey & Vella, 1982; Okey et a l . ,  1984a).
Nevertheless, the 4S protein was found to in te ract with to ta l  ra t l iv e r
DNA and several subclones of ra t cytochrome P-450c gene (Houser et a l . ,
1985). I t  therefore appears l ik e ly  that both proteins are involved in 
the transregulation of cytochrome P-448 expression, possibly through 
d i f fe re n t  mechanisms and in response to d if fe re n t  classes of inducing 
agents.
In addition to AHH induction, more than 20 other monooxygenase 
a c t iv i t ie s  and several glucuronyl transferases have also been found to 
be coordinately induced by PAHs,including ethoxyresorufin O-deethylase 
(Nebert, 1979; Bock et a l . ,  1982). The present study was undertaken to
establish i f  the dealky lation of a homologous series of 
alkoxyresorufins and the oxidation of phenoxazone to resorufin  are also 
associated with the Ah locus in the mouse.
MATERIALS AND METHODS 
Animal treatment
Male and female adult C57BL/6 and DBA/2 mice received a s ingle 
in traperitonea l administration of 3-MC (20 mg/kg) dissolved in corn o i l  
(5 mg/ml) or saline (4 ml/kg).
Preparation of hepatic microsomes
Hepatic microsomal frac tions  were prepared as described in.Chapter
2 .
Enzyme assays
The microsomal dealkylation of alkoxyresorufins and hydroxylation 
of phenoxazone, cytochrome P-450 and protein levels were determined in 
microsomal suspensions as described in Chapter 2.
RESULTS
Microsomal levels of to ta l  cytochromes P-450 and protein in contro l 
and 3-MC-treated animals are shown in Table 5.1.
In control mice of both stra ins and in both sexes, the dea lky la tion  
rate was highest with methoxyresorufin as substrate (Table 5.2) and 
increasing the length of the alkyl chain resulted in a decrease in the
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rate of dea lky la tion . Benzyloxyresorufin was metabolised at a rate 
intermediate between those fo r  ethoxy- and butoxy-resorufin  (Table 
5.2). Phenoxazone hydroxylation was slower than the demethylation of
methoxyresorufin in both sexes of C57BL mice but was fa s te r  than the 
demethylation in DBA mice. With a l l  alkoxyresorufins the dealkylation 
rates were higher in the C57BL mice than the DBA mice, whereas the rate 
of phenoxazone hydroxylation was higher in the DBA mice. Sex 
differences were observed in C57BL mice with a l l  a lkoxyresorufins, the 
female being more e f f ic ie n t  in dealkylating these compounds especia lly  
the propoxy-, butoxy- and pentoxy-analogues. Generally s im ila r ,  but 
somewhat less pronounced sex differences were observed in DBA mice. In 
only the DBA mice the females were more e ffec t ive  in hydroxyl at ing
phenoxazone than the males.
Treatment with 3-MC gave r ise  to an increase in the rates of
dealkylation of a l l  alkoxyresorufins in the male C57BL mice (Fig. 5 .1 ),
the extent of s tim ula tion being highest with propoxy- and 
butoxy-resorufin and least fo r  pentoxy-, heptoxy- and 
benzyloxy-resorufin (Fig. 5 .1). The extent of induction was s im ila r  in 
the male and female C57BL mice fo r  methoxy-, ethoxy-, and 
benzyloxy-resoruf in but was higher in the male fo r a l l  the other 
resorufin ethers. Phenoxazone hydroxyl at ion was not induced by 3-MC in 
male C57BL mice and was suppressed in females. In contrast, treatment 
of DBA mice with 3-MC resulted in no increase in the dealky la tion rates 
of the various substrates in both male and female animals, and with 
most substrates even in h ib i t io n  was observed (Fig. 5.1).
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F ig .5.1 THE EFFECT OF 3-METHYLCHOLANTHRENE ON THE
DEALKYLATION OF ALKOXYRESORUFINS AND OXIDATION OF 
PHENOXAZONE IN C57BL/6 AND DBA/2 MICE OF BOTH SEXES.
The numbers on the abscissa ind ica te  the number o f
carbon atoms in  the n-alkoxyresorufin  side-chain
(B), benzyloxyresorufin; (0 ) ,  phenoxazone. Animals received
a s ing le  in trape ritonea l dose o f 3-methylcholanthrene
(20 mg/kg) and were k i l le d  24 hr. la te r .  Each point
represents the mean ± S.E.M. fo r  fou r animals. Control
a c t iv i t ie s  were as given in Table 5.2 (o) DBA female,
(A )  DBA male, ( • )  C57BL/6 female and ( a )  C57BL/6 male.
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DISCUSSION
The O-dealkylation of a l l  the resorufin analogues was achieved by 
microsomal preparations derived from both DBA and C57BL mice. The rate 
of O-dealkylation by both s tra ins of mice was inversely re lated to the 
length of the alkoxy side-chain, with the methoxy- and ethoxy- 
derivatives being most read ily  dealkylated. S im ilar f ind ings in the 
C57BL mice have been reported e a r l ie r  (Burke & Mayer, 1983) and the 
present study shows that the inverse re la t ionsh ip  between 
O-dealkylation rate and a lky l chain length is not confined to th is  
s tra in  of mice, but is also observed in the DBA mice. The differences 
in O-dealkylation rate of the various alkoxyresorufins cannot be 
a ttr ibu ted  to substrate 1 ipophi1i c i t y  since no corre la t ion  was evident 
between the e ffects  of chain length on 1ipophi1i c i t y  and rate of 
O-dealkylation (Burke & Mayer, 1983). I t  was thought that the 
increased chain length may render the molecule inaccessible to 
cytochrome P-450 substrate binding s ite .  However, th is  is u n l ike ly  
since no co rre la t ion  was observed between the O-dealkylation rate and 
the magnitude of the type I spectrum (Burke & Mayer,1983) ind ica t ive  of 
substrate binding to the haemoprotein. An increase in the length of 
the alkoxy side-chain also did not appear to cause side-chain 
hydroxylation to take precedence over O-dealkylation (Burke & Mayer, 
1983).
Reactions that are -induced by 3-MC and s im ila r  PAHs in C57BL but 
not the DBA mice are generally considered to be con tro lled by the Ah 
locus (Nebert, 1979). In the present study treatment of C57BL mice
with 3-MC resulted in marked induction of the O-dealkylation of a l l  the 
resorufin  analogues, but not the aryl hydroxylation of phenoxazone. 
The extent of induction was highest with the propoxy-, followed by the 
butoxy, ethoxy- and methoxy- derivatives (Fig. 5 .1). In contrast, 
administration of the same dose of 3-MC to DBA mice gave no increase in 
the O-dealkylation rates of the alkoxyresorufins in e ither sex, and in 
most cases even an in h ib i t io n  of enzyme a c t iv i t y  occurred (Fig. 5.1). 
These observations ind icate that the O-dealkylation of a l l  these 
substrates is associated with the Ah locus.
The monooxygenases associated with the Ah locus in the mouse are 
associated s p e c i f ic a l ly  with isozymes of cytochrome P-450 induced 
p re fe re n t ia l ly  by PAHs, namely cytochromes Pj-450 and P3-450 (Nebert, 
1979). Indeed studies employing highly p u r if ied  proteins isolated from 
the ra t and rabbit have demonstrated conclusively that cytochromes 
P-448 (P-450c and P-450d in the ra t ,  forms 6 and 4 in the ra bb it)  
exclusive ly catalyze the EROD reaction (Guengerich et aT. ,  1982a;
Tamburini et a l . ,  1984; Astrom and DePierre 1985). Furthermore, since 
the present study shows that depropylation is the dealkylation reaction 
most extensively induced by 3-MC, propoxyresorufin may serve as a 
be tter substrate fo r  monitoring cytochrome P-448 a c t iv i t y  than 
ethoxyresorufin. Pretreatment with 3-MC also induces O-dealkylation of 
the long-chain ethers (pentoxy- to octoxy-resorufin) and debenzylation 
of benzyloxyresorufin, ind ica ting  that 3-MC-inducible cytochrome P-450 
isozymes contro lled by the Ah locus also contribute to the metabolism 
of these substrates. However, the extent of induction was re la t iv e ly  
small compared with that fo r  the propoxy ether, ind ica ting  that the
long-chain ethers are not su itable markers fo r  the Ah locus. In fa c t ,  
recent studies have shown that the depentylation reaction is 
p re fe re n t ia l ly  catalyzed by PB-inducible forms of cytochrome P-450 
isozymes in the ra t (Burke et a l . ,  1985; Lubet et a l . ,  1985).
Sex differences in dealkylation rates were seen with a l l  substrates 
in the C57BL mice, the female exh ib it ing  s ig n i f ic a n t ly  higher 
a c t iv i t ie s .  S im ilar sex differences were also observed in the DBA mice 
but were less pronounced. Using ethoxyresorufin as substrate Vodnicik 
and coworkers (1981) demonstrated a s im ila r  sex d ifference in the 
Sprague-Dawley ra t and provided experimental evidence that oestradio l 
was responsible fo r  the higher a c t iv i t y  in females. Since the 
O-deethylation of ethoxyresorufin is catalysed by cytochrome P-448, 
these workers suggested that the female animals possessed inherently  
higher cytochrome P-448-mediated monooxygenase a c t iv i t y .  Recent 
studies, in which trans la tab le  mRNAs were quantif ied using in v i t ro  
trans la t ion  techniques, in conjunction with immunoprecipitation with 
antibodfes spec if ic  to 3-MC- and PB-inducible cytochromes P-450, have 
shown that the mRNAs coding fo r 3-MC-inducible isozymes were higher in 
the female than in male ra t while, in contrast, the trans la tab le  mRNAs 
encoding the PB-inducible forms of the cytochrome were higher in the 
male (Gozukara et a l . ,  1984). The above evidence indicated that 
although both PB-cytochromes P-450 and cytochromes P-448 e xh ib it  sex 
d ifferences, the cytochromes P-448, in contrast to PB-cytochromes 
P-450, are higher in the female.
Generation of resorufin  from benzyloxyresorufin was catalysed by 
NADPH-supplemented contro l microsomes from both stra ins of mice, the 
debenzylation rate being higher in the C57BL s tra in . A lte rna tive  
pathways of metabolism such as arene oxidation of the benzyl-moiety 
catalysed by cytochromes P-450 is also l ik e ly .  Generation of resorufin 
from th is  substrate was increased fo llow ing 3-MC administration only in 
the C57BL s tra in , whereas in the DBA s tra in  the reaction rate was even 
inh ib ited  ind ica ting that debenzylation is also associated with the Ah 
locus.
The NADPH-dependent oxidation of phenoxazone to resoru fin  was 
catalysed by microsomal preparations from both stra ins of mice but 
pretreatment with 3-MC gave r ise  to in h ib i t io n  of th is  a c t iv i t y  which 
was especia lly  pronounced in the DBA straTn. Oxidation of phenoxazone 
is , therefore, not fa c i l i t a te d  by the 3-MC-inducible forms of 
cytochrome P-450.
In summary, the present study shows that (a) methoxy- and ethoxy- 
resorufin are the most read ily  dealkylated substrates by control 
microsomal preparations, (b) the female exh ib its  higher dealky lation 
rates fo r a l l  the alkoxyresorufins employed in th is  study, and f i n a l l y  
(c) the dealkylation of a l l  a lkoxyresorufin substrates to generate 
resoru fin , in contrast to the oxidation of phenoxazone, are associated 
with the Ah locus.
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CHAPTER 6:
RAT HEPATIC ALKOXYRESORUFIN O-DEALKYLASES: 
EFFECT OF TREATMENT WITH MIXED-FUNCTION 
OXIDASE INDUCERS
INTRODUCTION
The cytochrome P-450-dependent MFO system comprises m u lt ip le  
isozymes each exh ib it ing  d i f fe re n t  but often overlapping substrate 
s p e c i f ic i t ie s  (Lu & West, 1980). These isozymes also d i f f e r  from each 
other in th e ir  physicochemical properties, immunological 
ch a rac te r is t ics , primary amino acid structures and enzyme k ine tics  (Lu & 
West, 1980). Furthermore, the MFO system has a capacity fo r  profound 
induction on exposure to xenobiotics. Each xenobiotic induces a 
ch a ra c te r is t ic  polypeptide pattern, and the same form of cytochrome 
P-450 may be induced by s t ru c tu ra l ly  d i f fe re n t  xenobiotics (Thomas et 
al_. ,.1981; Vlasuk et a /L , 1982). Thus, cytochromes P-450b, P-450c and 
P-450d are the major isozymes induced in the ra t l iv e r  by PB, 3-MC and 
isosafro le  respective ly . A minor form of the haemoprotein, namely 
cytochrome P-450a is modestly induced by both PB and 3-MC only in female 
ra t and in immature males (Thomas et £]_., 1981). In contrast, cytochrome 
P-450e, which is immunochemically ind is t ingu ishable  from cytochrome 
P-450b using polyclonal antibodies (Ryan et aj_., 1982), is inducib le by 
PB but not by 3-MC (Ryan et £l_., 1979, 1980, 1982, 1985). Four isozymes 
namely, cytochromes P-450a, P-450b, P-450c and P-450d have been iso la ted 
from the l iv e rs  of isosa fro le -trea ted  ra ts (Ryan et  ^ aj_., 1980), while a l l  
f iv e  isozymes, namely cytochromes P-450a, P-450b, P-450c, P-450d and 
P-450e are induced by the polychlorinated biphenyl mixture Aroclor-1254 
(Ryan et al_., 1979, 1980, 1982).
Numerous studies have been carried out using the l iv e r  microsomal
O-dealkylation reactions of various compounds as probes fo r  the various 
isozymes of cytochrome P-450 (Burke & Mayer, 1974, 1975; Imai, 1979; 
Kamataki et aj_., 1980; Matsubara et aj_., 1982, 1983a). Pretreatment of 
ra ts with 3-MC or 6 -naphthof1avone resu lts  in p re fe ren tia l induction of
the O-deethylase and O-depropylase a c t iv i t ie s  of 7-hydroxycoumarin and 
7-hydroxyphenoxazone (reso ru fin )  0 -a lky l derivatives (Kamataki et a l . ,  
1980; Matsubara et al_., 1983b). In addition Davies and Creaven (1967) 
have shown that carcinogenic, po lycyc lic  hydrocarbons e xh ib it  a 
cha rac te r is t ic  pattern of induction towards the O-dealkylation of 2- and 
4-biphenyl 0 -a lky l derivatives in ra t  l iv e r  microsomes tha t is  d i f fe re n t  
from that of PB or non-carcinogenic inducers.
Ethoxyresorufin has been shown to be a spec if ic  substrate fo r  
cytochrome P-448 (Goldstein et a /L , 1982; Guengerich et a K , 1982a; 
Astrom & DePierre, 1985), and our e a r l ie r  study (Chapter 4) has 
demonstrated that EROD a c t iv i t y  was p re fe re n t ia l ly  induced by 
carcinogens. This led us to investigate whether other members of a 
homologous series of alkoxyresorufin derivatives would also be 
p re fe re n t ia l ly  induced by carcinogens, and the p o s s ib i l i t y  tha t th is  
series of compounds may be used c o l le c t iv e ly  as a spec if ic  probe to 
characterize cytochrome P-450 isozymes.
MATERIALS AND METHODS
Animal treatment
Male Wistar albino rats (150-200 g) received a s ing le  
in traperitonea l administration (50 mg/kg) of the tes t compound dissolved 
in e ithe r saline or corn o i l .
Preparation of hepatic microsomes
Hepatic microsomal frac t ions  were prepared as described in 
Chapter 2.
Enzyme assays
The fo llow ing enzyme assays were carried out on the microsomal 
suspensions: O-dealkylation of alkoxyresorufins and hydroxylation of
phenoxazone, cytochrome P-450 and prote in . Detailed methodology is  
described in Chapter 2.
RESULTS
Microsomal levels o f  to ta l cytochrome P-450 and protein in control 
animals and in animals treated with various carcinogens and non­
carcinogens are shown in Table 6.1. 3 ,3 ' -Dichlorobenzidine,
dich lorod iphenyltr ich loroethane (DDT), phenylbutazone and c lo f ib ra te -  
treated animals showed a moderate increase, while those treated with 
4-aminobiphenyl and 2-acetamidofluorene (2-AAF) showed a decrease, in 
hepatic microsomal cytochrome P-450 content. None of the compounds 
studied showed any s ig n if ic a n t  e f fe c t  on microsomal prote in  
concentration.
The d i f fe re n t  members of a homologous series of 0 -a lky l de riva tives 
of resoru fin , with si de-chains from 1-C (methoxyresorufin) to 8-C atoms 
(octoxyresorufin) were a l l  metabolized at d i f fe re n t  rates by both 
control microsomes and microsomes derived from animals treated with 
various inducers. The various types of induced microsomes also 
metabolized the parent compound phenoxazone (ary l hydroxylation) and the 
benzyl ether, benzyloxyresorufin (debenzylation) at d i f fe re n t  rates 
(Table 6.2a & b). In control microsomes, ethoxy- and propoxy-resorufin 
were the best substrates. S im ila r ly ,  with microsomes from animals 
treated with e ithe r Aroclor-1254, benzo(a)pyrene, 2-AAF, sa fro le  or 
3 -naphthoflavone, ethoxy- and propoxy-resorufin were dealkylated most 
ra p id ly .  DDT-induced microsomes catalyzed the debenzylation reaction
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most e f f ic ie n t ly ,  the rate of th is  reaction being 4- to 5 - fo ld  higher 
than those fo r  the next best substrates, propoxy- and pentoxy-resorufin. 
In phenylbutazone-induced microsomes, dealkylation rates were the 
highest with ethoxy- and propoxy-resorufin as substrates; in contrast, 
phenoxazone hydroxylase a c t iv i t y  was not detectable (Table 6.2b). In 
c lo fib ra te-induced microsomes, although ethoxy- and propoxy-resorufin 
dealkylations were the most ra p id ly  catalyzed reactions, these were 
s l ig h t ly  but not s ig n i f ic a n t ly  inh ib ited  when compared to control values 
(Table 6.2b).
A common feature of the various types of induced microsomes was that 
the rate of dealky lation was maximal with e ithe r ethoxy- or 
propoxy-resorufin as substrate, and subsequently decreased with an 
increase in the length of the alkoxy side-chain. Thus, phenoxazone and 
the longest-chain derivatives (hexoxy- to oc to xy -re so ru f in ) , 
p a r t ic u la r ly  the octy l de r iva tive , were generally among the poorest 
substrates fo r  the d i f fe re n t  types of microsomes studied (Table 6.2a & 
b). Benzyloxyresorufin was metabolized at a rate intermediate between 
those fo r  methoxy- and ethoxy-resorufin , except in DDT-induced 
microsomes fo r  which i t  was the best substrate.
In microsomes from animals treated with a p a r t icu la r  inducer, the 
substrate showing the highest rate of dealkylation was not necessarily 
the most extensively induced. Thus treatment with benzo(a)pyrene was 
characterized by marked induction of the dealkylation rates of a l l  the 
substrates except phenoxazone, with a p re fe ren t ia l induction of 
deethylation (36-fo ld) and to a smaller extent demethylation and 
debutylation (26-fo ld each), compared to depentylation (7 - fo ld ) .  In 
2-AAF-induced microsomes, the degree of induction was somewhat larger in
the higher analogues (butoxy- to heptoxy-resorufin) (6 - to 7 - fo ld )  
compared to the short-chain derivatives (methoxy- to propoxy-resorufin) 
(3 - fo ld ) .  Induction with safro le led to a moderate increase in 
dealkylation rates of a l l  the substrates tested. Furthermore,
d
phenoxazone hydroxylation was induced only by safro le but not by other 
inducers (Table 6.2a). In Aroclor-1254-induced microsomes the extent of 
induction of deethylation and debutylation (4-5 fo ld )  were la rger than 
those fo r  the dealkylation of the long-chain derivatives (pentoxy- to 
octoxy-resorufin) and benzyloxyresorufin. Only depentylation and 
oxidation of phenoxazone were not induced by Aroclor-1254 treatment. 
With 3 -naphthoflavone treatment, the dealkylations of methoxy-, 
ethoxy-, propoxy- and butoxy-resorufin were markedly enhanced. DDT- 
induction was characterized by a p re fe ren t ia l induction of deheptylation 
(2 7 -fo ld ) .  Induction with phenylbutazone led to a 4- to 6 - fo ld  increase 
in depentylation, deheptylation and debenzylation. However, c lo f ib ra te  
treatment had no e f fe c t  on the rate of dealkylation of any of the 
substrates tested (Table 6.2b).
Treatment with 3 ,3 ' -d ichlorobenzidine resulted in marked induction 
of the dealkylations of a l l  the substrates except phenoxazone 
hydroxylation which was unaffected; maximum induction (20- to  30-fo ld ) 
occurred when the short-chain derivatives were used as substrates 
(F ig .6 . la ) .  Pretreatment with the non-carcinogenic analogue 3 ,3 ' -  
diaminobenzidine led to a small induction (2.5- to 5 .5 - fo ld )  of the 
deethylation, debutylation and dehexylation reactions. Pretreatment 
with the carcinogens 4-aminobiphenyl and 4-dimethylaminoazobenzene were 
characterized by a somewhat larger induction of the dea lky la tion  rates 
of the short-chain derivatives (methoxy- to butoxy-resorufin) compared 
to those of the long-chain deriva tives. In contrast, th e i r  non-
F ig .6 .1a HYDROXYLATION OF PHENOXAZONE AND
O-DEALKYLATION OF A SERIES OF ALKOXYRESORUFINS 
BY HEPATIC MICROSOMES FROM RATS 
TREATED WITH SOME CARCINOGENS AND 
THEIR NON-CARCINOGENIC ANALOGUES.
The numbers beneath the histogram bars ind icate 
the number o f carbon atoms in the n-alkoxyresorufin 
side-chain. (B) benzyloxyresorufin; (0) 
phenoxazone. The t i t l e  above each histogram 
indicates the compound given to the ra ts .
A ll compounds are administered as single 
in traperitonea l in jec t ions  (50mg/kg) 24 
hr. before s a c r i f ic e .  Results are presented 
as % of control values (nmol/min per nmol 
cytochrome P-450, as in Table 6.2a); each 
value represents the mean ± S.E.M. o f four 
determinations. The bars with dotted lines 
ind ica te  enzyme a c t iv i t y  was below the detection 
l im i t  (0.001 nmol/min per nmol cytochrome 
P-450).
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carcinogenic analogues 2-aminobiphenyl and 4-dimethylaminoazobenzene-4- 
sulphonic acid Na s a l t  did not exert any marked induction on the 
dealkylations of any of the substrates tested (F ig .6 . lb & c ) .  Induction 
by benzidine led to a small increase in the rate of metabolism of the 
short-chain derivatives only, while deheptylation and deoctylation were 
even in h ib ite d . In 3 ,3 ' ,5,5 '-tetramethylbenzid ine-induced microsomes, 
there was a small increase in the dealkylation rates of methoxyresorufin 
and the long-chain derivatives and the debenzylation reaction , while 
deethylation and depropylation were unaffected (F ig .6 . Id ) .
DISCUSSION
Isozymes of cytochrome P-450 are d is t in c t  prote ins, being products 
of d is t in c t  s truc tu ra l genes, or a l l e l i c  forms of a gene (Bresnick et 
a l . ,  1981; Hardwick et £]_., 1983; Gozukara et a1_., 1984). Generally, 
the isozymes belonging to the same gene fam ily  share at least 70% 
s truc tu ra l homology whereas between fa m il ie s , isozymes share less than 
35% homology. Thus, the 3-MC-inducible cytochromes P-450c and P-450d 
are 68% s im ila r in th e ir  amino acid sequences (Kawajiri et al_.» 1983; 
Sogawa et aj_., 1984), while the PB-inducible cytochromes P-450b and 
P-450e share an even greater degree of homology (97%), d i f fe r in g  only in 
14 amino acids in a 491 amino acid sequence (Fujii-Kuriyama et ail_., 1982; 
Mizukami et a l . ,  1983; Yuan et aj_., 1983). In con trast, cytochrome 
P-450d exh ib its  only 30% homology with the PB-cytochromes P-450b and 
P-450e (Kawajiri et _al_., 1984; Sogawa et aT_., 1985). Not only are the 
PB- and 3-MC-inducible fam ilies of cytochromes P-450 s t ru c tu ra l ly  
d is t in c t ,  they also exh ib it  vastly  d i f fe re n t  substrate s p e c i f ic i t ie s  and 
substrate binding s ites (Ph il l ipson  et al_., 1982; Lewis et a l . , 1986). 
This concept is in agreement with the work of Dus (1982) which showed 
homology between the haemopeptides (comprising the substrate binding
s ite  and haem moiety) of PB-cytochromes P-450 but very l i t t l e  homology 
between the haemopeptides of PB-cytochromes P-450 and cytochromes P-448.
Several studies have shown tha t substrate binding and 
monooxygenation a c t iv i t y  of cytochrome P-450 is governed by substrate 
l i p o p h i l i c i t y  (Hansch, 1972; A1-Gailany et a /L , 1978). However, th is  
does not seem to be the case fo r  the alkoxyresorufin analogues as i t  has 
been previously shown that fo r  these compounds, substrate l i p o p h i l i c i t y  
does not a ffec t type 1 binding or 0-dealky la tion rates (Burke & Mayer, 
1983). Furthermore, since type 1 binding was not affected by the length 
of the alkoxy side-chain (Burke & Mayer, 1983), the inverse re la t ion sh ip  
between dealkylation rate and alkoxy chain-length observed in the 
present study could not be due to s te r ic  hindrance to the in te rac tion  of 
substrate with cytochrome P-450. In addition , an increase in the length 
of the alkoxy side-chain did not appear to cause side-chain 
hydroxylation to take precedence over dealkylation (Burke & Mayer, 
1983). Nevertheless, i t  is possible that non-specific in te rac t io n  
between the alkoxy side-chain and the apoprotein of cytochrome P-450 
leads to a conformational change in the haemoprotein which somehow 
resu lts  in in h ib i t io n  of substrate transformation, th is  e f fe c t  being 
more marked with an increase in the length of the alkoxy s ide-chain.
The re la t iv e  metabolic rates of the alkoxyresorufins are markedly 
altered by p r io r  induction of the microsomes, ind ica ting  that a number of 
d i f fe re n t  forms of cytochrome P-450 are involved in the metabolic 
process. Moreover, each inducing agent produced a c h a ra c te r is t ic  
pattern of induction of the dealkylation rates. Microsomes from 
benzo(a)pyrene-induced animals exhib ited high s e le c t iv i t y  fo r  
ethoxyresorufin 0-deethylation, which is consistent w ith previous
f ind ings fo r  other cytochrome P-448 inducers (Burke & Mayer, 1983; 
Matsubara et a K , 1983b; Burke et a l . , 1985). Aroclor-1254 has been 
shown to be a mixed-type inducer, and tre a ting  rats with the compound 
leads to the induction of both PB- and 3-MC-inducible isozymes of 
cytochrome P-450 (Alvares et aj_. ,  1973; Ryan et aj_., 1979, 1980, 1982). 
Indeed, i t  was shown to be the case in the present study. 
Ethoxyresorufin deethyla tion, a cytochrome P-448-mediated reaction , and 
benzyloxyresorufin debenzylation, which is  mediated by PB-cytochromes 
P-450 and cytochromes P-448 (Burke e t 'a l_ . , 1985), were both induced by 
Aroclor-1254 at the dose level used (50 mg/kg i .p .  s ing le  dose) 
(Table 6.2a). Surp ris ing ly , in contrast to e a r l ie r  reports (Burke et 
a l . ,  1985), pentoxyresorufin depentylation was unaffected. This
discrepancy may be a tt r ibu ted  to the higher dose regimen used by Burke 
and co-workers (250 mg/kg i . p .  d a i ly  x 1 day, followed by 25 mg/kg i .p .  
d a i ly  x 5 days). The d i f fe re n t  treatment regimens may also explain the 
lower degrees of induction observed in the present study compared to 
those of Burke et a l.  (1985) (4- and 2 - fo ld  induction in the present 
study compared to 60- and 30-fo ld , fo r  deethylation and debenzylation 
re spec t ive ly ) .
2-AAF is a potent hepatocarcinogen. Previous studies have shown 
that treatment of rats with 2-AAF led to induction of i t s  own metabolism 
(Sato et ad., 1981; Astrom et a_l_. ,  1983). I t  has now been shown that 
2-AAF induces cytochromes P-450c and P-450d as well as the PB- 
cytochromes P-450b (+ P-450e) and P-450 PCN, and epoxide hydrolase 
a c t iv i t y  (Astrom et al_., 1983, 1986). In the present study, 2-AAF 
enhanced the metabolic rates of a l l  the substrates, with the exception of 
phenoxazone, with a somewhat larger induction fo r  the long-chain ether 
deriva tives, which is consistent with the f ind ing  that the 2-AAF is a 
mixed-type inducer.
Safrole also induced both PB-cytochrome P-450 (depentylation)- and 
cytochrome P-448 (deethylation)-dependent reactions (Table 6.2a). This 
is in agreement with e a r l ie r  reports with ra t hepatic microsomes which 
showed that methylenedioxyphenyl compounds such as safro le  and 
isosa fro le  induced predominantly a novel haemoprotein, namely cytochrome 
P-450d but also induced to a lesser extent the major haemoproteins 
inducible by PB and 3-MC (Ryan et a /L , 1980; Thomas et _al_., 1983; 
Ioannides et al_., 1985; Yeowell e t  a4.,  1985). The above workers also 
showed tha t safro le  and isosa fro le  are metabolized to a product, 
presumably a carbene intermediate, tha t forms a complex with PB- 
cytochromes P-450 or cytochromes P-448, resu lt ing  in a loss of MFO 
a c t iv i t y .  Thus, the reaction rates observed in the present study would 
be an underestimation; the f u l l  extent of induction of dea lky la tion 
rates by safro le can only be observed a f te r  the safro le metabolite bound 
to the haem of cytochrome P-450 is displaced from the haemoproteins by an 
appropriate agent (El combe et a l . , 1975; Dickins et aj_., 1979; Delaforge 
et a l . ,  1980). Furthermore, the safro le  metabolite in h ib i ts  carbon 
monoxide binding to cytochrome P-450 with a resu ltan t underestimation of 
haemoprotein content (Dickins et aj_., 1978; Delaforge et a1_., 1980; Ryan 
e t  aj_., 1980). In addition , our resu lts  showed that at the dose level 
employed (50 mg/kg i . p .  s ing le dose), sa fro le  induced isozymes of 
cytochrome P-450 that e xh ib it  a high s e le c t iv i t y  fo r  phenoxazone 
hydroxylation.
3 -Naphthof1avone is a potent inducer of cytochromes P-448 (Lau & 
Strobe!, 1982; Lau et _al_., 1982), with a p re fe ren t ia l induction fo r  
cytochrome P-450c re la t iv e  to cytochrome P-450d (Thomas et a]_., 1983). 
Accordingly, 3 -naphthoflavone treatment led to a marked induction of 
EROD a c t iv i t y ,  and to a lesser extent dealkylation of the methoxy-,
propoxy- and butoxy-derivatives (Table 6.2b). Other 3 -naphthoflavone- 
induced isozymes (Lau & Strobel, 1982) may contribute to the metabolism 
of the long-chain de riva tives , as shown by the small induction of 
pentoxy- and hexoxy-resorufin dealkyl ations.
Organochlorine insectic ides such as DDT, a ld r in ,  d ie ld r in  and 
y-chlordane are well-known inducers of the PB-type. Treatment of ra ts 
with y-chlordane led to the induction o f cytochrome P-450k and P-450e in 
the l iv e r  (Thomas et a /L , 1981). DDT increases 1iver microsomal a n il in e  
N-hydroxylase a c t iv i t y  and decreases hexobarbital sleeping time in the 
rabb it (Lange, 1967; Parkki et , 1977). The present study showed 
that DDT markedly enhanced the dealky lation of the long-chain
alkoxyresorufin analogues with p re fe ren t ia l induction of deheptylation 
(Table 6.2b); debenzylation was also s ig n i f ic a n t ly  induced but 
dealkylations of the lower analogues were unaffected ind ica ting  tha t 
DDT-induced cytochromes P-450 did not contribute s ig n i f ic a n t ly  to the 
metabolism of the lower analogues. C lo f ib ra te  pretreatment had no
e ffe c t  on the rate of metabolism of any of the substrates tested
(Table 6.2b). Indeed, c lo f ib ra te  has been shown to induce a novel form 
of haemoprotein, namely cytochrome P-452 which exh ib its  re g io s e le c t iv i ty  
and high c a ta ly t ic  a c t iv i t y  towards the 12-hydroxylation of la u r ic  acid 
but had no detectable a c t iv i t y  towards ethoxyresorufin (Tamburini et 
al_., 1984).
The carcinogens 3 ,3 ' -d ichloroberiz id ine, 4-aminobiphenyl and 
4-dimethylaminoazobenzene were distinguished from th e ir  "matched pa ir"  
non-carcinogenic analogues in that a l l  three carcinogens showed a higher 
extent of induction of the dealkylation rates of the short-chain
alkoxyresorufin analogues (methoxy- to butoxy-resorufin) compared with
the long-chain deriva tives. In contrast, the non-carcinogenic analogues 
were e ithe r very weak inducers re la t iv e  to th e ir  "matched-pair" 
carcinogen ( i . e .  3 ' , 3 ' -diami nobenzidine vs. 3 ,3 ' -d ich lo robenz id ine ), or 
they did not s ig n i f ic a n t ly  a ffec t dealkylation rates ( i . e .  
2-aminobiphenyl, 4-dimethylamino-azobenzene-4-sulphonic acid Na s a l t ) .  
The carcinogen 4-dimethyl aminoazobenzene enhanced EROD a c t iv i t y  by 
4 - fo ld .  Recent studies in the ra t  have shown tha t
4-dimethyl aminoazobenzene se le c t ive ly  induces cytochrome P-450d (Degawa 
et a K , 1986) which catalyzes the O-deethylation of ethoxyresorufin but 
to a much lesser extent (5%) when compared to cytochrome P-450c (Astrom & 
DePierre, 1985). In contrast, benzidine and 3 ,3 ' , 5 ,5 ' -
tetramethylbenzidine did not e xh ib it  any c lear trend in th e ir  patterns 
of induction of the dealkylation reactions that could be corre lated to 
th e ir  respective carcinogenic p o te n t ia l.  This is consistent w ith 
previous studies which ind icate that Aroclor-1254-induced isozymes of 
cytochrome P-450 are not involved in the N-hydroxylation of benzidine 
(Smith & Ioannides, 1987). Furthermore, p u r if ie d  cytochromes P-450 of 
the major forms induced in ra t  l iv e r  by 6-naphthoflavone and PB did not 
convert benzidine to mutagens in the Ames tes t (Ioannides, C., personal 
communication).
Our observations together with those of previous workers (Matsubara 
et aj_., 1983b; Burke et _al_., 1985) showed that treatment of ra ts  with 
inducers of cytochrome P-448 p re fe re n t ia l ly  induced hepatic microsomal 
dealkylations of the short-chain alkoxyresorufin derivatives (methoxy- 
to bu toxy-resoru fin ). These data are consistent with previous f ind ings  
fo r  the 0 -a lky l derivatives of biphenyl (Davies & Creaven, 1967) and 
coumarin (Kamataki et aj_., 1980) that the deethylation and depropylation 
reactions were s p e c i f ic a l ly  enhanced in ra t l iv e r  microsomes a f te r
treatment with carcinogens. Recent studies using computer graphic 
techniques ind icate tha t the substrate binding s i te  of cytochrome P-448 
accepts planar molecules with a large area/depth ra t io  and a small depth 
(Lewis et a K , 1986). From the resu lts  of the present study, i t  can be 
fu r th e r  in fe rred tha t th is  substrate binding s i te  can op tim ally
accommodate substrates with a 1C to 4C alky l chain. Furthermore, since 
increasing the length of the a lkyl chain did not influence substrate 
binding a f f in i t y  per se (Burke & Mayer, 1983), i t  is  l i k e ly  tha t the 
a lky l chain of the molecule is orientated away from the enzyme active 
s i te .
In summary, the resu lts  of our present study ind ica te  tha t
(a) phenoxazone hydroxylation is se le c t ive ly  catalyzed by sa fro le -  
inducible forms of cytochrome P-450; (b) dealkylation o f the short-
chain alkoxyresorufins (methoxy- to butoxy-resorufin) is  p re fe re n t ia l ly  
induced by carcinogenic inducers of cytochrome P-448; 
(c) pentoxyresorufin depentylation and heptoxyresorufin deheptylation 
are p re fe re n t ia l ly  enhanced by PB-inducible forms of cytochrome P-450, 
and may be used as markers fo r  these isozymes; (d) benzyloxyresoruin 
debenzylation is enhanced by both carcinogenic and non-carcinogenic 
inducers and is consistent with e a r l ie r  reports that the reaction is
mediated by both PB-cytochromes P-450 and cytochromes P-448 (Burke et_
a l . ,  1985).
CHAPTER 7 :
EFFECT OF DOSE ON THE INDUCTION OF 
CYTOCHROME P-448 ACTIVITY
INTRODUCTION
Evidence to date indicates that there are at least fou r, and 
possibly s ix ,  cytochrome P-450 gene fam ilies  (Nebert & Gonzalez, 1985). 
Of these, the PB-inducible cytochromes P-450 and the 3-MC-inducible 
cytochromes P-448 have a ttracted the most in te res t la rge ly  because these 
isozymes have vas tly  d i f fe re n t  substrate s p e c i f ic i t ie s  and play 
contrasting roles in the detoxication and ac tiva tion  of xenobiotics 
(Parke & Ioannides, 1982). Hence, PB-cytochromes P-450 in te ra c t with 
g lobular, bulky molecules and p r im a r i ly  catalyze reactions that re su lt  
in the formation of less tox ic  metabolites. In contrast, cytochromes 
P-448 accommodate a re s tr ic te d  number of substrates which are 
esse n t ia l ly  planar with a large area/depth ra t io  and catalyze the 
metabolic ac tiva tion  of tox ic  chemicals and carcinogens (Parke & 
Ioannides, 1982; Lewis et aj_., 1986). The PB-cytochromes P-450 and 
cytochromes P-448 also d i f f e r  in several cha rac te r is t ics  including 
spectral and immunological properties (Thomas et a4., 1984; Reik et a l . ,  
1985), mechanism of induction (Parke, 1983), developmental patterns 
(Basu et al_., 1971; Song et aT. ,  1986), t issue d is t r ib u t io n  (Liem et 
a l . ,  1980) and sex and species differences (Vodicnik et aj_., 1981; 
Iwasaki et aj_., 1986).
In view of the vastly  contrasting roles of cytochromes P-448 and PB- 
cytochromes P-450 in drug metabolism, i t  is  conceivable tha t the 
re la t iv e  concentrations of these two cytochromes would determine the 
s u s c e p t ib i l i ty  of d i f fe re n t  tissues or ind iv idua ls  to the t o x ic i t y  and 
carc inogenic ity  of foreign compounds. Several reports have shown that 
induction of cytochrome P-448 is associated with increased 
s u s c e p t ib i l i ty  to chemically-induced to x ic i t y  and malignancy; 
furthermore, the potency of cytochrome P-448 induction is corre la ted to
the mutagenic and carcinogenic a c t iv i t y  of the inducing agents and to 
genetic po ten tia l fo r  malignancy (Nebert & Jensen, 1979; Nebert et a l . ,  
1979; Bandiera et a1_., 1984; Degawa et al_., 1985). Thus, induction of 
cytochrome P-448 a c t iv i t y  not only serves as an ind ica tion  of carcinogen 
s u s c e p t ib i l i ty  of a t issue type but also as an index of the potentia l 
ca rc in o g e n ic i ty / to x ic i ty  of chemicals whose activa t ion  is  mediated by 
the mixed-function oxidase system. To th is  end, i t  was desirable to 
investigate  the d i f fe re n t ia l  induction response to various doses of the 
inducing agent, and hence to optimize the dose required to te s t the 
cytochrome P-448-inducing po ten tia l of a compound.
The 0-deethylation of ethoxyresorufin constitu tes a h igh ly  spe c if ic  
and sensitive  method fo r  the determination of cytochrome P-448 a c t iv i t y  
(Goldstein et , 1982; Guengerich et al_., 1982a; Astrom & DePierre, 
1985). Using th is  substrate, the e f fe c t  of dose on the induction of 
cytochrome P-448 by some carcinogenic compounds was investigated.
MATERIALS AND METHODS
Animal treatment
Male Wistar albino rats (150-200 g) were given a s ingle 
in traperitonea l administration (0.05-20 mg/kg fo r  benzo(a)pyrene, 0.5- 
20 mg/kg fo r  other compounds) dissolved in normal saline or corn o i l .
In the time-dependent study of induction of cytochrome P-448, 
animals received a single in traperitonea l dose of benzo(a)pyrene 
(5 mg/kg) and were k i l le d  at regular time in te rva ls .
Preparation of hepatic microsomes
Hepatic microsomal frac t ions  were prepared as described in 
Chapter 2.
Enzyme assays
The fo llow ing enzyme assays were carried out: on microsomal
supernatants, biphenyl 2- and 4-hydroxylases; on microsomal 
suspensions, ethoxyresorufin 0-deethylase, to ta l  cytochrome P-450 and 
pro te in . Detailed methodology is  described in Chapter 2.
RESULTS
Benzo(a)pyrene administration markedly enhanced the 0-deethylation 
of ethoxyresorufin at a l l  dose levels studied including the lowest
(50 pg/kg). A maximum was reached at 5 mg/kg when a c t iv i t y ,  expressed 
per nmol cytochrome P-450, was 12-fold higher than control value. The
2-hydroxyl ation of biphenyl was also induced at doses of 0.1 mg/kg and
above, the extent of induction increasing with dose and at 20 mg/kg,
a c t iv i t y  was 6 - fo ld  that of control value. The 4-hydroxylation of 
biphenyl was also increased at high doses of benzo(a)pyrene, but to a 
lesser extent than was seen fo r  biphenyl 2-hydroxylation or fo r  EROD 
a c t iv i t y  (F ig .7.1 & 7.2a). The to ta l microsomal cytochromes P-450 
remained essen tia lly  the same at a l l  doses.
At the low dose of 0.5 mg/kg the 0-deethylation of ethoxyresorufin, 
and to a lesser extent the 2-hydroxylation of biphenyl, were the only 
a c t iv i t ie s  increased by treatment with 2-acetamidofluorene (2-AAF). 
Maximal induction of both a c t iv i t ie s  were reached at a dose of 2 mg/kg 
and then decreased with increasing doses so that at the highest dose 
level used, biphenyl 2-hydroxylase a c t iv i t y  was even in h ib ite d  
(F ig .7 .2b).
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F ig .7.1 HEPATIC MICROSOMAL MIXED-FUNCTION OXIDASES AFTER THE 
ADMINISTRATION OF SMALL DOSES OF BENZO(A)PYRENE.
Animals received a s ing le in traperitonea l dose o f the / 
carcinogen and were k i l le d  24 hr. la te r .  Each point 
represents the mean ± S.E.M. fo r  four animals. Control 
a c t iv i t ie s  were: biphenyl 4-hydroxylase (□), 4.6±0.8;
biphenyl 2-hydroxylase (■) 0.09±0.03; ethoxyresorufin 
O-deethylase (o ),  0.032±0.006, nmol/min per nmol cytochrome 
P-450 while-cytochrome P-450 level ( • )  was 0 .9±0.1 nmol/mg 
p ro te in .
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F ig .7 .2a EFFECT OF DOSE ON THE INDUCTION OF RAT HEPATIC 
MIXED-FUNCTION OXIDASES BY VARIOUS CARCINOGENS.
Animals received a s ing le peritoneal dose o f the carcinogen 
and were k i l le d  24 hr. la te r .  Each po in t represents the 
mean ± S.E.M. fo r  four animals. Control a c t iv i t ie s  were: 
biphenyl 4-hydroxylase, (□ ), 7.5±0.6; biphenyl 2-hydroxylase (■), 
0.35±0.Q3; ethoxyresorufin O-deethylase (o ) , 0.17±0.01, 
nmol/min per nmol cytochrome P-450 and cytochrome P-450 level 
( • )  was 0.8±0.1 nmol/mg prote in .
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F ig .7 .2b EFFECT OF DOSE ON THE INDUCTION OF RAT HE’PATIC 
MIXED-FUNCTION OXIDASES BY VARIOUS CARCINOGENS.
Legend as in F ig .7 .2a
Control a c t iv i t ie s  were: biphenyl 4-hydroxylase (□),
4.6±0.3; biphenyl 2-hydroxylase (■ ), 0.29±0.03; 
ethoxyresorufin O-deethylase ( o ) , 0.040±0.008, nmol/min 
per nmol cytochrome P-450 and cytochrome P-450 level ( • )  was 
1.0±0.1 nmol/mg pro te in .
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Safrole administration (0.5-20 mg/kg) again markedly enhanced EROD 
a c t iv i t y  even at the low dose of 0.5 mg/kg; the 2-hydroxylation of
biphenyl was also increased but to a lesser extent (F ig .7 .2c). No marked
changes were seen in e ithe r the 4-hydroxylation of biphenyl or the to ta l
cytochromes P-450 content.
In contrast, N,N' -dimethylnitrosamine (DMN) (0.5-20 mg/kg) did not 
enhance EROD a c t iv i t y  and at the highest doses (10 and 20 mg/kg) ac tua lly  
caused a decrease in a c t iv i t y .  Biphenyl 2- and 4-hydroxylase a c t iv i t ie s  
were increased at the highest dose (20 mg/kg) but only s l ig h t ly  
(F ig .7.2d).
F in a l ly ,  with the d ire c t-a c t ing  carcinogen N-methyl-N1-n it ro -N -  
nitrosoguanidine (MNNG), none of the a c t iv i t ie s  studied was enhanced and 
the 2-hydroxylation of biphenyl was even inh ib ited  at doses of 5 mg/kg 
and above (F ig .7 .2e).
In the time-dependent study, EROD a c t iv i t y  increased to a maximum 
(33-fo ld) 24 hours a fte r  a single dose of benzo(a)pyrene (5 mg/kg). 
This was followed by a decay of a c t iv i t y  to approach control values four 
days a fte r  administration (F ig .7.3). A s im ila r pattern was seen with 
biphenyl 2-hydroxylase a c t iv i t y .
DISCUSSION
The q u a l i ta t iv e  and quan tita tive  d is t r ib u t io n  of cytochrome P-450 
isozymes e xh ib it  in te r- in d iv id u a l and in te r- t is s u e  var ia tions  and are 
influenced by factors such as genetics, sex, age, hormonal and 
n u tr i t io n a l status, and by exposure to environmental chemicals (Conney, 
1967; Lu & West, 1980). Mixed-function oxidation catalyzed by
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F ig .7 .2c EFFECT OF DOSE ON THE INDUCTION OF RAT HEPATIC 
MIXED-FUNCTION OXIDASES BY VARIOUS CARCINOGENS.
Legend as in F ig .7 .2a
Control a c t iv i t ie s  were: biphenyl 4-hydroxylase (□),
2.9±0.6; biphenyl 2-hydroxylase (■), 0 .26±0.03; 
ethoxyresorufin O-deethylase (o ) ,  0 .075±0.015; nmol/min per nmol 
cytochrome P-450 and cytochrome P-450 level ( • )  was 
0.7±0.1 nmol/mg prote in .
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F ig .7.2d EFFECT OF DOSE ON THE INDUCTION OF RAT HEPATIC 
MIXED-FUNCTION OXIDASES BY VARIOUS CARCINOGENS.
Legend as in F ig .7 .2a
Control a c t iv i t ie s  were: biphenyl 4-hydroxylase (□),
1.5±0.1; biphenyl 2-hydroxylase (■ ), 0-11±0.01; 
ethoxyresorufin b-deethylase (o ), 0.16±0.03, nmol/min 
per nmol cytochrome P-450 and cytochrome P-450 level ( • )  
was 1.1±0.2 nmol/mg prote in .
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Fig.7.2e EFFECT OF DOSE ON THE INDUCTION OF RAT HEPATIC 
MIXED-FUNCTION OXIDASES BY VARIOUS CARCINOGENS.
Legend as in F ig .7 .2a
Control a c i t iv i te s  were: biphenyl 4-hydroxylase (□),
3.8±0.2; biphenyl 2-hydroxylase (■), 0.49±0.02; 
ethoxyresorufin O-deethylase (o ), 0.36±0.04; nmol/min 
per nmol cytochrome P-450 and cytochrome P-450 level 
( • )  was 0.9±0.1 nmol/mg prote in .
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F ig .7.3 TIME-DEPENDENT DECAY OF BENZO(A)PYRENE-I'NDUCED 
HEPATIC MIXED-FUNCTION OXIDASES IN THE RAT.
Animals received a s ing le in trape ritonea l dose o f benzo(a) 
pyrene (5mg/kg) and were k i l le d  at regular time in te rva ls  
a f te r  adm in istra tion . Each point represents the mean ± S.E.M. 
o f four animals. Control a c i t i v i t i e s  were: biphenyl
2-hydroxylase (■), 0.08±0.01 and ethoxyresorufin O-deethylase 
(o),-0.02±0.01, nmol/min per nmol cytochrome P-450.
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cytochrome P-448 resu lts  in the ac tiva tion  of chemicals to reactive 
intermediates which give r ise  to c a rc in o g e n ic i ty / to x ic ity  (Parke & 
Ioannides, 1982). Conceivably, animals exh ib it ing  high levels of 
cytochrome P-448 a c t iv i t y  would be more susceptible to the to x ic i t y  of 
certa in chemicals. Indeed the neonatal ra t ,  which exh ib its  higher 
cytochrome P-448 a c t iv i t y  than the adult animal (Basu et al_., 1971), is 
more e f f ic ie n t  in converting paracetamol to i t s  reactive intermediates 
(Green & Fisher, 1984), a drug whose activa tion  is catalyzed only by 
cytochrome P-448 (Steele et al_., 1983) and oxygen free rad ica ls , but not 
by the PB-inducible cytochrome P-450. Genetica lly responsive inbred 
mice, which e xh ib it  high in d u c ib i l i t y  of cytochromes P-448 are more 
susceptible to 3-MC-induced tumorigenesis compared with non-responsive 
s tra ins (Kouri et a K , 1973, 1980). Furthermore, maintaining ra ts  
continuously fo r  ten generations on a d ie t containing the 
hepatocarcinogen 3'-methyl-4-dimethylaminoazobenzene led to se lection 
of carcinogen-resistant generations which exhibited low cytochrome P-448 
in d u c ib i l i t y  (Yoshimoto et a1_., 1985). Likewise, the guinea p ig , a 
species known to be res is tan t to chemical carcinogens, is  re la t iv e ly  
res is tan t to induction of cytochromes P-448 by 3-MC (Abe & Watanabe,
1982). In addition, the hepatotoxic potencies in chick embryo of a 
number of polychlorinated biphenyls have been shown to be corre la ted 
with th e ir  cytochrome P-448-inducing potencies as measured by EROD and 
AHH (R ifk ind et a]_., 1984). In view of the co rre la t io n  between
cytochrome P-448 levels and s u s c e p t ib i l i ty  to c a rc in o g e n ic i ty / to x ic i ty ,  
the a v a i la b i l i t y  of a re l ia b le  probe to measure cytochrome P-448 would be 
useful in id e n t ify in g  ind iv idua ls with high s u s c e p t ib i l i ty  to cancer, 
making imperative a reduction of th e ir  exposure to carcinogens and to x ic  
chemicals.
The most extensively used assay method fo r  cytochrome P-448 
a c t iv i t y  has been the f lu o r im e tr ic  determination of AHH, or more 
s p e c i f ic a l ly  benzo(a)pyrene hydroxylase a c t iv i t y ,  which uses 
benzo(a)pyrene as substrate (Dehnen et a l . ,  1973). However th is  assay 
favours the measurement of only certa in  metabolites tha t fluoresce 
s im i la r ly  to 3-hydroxybenzo(a)pyrene such as the 9-phenols (Holder et 
a l . ,  1975). Moreover, the metabolism of benzo(a)pyrene to d i f fe re n t  
metabolites is catalyzed by various isozymes; thus the AHH assay does 
not s p e c i f ic a l ly  re f le c t  cytochrome P-448 a c t iv i t y  (Deutsch et a l . ,  
1978; Guengerich, 1977; Guengerich et al_., 1982a; Abe & Watanabe,
1983). In addition , 3-hydroxybenzo(a)pyrene is  fu r th e r  metabolised by 
hepatic microsomal preparations with loss of fluorescence (P h il l ipso n  et 
a l . ,  1984) so tha t the amount of 3-hydroxybenzo(a)pyrene determined is  
the net e f fe c t  of AHH and of subsequent enzymic oxygenation. The assay 
is also associated with many technical d i f f i c u l t i e s  including the 
influence of solvent used to dissolve the substrate and the 
preincubation conditions (Yang ^ t  a l . ,  1978), as well as the need fo r  an 
extraction procedure, which is both tedious and in e f f ic ie n t  (DePierre et 
a l . ,  1975; Yanget jil_., 1975).
The 2-hydroxylation of biphenyl is h igh ly spe c if ic  fo r  cytochrome 
P-448. Nevertheless, the methodology involved in biphenyl hydroxylase 
assay is in s u f f ic ie n t ly  sensitive because 4-hydroxybiphenyl, the major 
metabolite, also contributes towards the fluorescence at the wavelengths 
cha rac te r is t ic  of the 2-hydroxy de r iva tive , so that a correction fa c to r  
must be applied (Creaven et  ^ a K , 1965). In add it ion , f luorescent
metabolites may be formed from the carcinogen under inves tiga tion  which 
in te r fe re  with the f lu o r im e tr ic  assay (Tong et aj_., 1977). Although 
these problems may be overcome by the use of high-pressure l iq u id
chromatographic techniques (Burke et aj_., 1977), these are cumbersome 
and time consuming. In contrast, ethoxyresorufin is s p e c i f ic a l ly  
O-deethylated to only one product, resoru fin  which is h igh ly  fluorescent 
and does not undergo fu r th e r  metabolism Jji v i t r o  (Phi 11ipson et a l . ,
1984). The O-deethylation reaction is  s p e c i f ic a l ly  catalyzed by 
cytochromes P-448 but not by the PB-inducible cytochromes P-450 
(Goldstein et al_., 1982; Guengerich et _al_., 1982a; Phi 111 pson et a l . ,  
1984; Astrom & DePierre, 1985).
In the present study, administration of small in trape ritonea l doses 
of (50-300 pg/kg) of benzo(a)pyrene to rats resulted in marked 
induction of EROD a c t iv i t y  even at the lowest dose. In fa c t ,  at 
50 pg/kg, only the O-deethylation of ethoxyresorufin was enhanced while 
the 2- and 4-hydroxyl ations biphenyl were unaffected. At a higher dose 
level (100 pg/kg), biphenyl 2-hydroxylase a c t iv i t y  was also induced. 
In contrast AHH showed only a small increase even at the highest dose 
(300 mg/kg) (Ph ill ipson  et a ^ . , 1984). These data support previous 
find ings (Burke & Mayer, 1974, 1975; Burke et a]_., 1977) tha t the 
f lu o r im e tr ic  assay of EROD a c t iv i t y  is the most sp e c if ic ,  sens it ive , 
rapid and reproducible means of determining cytochrome P-448 a c t iv i t y .
Results of the present study showed that maximal induction of 
cytochrome P-448 occurred at low doses, around 2-5 mg/kg, which suggests 
very low concentrations of the inducing agents at tissue le ve l.  At these 
low concentrations, i t  is un l ike ly  tha t these maxima re f le c t  saturation 
of one of the pharmacokinetic processes such as saturation of receptor 
binding s ites , but i t  probably re f le c ts  saturation of one of the 
processes leading to induction of the cytochrome P-448 a c t iv i t y  
fo llow ing the formation of the inducer-receptor complex.
I t  is known that cytochrome P-450 is present in higher
concentrations than the flavopro te in  NADPH-cytochrome P-450 reductase in 
endoplasmic membranes and that the molar ra t io  of cytochrome P-450 to 
NADPH-cytochrome P-450 reductase may be altered in response to induction 
by some xenobiotics. Drugs as exemplified by PB induce both cytochrome 
P-450 and i t s  reductase whereas induction by carcinogenic po lycyc lic  
hydrocarbons (e.g. 3-MC) increase only cytochrome P-448 content but not 
the reductase (Parke, 1983; P h i l l ip s  et , 1985). Since NADPH-
cytochrome P-450 reductase functions to trans fe r electrons from NADPH to 
cytochrome P-450, i t  is  conceivable tha t MFO a c t iv i t y  would be
influenced by the molar ra t io  of cytochrome P-450 to reductase. Indeed, 
recent studies using reconstitu ted MFO systems have demonstrated tha t 
the cytochrome P-448-mediated metabolism of benzo(a)pyrene exhibited 
maximal a c t iv i t y  when the ra t io  of cytochrome P-448 to reductase was 5:1; 
exceeding th is  ra t io  led to a decrease in c a ta ly t ic  a c t iv i t y  of 
cytochrome P-448 (Grishanova et a K , 1985). In agreement with th is ,
Domin and Phil pot (1986) showed that the addition of p u r i f ie d  NADPH- 
cytochrome P-450 reductase to TCDD-induced rabb it pulmonary microsomal 
preparations fu r th e r  enhanced benzo(a)pyrene hydroxylase and EROD 
a c t iv i t ie s  presumably by increasing the e f f ic ie n cy  of electron trans fe r 
to the haemoprotein.
The induction of cytochrome P-448 a c t iv i t y  is  not re s tr ic te d  to 
po lycyc lic  aromatic hydrocarbons and polychlorinated biphenyls, as 
chemical carcinogens of other kinds, such as aromatic amines (Steele & 
Ioannides, 1986), methylenedioxybenzene derivatives (Ioannides et a l . ,
1985) and aromatic amides (Astrom & DePierre, 1985) also stimulate th is  
a c t iv i t y  at doses as low as 0.5 mg/kg. However, the present study showed 
that maximal induction occurred at doses around 2-5 mg/kg, ind ica ting
that i t  is  possible that the inductive e f fe c t  of a compound may be missed 
because of the use of an inappropriate dose regimen. For example, 
maximal induction of cytochrome P-448 a c t iv i t y  by 2-AAF occurred at 
about 2 mg/kg and at higher doses, the extent of induction was 
d ra s t ic a l ly  decreased (F ig .7 .2b), possibly because of the hepato tox ic ity  
of the agent.
DMN is a potent hepatocarcinogen and hepatotoxin with an oral LD^q 
of 27-41 mg/kg in adu lt, male ra ts  (Shank, 1975). I t  is  now known to be 
m etabo lica lly  activated by an isozyme of cytochrome P-450 which is  
inducible by ethanol or acetone treatment but not by PB-cytochromes 
P-450 or cytochromes P-448 (Yang et a /L , 1985; Levin e ta l_ .,  1986), thus 
accounting fo r  the lack of induction of EROD a c t iv i t y  in the present 
study. At doses of 10 and 20 mg/kg in tra p e r i to n e a l ly ,  EROD a c t iv i t y  was 
in h ib ite d , possibly because of the hepato tox ic ity  of the inducing 
chemical.
MNNG is a potent a lky la t ing  carcinogen that does not require p r io r  
ac t iva t ion , thus accounting fo r  the lack of induction of cytochrome 
P-448 a c t iv i t ie s  in the present study.
K ine tic  studies have shown that in the ra t  l i v e r ,  mRNAs coding fo r  
cytochromes P-448 increased ra p id ly  a f te r  3-MC treatment, reaching a 
maximum a fte r  24 hours. AHH a c t iv i t y  lagged 10 hours behind the 
induction of cytochrome P-448 mRNA, reaching a maximum at 24 hours and 
remained at th is  level fo r  at least 48 hours even though cytochrome P-448 
mRNA level began to decline during th is  time period (Fagan et aj_., 1986). 
Likewise, a fte r  a single dose in tra p e r i to n e a l ly  of benzo(a)pyrene 
(5 mg/kg), EROD a c t iv i t y  increased to a maximum w ith in  24 hours and
declined the rea fte r to approach control values four days a f te r  
administration (F ig .7.3). Biphenyl 2-hydroxylase a c t iv i t y  increased 
more slowly, reaching a plateau around 24 to 48 hours a fte r  dosing and 
subsequently declined to control values. These data ind icate that in a l l  
our studies EROD a c t iv i t y  were measured at the time-point of maximal 
induction.
In summary, in the present study we have demonstrated tha t maximal 
induction of cytochrome P-448 a c t iv i t y  occurred at doses of 2-5 mg/kg of 
the inducing agent. This study also showed that the O-deethylation of 
ethoxyresorufin is  a more sensitive  index fo r  cytochrome P-448 a c t iv i t y  
than the 2-hydroxylation of biphenyl.
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CHAPTER 8:
INTERACTIONS OF CIMETIDINE AND NITROSOCIMETIDINE 
WITH HEPATIC AND EXTRAHEPATIC MICROSOMAL MIXED-FUNCTION 
OXIDASE ACTIVITIES IN THE RAT
INTRODUCTION
Cimetidine (N-cyano-N-methyl-N1-(2 -[5 -m e thy lim idazole-4-y l-
-m ethy lth io ]e thy l)guanid ine) is a H2-receptor antagonist which is 
widely used as an an ti-pep tic  ulcer drug. Studies have shown that i t  
in h ib i ts  the cytochrome P-450-mediated metabolism of several 
concomitantly administered drugs such as warfarin (Serlin  et a l . ,  
1979), diazepam (Koltz & Reimann, 1980), an tipyrine and aminopyrine
(Pelkonen & Puurunen, 1980, Dossing _et al_., 1983), carbamazepine
(Grasela & Rocci, 1984), theophylline (Roberts et a l . ,  1981; Grygiel 
et a l . ,  1984) and triazolam (B rit ton  & Waller, 1985). S tru c tu ra l ly ,  
cimetidine is a 4 ,5-substitu ted imidazole (Fig. 8.1) and such imidazole 
derivatives have been shown to be potent in h ib ito rs  of the hepatic 
microsomal MFO a c t iv i t ie s  (Wilkinson et a l . ,  1974). In v i t ro  studies 
have shown that cimetidine binds revers ib ly  to cytochrome P-450 to give 
a type I I  spectrum ind ica ting binding of cimetidine to the s ix th  ligand 
position of the haem part of cytochrome P-450 (Rendic et a l . ,  1979; 
Speeg et a l . ,  1982; Bast et a l . ,  1984), most l ik e ly  via the amino and 
imidazole nitrogens (Rendic et a l . ,  1979, 1983). R an it id ine , another 
H2-antagonist which does not contain the imidazole r ing , has a lower 
a f f in i t y  in te raction  with cytochrome P-450 and is a fa r  less potent 
in h ib i to r  of drug metabolism than cimetidine (Knodell et a l . ,  1982; 
Bast et a l . ,  1984; Rendic et a l . ,  1984; Hoensch et a l . ,  1985).
Several studies have suggested that cimetidine se le c t ive ly  in h ib i ts  
cytochrome P-448-mediated reactions such as the 3-MC-inducible 
benzo(a)pyrene hydroxylase (Drew et a l . ,  1981), 7-ethoxycoumarin
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F ig .8.1 CHEMICAL STRUCTURES OF CIMETIDINE, NITROSOCIMETIDINE,
RANITIDINE AND N-METHYL-N'-NITRO-N-NITROSOGUANIDINE
O-deethylase (Borm et a l . ,  1981) and caffe ine demethylation (Desmond et 
a l . ,  1980). Cimetidine has also been found to in h ib i t  the metabolism
of paracetamol to tox ic  intermediates (M itchell et a K , 1984), a
reaction which is s p e c i f ic a l ly  catalysed by cytochrome P-448 (Ioannides 
et a l . ,  1983; Steele et a l . ,  1983). However, there is as yet no report 
on the e ffec t of cimetidine on the O-deethylation of ethoxyresorufin, 
which is a h ighly spec if ic  and sensitive marker fo r  cytochrome P-448 
a c t iv i ty  (Goldstein et a l . ,  1982; Guengerich et a l .,1982a; Astrom & 
DePierre 1985). Furthermore, since cytochrome P-448 is associated with 
the activa tion  of tox ic  chemicals and carcinogens, i t  would be useful 
i f  cimetidine does in fac t s p e c i f ic a l ly  in h ib i t  cytochrome P-448 
a c t iv i ty ,  and hence the ac tiva tion  pathway.
Reports on a possible association of cimetidine with gas tr ic  
carcinoma (Elder et a l . ,  1979; Taylor et a l .,1979) has provoked some 
concern that n itrosa tion  of th is  N-substituted guanidine could form 
nitrosocimetid ine which has a chemical s tructure very s im ila r to that 
of the potent mutagen and gastric  carcinogen, 
N-methyl-N '-nitro-N-nitrosoguanidine (MNNG). Cimetidine can be read ily  
nitrosated to i ts  n itroso analogue in v i t ro  (Foster ef a l . ,  1980) and 
when incubated with n itra te-enriched human gastr ic  ju ice  gives r ise  to 
a mutagen (DeFlora & P icc io t to ,  1980). However, there is to date no 
d irec t evidence that n itrosocim etid ine is generated in v iv o . 
Nevertheless, a p o s s ib i l i t y  ex ists that small amounts of 
n itrosocimetid ine may be generated in the stomachs of patients taking 
cimetidine o ra l ly  (Fine et a l . ,  1977; Ohshima & Bartsch, 1981).
The present study was undertaken to investigate the e ffec ts  of
cimetidine and n itrosocim etid ine on cytochrome P-448 a c t iv i t y ,  using 
the O-deethylation of ethoxyresorufin as a spec if ic  probe, and also on 
other hepatic microsomal MFO a c t iv i t ie s  in ra ts . The effects  of in 
vivo cimetidine and n itrosoc im etid ine administered to rats on the 
a b i l i t y  of PB- or 3-MC-induced hepatic S9 frac tions  to activate 
,benzo(a)pyrene into mutagenic intermediates were also studied.
MATERIALS AND METHODS 
Animal treatment
Cimetidine, n itrosocim etid ine and PB were dissolved in normal 
saline and 3-MC was dissolved in corn o i l .  Cimetidine and 
n itrosocim etid ine were administered to male Wistar albino rats 
(150-200g) in tra p e r i to n e a l ly  at doses of 50 mg/kg da ily  (single dose), 
100 mg/kg da ily  (s ing le dose) or 100 mg/kg da ily  fo r  3 consecutive 
days. Animals were k i l le d  24 hours a fte r the last in jec t io n .
In the study on the metabolic ac tiva tion  of benzo(a)pyrene, animals 
were treated with PB (80 mg/kg) or 3-MC (25mg/kg) in tra p e r i to n e a l ly  fo r  
3 consecutive days. At 23 hours a fte r the last in je c t io n , animals 
received 100 mg/kg in t ra p e r i to n e a l ly  of e ither cimetid ine or 
n itrosocimetid ine or an equal volume of normal saline (contro ls) and 
then sacr if iced  by cervica l d is loca tion  one hour la te r .
Preparation of microsomes
Hepatic post-mitochondrial supernatants and microsomal suspensions 
were prepared as previously described (Chapter 2). Microsomes from 
kidney tissues were prepared using the same procedure as fo r hepatic
microsomes. The lungs were f i r s t  homogenized in a polytron homogenizer 
p r io r  to homogenization in a Potter-Elvehjem homogenizer; a l l  
subsequent steps were the same as those fo r the preparation of hepatic 
microsomes.
Enzyme assays
Benzphetamine N-demethylase and biphenyl 2- and 4-hydroxylases were 
determined on the post-mitochondrial supernatant; EROD, 
NADPH-cytochrome c reductase, cytochromes P-450 and b5 and protein were 
determined on the microsomal suspension. Detailed methodology is
described in Chapter 2.
The ac tiva tion  of benzo(a)pyrene to mutagens in the Ames tes t was 
carried out as described in Chapter 2.
RESULTS
Cimetidine administered as a single dose of 50 mg/kg body weight 
had no e ffe c t on EROD a c t iv i t y  e ithe r in hepatic or extrahepatic 
microsomes (Table 8 .1 ). There were also no changes in cytochrome P-450 
and microsomal protein contents in the l iv e r ,  kidney and lung tissues. 
The same dose of n itrosocimetid ine induced EROD a c t iv i t y  in hepatic 
microsomes 2 - fo ld , but had no s ig n if ic a n t  e ffec t on a c t iv i t ie s  in the 
kidney and lung microsomes (Table 8.2).
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Increasing the dose of cimetidine to 100 mg/kg body weight da ily  
fo r  3 days also did not a ffec t EROD a c t iv i t y ,  biphenyl 2- and 
4-hydroxylase nor benzphetamine N-demethylase a c t iv i t ie s  in the l iv e r  
(Table 8 .3 ). Nitrosocimetid ine administered at the same dosage regimen 
enhanced biphenyl 2-hydroxylase a c t iv i t y  while benzphetamine 
N-demethylase a c t iv i t y  was in h ib ite d ; EROD a c t iv i t y  was unchanged 
(Table 8.3) NADPH-cytochrome c-reductase, cytochromes P-450 and b5 and 
microsomal protein contents were not altered with in e ithe r cimetidine 
or n itrosoc im etid ine-treated animals compared with untreated contro ls .
Administration of e ither cimetidine or n itrosocim etid ine at a dose 
level of 50 mg/kg body weight to PB-treated animals inh ib ited  hepatic 
microsomal O-deethylation of ethoxyresorufin but did not a l te r  other 
enzyme a c t iv i t ie s  compared with PB-treated controls (Tables 8.4 & 8 .5 ).
In 3-MC-treated animals, c imetidine enhanced NADPH-cytochrome 
c-reductase a c t iv i t y  compared with 3-MC-treated con tro ls . 
Benzphetamine N-demethylase a c t iv i t y  was increased but was not 
s t a t is t i c a l l y  s ig n if ic a n t  (Table 8 .4). Administration of
n itrosocim etid ine to 3-MC-treated animals did not a l te r  any of the 
microsomal MFO a c t iv i t ie s  (Table 8.5).
The S9 frac tions  from PB-treated animals did not read ily  activate 
benzo(a)pyrene to mutagenic intermediates. Administration of 
cimetidine to PB-treated animals one hour p r io r  to s a c r i f ic e  did not 
a ffec t the metabolic ac tiva tion  of benzo(a)pyrene by S9 frac t ions  
compared with PB-treated controls (Fig. 8.2). The S9 frac tions  from
3-MC-treated animals exhibited higher benzo(a)pyrene ac tiva t ing  
a b i l i t y  than those obtained from PB-treated animals.
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F ig .8.2 EFFECT OF CIMETIDINE ON THE
METABOLIC ACTIVATION OF BENZO(A)PYRENE 
TO MUTAGENS IN THE AMES TEST.
Animals were treated with phenobarbital 
80mg/kg i . p .  d a i ly  fo r  3 days (o ),  followed 
by c imetid ine 100mg/kg i . p .  one hr. p r io r  
to s a c r i f ic e  (a ) s or 3-methylcholanthrene 
25mg/kg i . p .  d a i ly  fo r  3 days ( • ) ,  followed 
by cimetidine 100mg/kg i .p .  one hr. p r io r  
to s a c r if ic e  (a ). Salmonella typhimurium 
s tra in  TA-100 was used. Results are presented 
as the mean ± S.E.M. fo r  t r ip l i c a t e  plates 
a f te r  the spontaneous reversion rate (ranged 
93-127 h is t id in e  revertants per p la te) had 
been subtracted.
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F i g . 8 . 2
Again, administration of cimetidine had no s ig n if ic a n t  e ffec t on 
the benzo(a)pyrene-activating a b i l i t y  of the hepatic S9 frac t ions  
compared with those of 3-MC-treated controls (Fig. 8.2).
Administration of n itrosocim etid ine to e ith e r PB-or 3-MC-treated 
animals one hour p r io r  to s a c r if ice  did not exert any e f fe c t  on the 
m e tabo lic -ac tiva t ing  a b i l i t y  of the hepatic S9 frac t ions  compared to 
those obtained from PB- or 3-MC-treated controls (Fig. 8 .3).
DISCUSSION
Studies in v i t r o  with hepatic microsomes and p u r if ie d  cytochrome 
P-450 preparations indicate that cimetid ine undergoes d ire c t  binding to 
cytochrome P-450 through i ts  imidazole ring structure (Rendic et a ! . ,  
1979, 1983, 1984; Speeg et a ! . ,  1982; Bast et a ! . ,  1984) and that th is  
may be the mechanism by which cimetidine exerts i ts  in h ib i to ry  e ffe c t 
on hepatic microsomal oxidation . The work of Jensen and Gugler (1985) 
fu r th e r indicated that a complex of cytochrome P-450 with cimetid ine or 
i ts  active intermediate metabolite was formed in v iv o . An active 
metabolite other than cimetidine sulphoxide may be involved since the 
sulphoxide has already been shown to be a weak in h ib i to r  of ox idative  
drug metabolism (Speeg et a l . ,  1982; M itche ll et a l . ,1984).
Recent evidence indicated the existence of two d is t in c t  classes of 
cimetidine binding s ites in rat and human l iv e r  microsomes, a low 
a f f in i t y  and a high a f f in i t y  binding type with d issocia tion constants 
of about 8 yM and 100 yM respective ly (R e i l ly  et a l . ,  1983; Ioannoni
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F ig .8.3 EFFECT OF NITROSOCIMETIDINE ON THE
METABOLIC ACTIVATION OF BENZO(A)PYRENE 
TO MUTAGENS IN THE AMES TEST.
Animals were treated w ith phenobarbital 80mg/kg 
d a i ly  i .p .  fo r  3 days (o ),  followed by n itrosocim etid ine 
lOOmg/kg i .p .  one hr. p r io r  to s a c r i f ic e  (a ) ,  
or 3-methylcholanthrene 25mg/kg d a i ly  i . p .  
fo r  3 days ( • ) ,  followed by n itrosocim etid ine 
100mg/kg i .p .  one hr. p r io r  to s a c r i f ic e  (a ).
Salmonel1 a typhimuriurn s tra in  TA-100 was used.
Results are presented as the mean ± S.E.M. 
fo r  t r ip l i c a te  plates a f te r  the spontaneous 
reversion rate (78 h is t id in e  revertants per 
p la te) had been subtracted.
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et a l . ,  1986). The class of s ites with high a f f in i t y  fo r cimetidine 
requires a l ip o p h i l ic  environment fo r  i ts  expression whereas the low 
a f f in i t y  class shows less s e n s i t iv i t y  to the presence of phospholipid 
(Ioannoni et a l . ,  1985). A fte r normal therapeutic dosage (20 mg/kg 
d a i ly ,  o ra l ly ) ,  peak plasma levels of cimetidine ty p ic a l ly  reaches 4-10 
pM, suggesting that - inh ib it ion  of ox idative drug metabolism observed 
c l in i c a l l y  with cimetidine results from i ts  high a f f in i t y  in te raction
with c imetid ine. In contrast, in v i t ro  studies with l iv e r  microsomes 
generally require concentrations of cimetidine in the m il l im o la r range 
fo r in h ib i t io n  of drug metabolism to be observed (Pelkonen & Puurunen, 
1980; Puurunen et a l . ,  1980; Knodell et a l . ,  1982; Speeg et a l . ,  1982) 
ind ica ting that the in te rac tion  being studied is most l ik e ly  that 
between the drug and the weaker, c l in i c a l l y  irre levan t class of binding 
s i te .
Studies have now shown that cimetid ine exh ib its  d i f fe re n t  
a f f in i t ie s  towards the m u lt ip le  forms of cytochrome P-450 (Pelkonen & 
Puurunen, 1980; Drew et a l . ,  1981; Ioannoni et a l ., 1983; Grygiel et_
a l . ,  1984; Shaw et a l . ,  1986). Thus PB- and 3-MC-inducible isozymes of
cytochrome P-450 have lower binding a f f in i t ie s  fo r  cimetidine compared 
with the co n s t itu t ive  forms (Ioannoni et a l . ,  1983). Recent studies in 
man have shown that cimetidine se le c t ive ly  inh ib ited  the 1- and 
3-demethyl at ion of theophylline but had no e ffec t on the 8-oxidation
reaction (Grygiel et a l . ,  1984). Further to th is ,  Shaw and coworkers 
(1986) found that in ra t ,  cimetidine inh ib ited  the
3-methylhydroxylation and N-demethylation of an tipyrine , but the
4-hydroxylation reaction was unaffected. The studies of Ioannoni and
coworkers (1986) fu r th e r  indicate that cimetidine acts both as an 
inducer and an in h ib i to r  of cytochrome P-450. Thus, treatment with 
cimetidine can a l te r  the re la t iv e  abundance of cytochrome P-450 
isozymes, and impairment of ox idative drug metabolism resu lts  from a 
decrease in the proportion of those isozymes cata lyzing these 
reactions.
In the present study, cimetidine treatment had no s ig n if ic a n t  
e ffec t on hepatic microsomal benzo(a)pyrene hydoxylase a c t iv i t y  as 
measured by the metabolic ac tiva tion  of benzo(a)pyrene in the Ames 
assay. In addition neither acute nor repeated administration of 
cimetidine affected PB-cytochromes P-450-or cytochrome P-448-mediated 
MFO a c t iv i t ie s  in the ra t .  This is in contrast to the resu lts  of 
previous studies which cons is tently  showed that cimetidine was an 
in h ib i to r  of microsomal drug metabolism (Serlin et a l . ,  1979; Pelkonen 
& Puurunen, 1980; Desmond et a l . ,  1980; Drew et a l . ,  1981; Speeg et
a l . ,  1982; Grasela & Rocci, 1984; Solangi et a K ,1984). This
discrepancy may be a ttr ibu ted  to differences in the dosage regimens 
employed. In the present study, the highest dose of cimetidine 
employed was 100 mg/kg body weight d a i ly  in tra p e r i to n e a l ly  fo r  three 
days whereas previous workers have used higher dose levels fo r  longer 
periods. Thus, cimetidine administered at 75 mg/kg subcutaneously 
three times da ily  fo r six days led to in h ib i t io n  of hepatic microsomal 
benzo(a)pyrene hydroxylase a c t iv i t y  in the ra t (Pelkonen & Puurunen
1980). In another study, cimetidine administered to rats at 165 mg/kg 
in tra p e r ito n e a lly  four times da ily  fo r  two days resulted in in h ib i t io n  
of hepatic microsomal an il ine  hydroxylase and aminopyrine N-demethylase 
a c t iv i t ie s  (Solangi et a l . ,  1984).
The lack of e ffects  of cimetidine on microsomal enzyme a c t iv i t ie s  
in the present study may also be due to the fac t that animals were 
k i l le d  24 hours .a fte r the last dose. Indeed, i t  has been observed that 
the in h ib i to ry  e ffe c t of cimetidine has a rapid onset, occurring w ith in  
hours of a single dose and recovery is w ith in  24 hours a fte r withdrawal 
of treatment (Drew et a l . ,  1981; Patwardhan et a l . ,  1981; Speeg et a l . ,  
1982; Dossing et a l . ,  1983; Grasela & Rocci 1984; Plummer et a 1. ,
1984). Nevertheless, administration of cimetid ine to PB- or
3-MC-treated animals one hour p r io r to sa c r if ice  did not a ffec t the 
metabolic ac t iva t ion  of benzo(a)pyrene by S9 frac tions  compared to PB- 
or 3-MC-treated controls (Fig. 8.2).
When cimetidine or n itrosocimetid ine was administered to PB-treated 
rats and the animals k i l le d  one hour la te r ,  in h ib i t io n  of hepatic 
microsomal EROD a c t iv i t y  compared with PB-treated animals was 
observed. However, cimetidine and n itrosocimetid ine in the same dose 
regimen, did not a ffec t EROD a c t iv i t y  in 3-MC-treated animals. This 
d i f fe re n t  a c t iv i t y  in 3-MC-treated animals is consistent with the
suggestion that the in h ib i to ry  e ffects  of cimetidine depends on the 
d if fe re n t  isozyme patterns of microsomes.
In summary, the resu lts  of our present study indicate that at the dose 
levels employed, which at 100 mg/kg body weight per day is equivalent 
to f iv e  times the oral therapeutic dose of cimetidine in man (20
mg/kg/day), cimetidine and n itrosocimetid ine are at best only very weak
in h ib i to rs  of microsomal oxidative drug-metabolizing a c t iv i t ie s .  The 
lack of e ffects  of these compounds on other microsomal MFO parameters 
such as NADPH-cytochrome c-reductase, cytochromes P-450 and b5 and 
protein contents were in agreement with previous find ings (Pelkonen & 
Puurunen,1980; Drew et a l ., 1981). However, in man, normal therapeutic 
use of cimetid ine involves m u lt ip le  d a i ly  doses administered fo r  
prolonged periods, hence the dosage regimens used in th is  study do not 
re f le c t  f u l l y  the c l in ic a l  s itu a t io n .
CHAPTER 9: 
GENERAL DISCUSSION
There is now convincing evidence that the PB-inducible cytochromes 
P-450 and cytochromes P-448 are d is t in c t  enzyme systems ra ther than ju s t  
isozymes. They are products of d is t in c t  s truc tu ra l genes which are 
located on d i f fe re n t  chromosomes (Hardwick et a /L , 1983; Simmons & 
Kasper, 1983; Tukey et _al_., 1984), and the mRNAs encoding PB-cytochromes 
P-450 and cytochromes P-448 share very low homology in th e i r  coding 
nucleotide sequences (M orv il ie  et a /L , 1983). Furthermore, the primary 
amino acid sequences of PB-cytochromes P-450 and cytochromes P-448 are 
d i f fe re n t ,  sharing only 30% s im i la r i t y  in general (Kawajir i et a l . ,  
1984; Sogawa et aj_., 1985), and are immunologically d is t in c t  (Thomas et 
a l . ,  1984; Reik et aT. ,  1985). These two gene fam ilies  are also under 
d i f fe re n t  regulatory control and are expressed independently during 
ontogenic development. Thus, the PB-cytochrome P-450-dependent 
benzphetamine N-demethylase a c t iv i t y  is low at b ir th  but increases with 
age while, in contrast, the cytochrome P-448-dependent biphenyl
2-hydroxylase and EROD a c t iv i t ie s  are higher in the neonate, reaching 
maximum levels at about two weeks postpartum and decline with age 
(Chapter 3). Notably, the age-related development of cytochrome P-448 
a c t iv i t y  appears to pa ra l le l the ontogeny of the Ah receptor in ra t  
l i v e r ;  Ah receptor concentrations were very low or undetectable p r io r  to 
b i r th ,  increased postna ta lly  to maximal levels at 1 to 3 weeks a f te r  
b i r th  and then declined with age (Gasiewiez et aj_., 1984).
The most s t r ik in g  and indeed the most important d iffe rence between 
PB-cytochromes P-450 and cytochromes P-448 l ie s  in th e i r  substrate 
binding s ites  and substrate s p e c i f ic i t ie s .  PB-Cytochromes P-450 accept 
a wide range of substrates which are g lobular, bulky and generally 
f le x ib le  in th e ir  molecular conformation whereas cytochromes P-448 
p re fe re n t ia l ly  in te rac t with a much narrower range of substrates which
are r ig id ,  planar molecules with a large area/depth ra t io  ( Phi 11ipson et 
a l . ,  1982; Lewis £ t  aj_., 1986). Furthermore, metabolism by
PB-cytochromes P-450 leads to the formation of less tox ic  products. In 
contrast, metabolism by cytochromes P-448 almost inva r iab ly  involves 
oxygenation at conformationally hindered positions resu lt ing  in the 
formation of tox ic  metabolites which, being less re ad ily  conjugated by 
epoxide hydrolase or g lutath ione transferase, become availab le to 
in te rac t with c e l lu la r  macromolecules, leading to c e l lu la r  
to x ic i ty /c a rc in o g e n ic ity  (Parke & Ioannides, 1982).
Induction of cytochrome P-448 is now known to be mediated v ia  
binding of the inducing agent with a cy toso lic  receptor, termed the Ah 
receptor (Nebert, 1985). There is now convincing evidence fo r  the ro le  
of the Ah receptor in mediating induction of cytochrome P-448. Thus, in 
a series of polychlorinated biphenyls, the coplanar de riva tives , 
substituted at both para- and meta-positions, bind with the highest 
a v id ity  to the Ah receptor and are the most potent inducers of 
cytochromes P-448 as measured by the increase in EROD a c t iv i t y  (Safe et 
a l . ,  1985). The mono-ortho analogues, which are less planar, bind to the 
receptor with lower a v id ity  and. are "mixed-type" inducers, increasing 
the levels of both PB-cytochromes P-450 and cytochromes P-448. When two 
ortho chloro-substituents are introduced, there is a marked loss of 
cop lanarity  accompanied by poor cytochrome P-448 induction potency; 
instead these analogues induce PB-cytochromes P-450 (Safe e t ^ . ,  1985). 
Furthermore, excellent corre la t ions have been shown between the 
area/depth ra tios  of the polychlorinated biphenyls with th e i r  binding 
a v id ity  to the Ah receptor, and also with th e ir  cytochrome P-448 
induction potencies as determined by an increase in EROD a c t iv i t y  (Parke 
et a l . ,  1986).
Further to th is ,  studies have shown a corre la t ion  between the 
induction of cytochrome P-448 and chemical to x ic i ty /ca rc in o g e n ic ity .  
For instance, the Ah response mice are more susceptible to  PAH-induced 
tumorigenesis and other chemically-induced to x ic i t y  (Nebert et a l . ,  
1979; Nebert, 1981; Lubet et a /L , 1983; Silkworth et a /L , 1984).
Moreover, coplanar polychlorinated biphenyls which are potent inducers 
of cytochromes P-448 are h igh ly  to x ic ,  whereas the non-planar congeners 
such as 2 ,2 1,4 ,4 ‘ -te trachlorobiphenyl which are PB-type cytochrome P-450 
inducers are re la t iv e ly  non-toxic (Safe et a /L , 1985). In the present 
study, i t  was shown that carcinogens, but not th e ir  non-carcinogenic 
analogues, enhanced cytochrome P-448 as determined by the EROD assay. 
Moreover, only carcinogens that are m etabo lica lly  activated by 
cytochrome P-448 were e f fe c t iv e  inducers of the enzyme (Chapter 4). 
This is compatible with the find ings of Lewis and co-workers (1986) tha t 
spec if ic  substrates and inducers of cytochrome P-448 possess s im ila r  
molecular dimensions. These data ind icate that the substrate binding
s i te  of cytochrome P-448 may e xh ib it  s truc tu ra l s im i la r i t ie s  to the Ah 
receptor s i te .  Thus, chemicals which f i t  in to  the cytochrome P-448 
active s i te  and are consequently metabolized to reactive intermediates, 
are also l i k e ly  to bind to the Ah receptor and e l i c i t  an increase in the 
de novo synthesis of the ac tiva ting  enzymes, thereby re su lt in g  in
autocatalysi s .
In view of the co rre la t ion  between the induction of cytochrome 
P-448 and chemical to x ic i ty /c a rc in o g e n ic i ty ,  i t  has been suggested tha t 
the tes t fo r  cytochrome P-448 inducing potency, coupled with 
quan tita t ive  s t r u c tu ra l -a c t iv i ty  re la t ionsh ip  studies, may be employed 
along with the Ames tes t and other short-time tests fo r  mutagenicity as a 
general ind ica tion  of chemical to x ic i ty /c a rc in o g e n ic ity  (Parke et a l . ,
1986). The commonly used short-term mutagenicity tests measure DNA 
lesions as the end-point. On the other hand, the EROD assay uses a 
biochemical end-point, tha t of induction of cytochrome P-448, which is  a 
step p r io r  to the manifestation of to x ic  e f fe c ts ,  and hence is l i k e ly  to 
be a more sens it ive  ind ica to r .  Our present studies provide evidence tha t 
the EROD assay is  a h igh ly spec if ic  and sensitive probe fo r  monitoring 
cytochrome P-448 a c t iv i t y .  S tru c tu ra l ly ,  ethoxyresorufin is a planar 
molecule with a high area/depth ra t io  (34.1) and a small depth (3.9 8 ), 
and hence f i t s  in to  the molecular dimensions required fo r  the spec if ic  
substrates of cytochrome P-448 (Lewis et a l . , 1986). The 0-deethylation 
of ethoxyresorufin has been shown to be catalyzed s p e c i f ic a l ly  by 
cytochrome P-450c and to a much lesser extent (5%) by cytochrome P-450d 
(Goldstein et _al_., 1982; Guengerich £ t  _a]_., 1982a; Astrom & DePierre,
1985). Moreover, high corre la t ions have been obtained between induction 
of EROD a c t iv i t y  and that of cytochrome P-450c protein as determined by 
immunochemical techniques (Kaminsky et al_., 1983; Astrom et a]_., 1986). 
Furthermore, studies in responsive and non-responsive s tra ins  of mice 
ind icate that the EROD a c t iv i t y  is  associated with the Ah locus 
(Chapter 5).
Results of our present investiga tion  (Chapter 4) showed tha t 
carcinogen pretreatment in the ra t enhanced EROD a c t iv i t y  most markedly 
in the l iv e r ,  and to a much smaller extent, in the kidney and lung. 
Induction of EROD a c t iv i t y  is also species-dependent, the male ra t  being 
more sensitive than the hamster or mouse (Iwasaki et al_., 1986). In 
addition , enhancement of a c t iv i t y  was achieved by very small doses of the 
inducing agent which is consistent with the concept of a receptor- 
mediated induction process. Doses as low as 50 yg/kg in the case of 
benzo(a)pyrene resulted in 100% induction of EROD a c t iv i t y  (Chapter 7).
The EROD a c t iv i t y  was also s ig n i f ic a n t ly  enhanced by sing le 
in traperitonea l doses of 0.5 mg/kg of 2-AAF or sa fro le . Maximum 
induction was achieved at dose levels of 2-5 mg/kg, with peak a c t iv i t y  
occurring 24 hours a fte r  dosing. Based on these re su lts ,  an appropriate 
dose regimen may be selected fo r  tes t ing  the cytochrome P-448 inducing 
potency of a chemical.
In contrast to ethoxyresorufin, the pentoxy-analogue is  a good 
substrate fo r  PB-cytochromes P-450 (Chapter 6). Hence, pentoxyresorufin 
dealkyl ation may be superior to benzphetamine N-demethylase fo r  
determining the PB-inducible forms of cytochrome P-450 (Burke e t a l . ,  
1985; Lubet et , 1985). Furthermore, recent evidence have shown tha t 
benzphetamine N-demethylase a c t iv i t y  is  not spec if ic  fo r  PB-cytochromes 
P-450 since other forms of cytochrome P-450 may also catalyse the 
reaction. For instance, a co n s t i tu t ive  male-specific form iso la ted from 
mouse l iv e r  which p re fe re n t ia l ly  catalyses testosterone 16a - 
hydroxylation, also exh ib its  high a c t iv i t y  towards the N-demethylation 
of benzphetamine (Harada & Negishi, 1984a).
In our present study, carcinogens induced the dealky la tion of the 
short-chain alkoxyresorufins to a greater extent than did the long-chain 
derivatives (Chapter 6). In addition , microsomes of DDT-treated animals 
exhibited high a c t iv i t y  towards heptoxyresorufin dea lky la t ion , 
ind ica ting  that DDT may induce an isozyme(s) of cytochrome P-450 which is 
d is t in c t  from those induced by other known inducers. Thus, the 
alkoxyresorufins may be useful probes fo r  the study of cytochrome P-450 
isozymes.
Since cytochrome P-448 is associated with the ac tiva tion  of tox ic  
chemicals and carcinogens, i t  would be desirable i f  a chemical can be 
found which s p e c i f ic a l ly  in h ib i ts  cytochrome P-448 a c t iv i t y  and hence, 
the ac tiva tion  pathway. Several reports have shown tha t cimetidine 
in h ib i ts  hepatic drug metabolism by v ir tu e  of i t s  in te rac t io n  with 
cytochrome P-450 (Koltz & Reimann, 1980; Drew et a K , 1981; Grasela & 
Rocci, 1984; M itche ll et _aK, 1984). Moreover, as a widely used a n t i ­
peptic ulcer drug, i t s  to x ic i t y  has already been well tested. This led 
us to investigate  whether cimetidine is a spec if ic  in h ib i to r  of 
cytochrome P-448 a c t iv i t y .  Since j_n v i t r o  studies ind ica te  tha t 
n itrosocim etid ine may be formed via n itrosa tion  of c imetid ine in the 
human stomach during cimetidine treatment (Fine, 1978; Ohshima & 
Bartsch, 1981), n itrosocimetid ine was also studied fo r  possible 
in h ib i to ry  e ffec ts  on EROD a c t iv i t y .  However, our studies showed tha t 
these compounds had no s ig n if ic a n t  e ffe c t on EROD a c t iv i t y  in ra ts  even 
when administered at f iv e  times the normal oral therapeutic dose of man 
(Chapter 8).
Another point of s ign if icance which was observed in the present 
study is that cytochrome P-448 appears to be the predominant form in 
foe ta l l iv e r  and is gradually replaced by PB-cytochrome P-450 
postna ta lly . Previous f ind ings also showed the presence of an MFO system 
capable of ac tiva ting  benzo(a)pyrene in to  reactive intermediates in 
embryonic tissues from responsive, but not from non-responsive, mice 
( F i l le r  & Lew, 1981; Pedersen et a K , 1985). Hence, although the 
placental b a rr ie r ,  and placental detoxication such as conjugation, may 
protect the foetus from tox ic  intermediates, PAH compounds tha t reach 
the foetus would be activated j_n s i t u , resu lt ing  in the formation of 
embryotoxic intermediates.
Furthermore, i t  is conceivable that the foetus and neonate may be 
p a r t ic u la r ly  susceptible to the to x ic i t y  of chemicals which are 
activated by cytochromes P-448. In agreement with th is ,  recent studies 
have shown tha t the neonatal ra t  has a higher capacity to  generate 
reactive intermediates from paracetamol than the adult animals (Green & 
Fisher, 1984). In contrast, PB-cytochrome P-450 dependent a c t iv i t ie s '  
and detoxication pathways such as glucuronidation are lacking in 
embryonic tissues (Fantel et a K , 1979; A llen et j f L ,  1981; F i l l e r  & Lew,
1981). The absence, or low a c t iv i t y ,  of de tox ify ing  enzymes in the 
foetus appears to be a protective mechanism since any water-soluble 
metabolites formed by the foetus would accumulate in the amniotic f l u id  
instead of d if fu s in g  in to  the maternal c irc u la t io n  to be excreted.
Although the ro le of cytochrome P-448 in the ac tiva t ion  of to x ic  
chemicals and carcinogens is now well-estab lished, i t s  physio logica l 
ro le  is yet to be id e n t i f ie d .  The early  appearance of th is  enzyme during 
ontogeny indicates i t s  involvement in a v i ta l  physio logica l ro le ,  
possibly in the biogenesis of s tero id hormones and prostaglandins, since 
these pathways necessitate oxygenation at s te r ic a l ly  hindered positions 
and cytochrome P-448 has indeed been shown to catalyze the (w-1) and 
(w-2) hydroxylation of prostaglandins (Holm et aj_., 1985). Any
involvement of cytochrome P-448 with foreign chemicals is fo r tu i to u s ,  
leading to the accumulation of tox ic  metabolites, a key event which 
through evolutionary pressures gradually resu lts  in the natural 
selection of enzyme variants capable of oxygenating chemicals at non­
hindered positions (Ioannides & Parke, 1986).
In conclusion, the resu lts  of our present investiga tions showed 
that the induction of cytochrome P-448 may be used as a general
ind ica tion  of chemical to x ic i ty /c a rc in o g e n ic ity  and confirmed that the 
O-deethylation of ethoxyresorufin is  a more spec if ic  and sensitive  index 
of cytochrome P-448 a c t iv i t y  than the 2-hydroxylation of biphenyl. In 
addition , the determination of the tissue levels of cytochrome P-448 
a c t iv i t y  may be a useful marker fo r  id e n t i fy in g  subjects with high 
s u s c e p t ib i l i ty  to chemical-induced to x ic i ty /c a rc in o g e n ic ity .  To th is  
e f fe c t ,  paracetamol has been shown to be p re fe re n t ia l ly  activated by 
cytochromes P-448 (Steele et a]_., 1983). Animals pretreated with 3-MC 
showed increased urinary excretion of thio-products derived from 
reactive intermediates of paracetamol (Gemboys & Mudge, 1981). 
Furthermore, patients maintained on drugs which are PB-type inducers of 
cytochrome P-450 exhibited shorter paracetamol h a l f - l i f e  associated with 
increased glucuronidation (Prescott et a K , 1981). Thus, paracetamol 
may be a p o te n t ia l ly  useful ind ica to r fo r  monitoring cytochrome P-448 
a c t iv i t y  in subjects who may be exposed occupationally or 
environmentally to chemical carcinogens. Indeed, c iga re tte  smoking has 
been demonstrated to induce cytochrome P-448 a c t iv i t y  in human l iv e r  
(Pelkonen et a]_., 1987).
An appreciation of the s tructure of the Ah receptor w i l l  enable the 
design of chemicals which do not induce cytochrome P-448 and which are 
not substrates of the enzymes, and hence are u n l ike ly  to cause t o x ic i t y  
or carc inogenic ity . Chemicals which bind av id ly  to the Ah receptor but 
do not induce cytochromes P-448 w i l l  also be useful as in h ib i to rs  of 
cytochrome P-448 induction, and consequently, of cytochrome P-448- 
medi ated to x ic i ty /c a rc i  nogenici t y .
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